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miRNAs are short, non-coding RNA molecules that regulate gene expression post-
transcriptionally through inhibition of translation and/or mRNA degradation.
Mammalian development is a complex series of developmental transitions, which
relies on accurate spatial and temporal regulation of gene expression and we are
interested in the role that miRNAs may play in these developmental transitions.
An initial objective was to establish which, if any, miRNAs were dynamically
regulated in a cell model of an early developmental transition, and to establish
whether differential expression of any particular miRNA played a functional role
in this developmental process. Having established a role for specific miRNAs,
further objectives were to assess the reliability of current miRNA-mRNA target
identification procedures and to assess the general role of miRNAs in cellular
differentiation.
In order to explore the roles of miRNAs during an early developmental transition,
an embryonic stem (ES) cell model of trophectoderm differentiation was used. In
this model system the expression of the key ES cell regulatory gene, Oct4, can be
conditionally repressed, which induces the ES cells to differentiate down the tro-
phectoderm lineage. The expression of microRNAs was profiled in this model sys-
tem by cloning and sequencing of small RNAs. This approach identified miRNAs
that were dynamically regulated during differentiation. The expression patterns
of differentially regulated miRNAs were confirmed by miRNA northern analysis.
The miRNA profiling data showed that mmu-miR-294 and mmu-mir-295 are
expressed at similar levels in ES cells and differentiated cells, which disagrees
with previous reports that these miRNAs are ES cell specific. Several of the
miRNAs with higher expression levels in differentiated cells are encoded within
a placental-enriched polycomb group gene, Sfmbt2, suggesting an important role
for these miRNAs in extraembryonic development. One of the miRNAs that was
expressed at higher levels in ES cells than in differentiated cells, mmu-miR-92a,
was shown to play a role in regulation of cell proliferation.
Three current methods of identifying miRNA targets were assessed. A sequence-
based method using the web-based utility miRecords, which amalgamates results
from numerous target prediction databases, was used to generate lists of poten-
tial targets of the Sfmbt2 miRNA cluster and of mmu-miR-92a. Amalgamating
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results from multiple target prediction programs may improve the likelihood that
the predicted targets are real. Exemplifying this, the single mmu-miR-92a target
that was predicted by six different target prediction programs had been pre-
viously experimentally verified. An experimental method of identifying direct
miRNA targets, PAR-CLIP, was investigated but proved technically limiting for
routine use in the laboratory. A proteome-based experimental method for iden-
tifying potential miRNA targets, called SILAC, was successfully used to identify
proteins that were differentially expressed in the cell model of trophectoderm dif-
ferentiation. Differential expression of two of these proteins, CTBP2 and CKB,
was confirmed by western analysis. miRecords was then used to assess whether
the differentially expressed proteins were likely to be targets of the differentially
expressed miRNAs that had been identified in the miRNA profiling analysis.
The general role of miRNAs in cell differentiation was investigated using a cell
line that does not express miRNAs. This ES cell line is deficient for the miRNA-
processing enzyme DGCR8, which results in loss of expression of mature miR-
NAs in these cells. Compared to wild type ES cells, miRNA-deficient ES cells
expressed normal levels of the ES cell marker genes Oct4 and Sox2 but elevated
levels of Nanog. In contrast to wild type ES cells, miRNA-deficient ES cells
did not upregulate the mesoderm marker gene Brachyury during embryoid body
differentiation and showed reduced upregulation of the endoderm marker gene
Gata6. These findings suggest that miRNAs are not required for maintenance of
pluripotency, but are essential for proper ES cell differentiation.
The results presented in this thesis show that miRNAs are dynamically expressed
during a mammalian developmental transition and are involved in regulating early
developmental processes. We believe that miRNAs act as an additional level of
genetic regulation to ensure canalisation during embryonic development.
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The process of embryonic development, whereby an organism develops from a
single cell to a complex form consisting of highly specialised structures, tissues
and cell types, is truly remarkable and far from being understood. In order to
study mammalian development, in vivo and in vitro methods can be used, in-
cluding the derivation and culture of embryonic cell types such as embryonic stem
(ES) cells. ES cells are unique in their ability to self-renew indefinitely and retain
pluripotency: the ability to differentiate into cell types of any germ layer. Trans-
fer of ES cells to appropriate conditions can induce their differentiation into more
specialised cell types, allowing the factors controlling these transitions to be in-
vestigated. Understanding the factors that control developmental transitions will
not only provide insight into the regulation of normal and abnormal embryonic
development, but may also lead to the establishment of an unlimited source of
specialised cell types and organs for therapeutic benefit.
In order to generate the vast array of cell types observed during the develop-
ment process and in the adult organism, accurate spatial and temporal regula-
tion of gene expression is essential. Some means of regulating gene expression,
such as control of transcription and protein modification, have long been estab-
lished. Recently, an entirely novel level of regulation has been described – post-
transcriptional regulation of gene expression by microRNAs (miRNAs). miRNAs
1
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are short, non-coding RNA molecules of approximately 22 nucleotides in length
that have been found in all eukaryotic organisms investigated to date. Some
miRNAs are highly conserved across species, and research suggests that miRNAs
have existed since early animal evolution (Grimson et al., 2008). miRNAs were
initially discovered as regulators of development in nematode worms and have
since been shown to have roles in the developmental of numerous animals and
plants. It is possible that miRNAs function as master regulators of developmen-
tal processes or to ensure canalisation during development. A combination of
both these functions is also possible. We believe that miRNAs act primarily as
an additional level of genetic regulation to ensure canalisation during embryonic
development.
This thesis describes the results of investigating the role of miRNAs in early mam-
malian developmental transitions. In order to investigate the role of miRNAs in
regulating developmental processes, ES cells were used to model differentiation
events in vitro. To explore the specific roles of miRNAs during an early develop-
mental transition, an embryonic stem (ES) cell model of trophectoderm differen-
tiation was used, and to explore the general roles of miRNAs in developmental
transitions, the differentiation capabilities of wild type and miRNA-deficient ES
cells were compared. This introduction will: (1) describe what is currently known
about the biogenesis, regulation and function of miRNAs; (2) detail early mouse
development; (3) discuss what is known about ES cells and why they are suitable
as models of developmental processes; and (4) describe the known roles of miR-
NAs in development, with particular attention to the roles of miRNAs in early
mouse development.
1.2 The biology of miRNAs
MicroRNAs (miRNAs) are short, single-stranded RNA molecules that represent
an entirely novel mechanism of genetic regulation, whereby gene activity is at-
tenuated post-transcriptionally through translational inhibition and/or destabil-
isation of messenger-RNA. miRNAs were first discovered in the nematode worm,
C. elegans, but are now thought to function in most, if not all, multicellular
organisms as well as some viruses.
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1.2.1 The history of miRNA
1.2.1.1 The discovery of lin-4
The first description of an endogenous small RNA with translational suppres-
sion capabilities was published in Cell in 1993 (Lee et al., 1993). This report
showed that in C. elegans a non-protein coding transcript of 22nt in length,
known as lin-4, was complementary to a repeated sequence found in the 3’ UTR
of lin-14 mRNA. A loss of function of lin-4 resulted in early developmental fates
re-occurring at late developmental stages whereas the opposite was true for loss
of function of LIN-14. It was therefore thought that lin-4 could function to neg-
atively regulate the level of LIN-14 protein. Lee et al. cloned the lin-4 locus and
showed complementarity between lin-4 and lin-14. Because lin-4 did not pro-
duce a protein-coding transcript, it was suggested that the regulation represented
inhibition of translation via an antisense RNA-RNA interaction.
1.2.1.2 miRNAs as general regulators of gene expression
It wasn’t until 2001 that the term ‘microRNA’ (abbreviated to miRNA) was first
coined in a series of three papers presented in Science (Lee & Ambros, 2001, Lau
et al., 2001, Lagos-Quintana et al., 2001). Lee & Ambros used bioinformatics
approaches and cDNA cloning to discover 15 new miRNA genes while Lau et al.
discovered 55 new miRNAs by isolating and cloning endogenous RNAs. Both of
these studies were performed in C. elegans. By isolating and cloning miRNAs
from HeLa cells and D. melanogaster, Lagos-Quintana et al. showed that miR-
NAs are expressed in both vertebrates and invertebrates. This series of articles
led to speculation that miRNAs were numerous, widespread mediators of post-
transcriptional genetic regulation. Since these papers were published the field of
miRNA biology has expanded rapidly and miRNAs are now thought to exist in
most multicellular organisms.
1.2.1.3 The extent of miRNA regulation
The extent to which miRNA regulation operates is gradually being realised.
The latest release of the miRBase database (http://www.mirbase.org/, Griffiths-
Jones, 2004), which lists published microRNA sequences, contains ‘18226 entries
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representing hairpin precursor miRNAs, expressing 21643 mature miRNA prod-
ucts, in 168 species’. This includes over 700 different mouse miRNAs. In 2005
it was reported that human miRNAs might regulate up to 30% of human pro-
tein coding genes (Lewis et al., 2005). A more recent estimate suggests that the
human genome may encode over 1000 different miRNAs, which are predicted to
regulate >60% of human protein coding genes (Friedman et al., 2009). How-
ever, only 2286 miRNA:mRNA interactions appear in the miRecords database
(http://mirecords.biolead.org, Xiao et al., 2009), which is the largest collection
of ‘validated’ miRNA targets available. Bearing in mind that each miRNA is
predicted to target hundreds of mRNAs (Lim et al., 2005), and the number of
confirmed interactions makes up a very small proportion of the interactions that
are likely to occur.
Additionally, only a small proportion of known miRNAs have been functionally
characterised to date. Mice deficient for specific miRNAs or miRNA clusters have
been generated and show roles for miR-1 and miR-208 in cardiogenesis (van Rooij
et al., 2007, Zhao et al., 2007), miR-155 and miR-146a in the immune system
(Rodriguez et al., 2007, Thai et al., 2007, Boldin et al., 2011), and the miR-
17-92a cluster in development of the heart, lung and immune system (Ventura
et al., 2008). Recently, a library of germline-transmissible mouse ES cell lines
that harbour deletions for 392 miRNA genes has been generated (Prosser et al.,
2011). This resource will provide material for the functional characterisation of
many more mouse miRNAs. One area of miRNA biology that is reasonably well
understood is miRNA biogenesis.
1.2.2 miRNA biogenesis
The stages of miRNA biogenesis from transcription to incorporation into the
RISC complex are shown in Figure 1.1. The following is an account of the current
understanding regarding miRNA biogenesis.
1.2.2.1 Genomic location of miRNAs
MicroRNAs are transcribed from the genome as long precursor molecules called
pri-miRNAs. miRNAs may be located in intergenic regions of the genome or
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Figure 1.1 – miRNA genomic organisation, biogenesis and function. miRNAs are localised
in the genome as polycistrons that are subsequently cleaved into multiple pre-miRNAs
(A), in intergenic regions (B) or in intronic/exonic regions of protein coding genes (C).
Primary miRNAs (Pri-miRNA) are transcribed from the genome by RNA polymerase II
and have a 7-methylguanosine (7mGpppG) Cap and a poly(A) tail. Pri-miRNA molecules
are processed into ~60nt hairpin pre-miRNAs by the microprocessor complex composed of
the RNAse III enzyme DROSHA and the ds RNA binding protein DGCR8. Exportin 5
(XPO5) actively transports the pre-miRNA into the cytosol, where it is processed by the
RNAse III enzyme DICER with its partner, the RNA binding protein, TRBP into mature
~22nt double stranded miRNA. TRBP facilitates recruitment of AGO2, a key component of
the RNA-induced silencing complex (RISC) and a single strand of the miRNA (the ‘guide’
strand) is incorporated into the RISC complex. The mature miRNA sequence then guides
the RISC complex to regions of partial complementarity in the target mRNA sequence
and represses target expression by one of a number of mechanisms: repression of mRNA
translation, miRNA cleavage and subsequent degradation or deadenylation of the mRNA
and subsequent degradation. Figure adapted from Fazi & Nervi, 2008.
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within the introns of protein-coding genes (Ying & Lin, 2005). It was initially as-
sumed that all intronic miRNAs are transcribed as part of the host protein-coding
transcript. However, it is now known that some intronic miRNAs have their own
promoter and enhancer, which means the miRNAs will be synthesised as a sepa-
rate transcriptional unit from the host gene (Ozsolak et al., 2008, Monteys et al.,
2010). This may explain why the expression profiles of some intronic miRNAs
do not correlate with the expression pattern of their host gene (Ozsolak et al.,
2008, Sikand et al., 2009). Some miRNAs are organised in clusters in the genome.
By analysis of nucleosome positioning patterns and ChIP-chip screens. Ozsolak
et al. found either one promoter or no promoter upstream of miRNA clusters,
which suggested either a shared transcriptional start site or the presence of ad-
ditional promoters not identified in their analysis. Together with the additional
observation that polycistronic transcripts for several miRNA clusters exist (Lee
et al., 2002), this suggests that miRNA clusters can be transcribed as a single
pri-miRNA.
1.2.2.2 miRNA transcription
While the majority of small RNAs (e.g. tRNAs and U6 snRNAs) are transcribed
using an RNA polymerase III dependent mechanism, most microRNAs are tran-
scribed by RNA polymerase II (Lee et al., 2004). pri-miRNAs have characteristics
of protein-coding transcripts exhibiting 5’ caps and 3’ poly(A) tails in their tran-
scripts. Lee et al. showed that transcription of miRNA genes was dependent on
RNA polymerase II, and therefore miRNA genes could be classified as being of
class II. However, there is evidence to suggest that at least some miRNAs are
transcribed by RNA polymerase III if their genomic location is within an Alu
repeat region as Alu transcription occurs through RNA polymerase III (Borchert
et al., 2006). Transcription results in the formation of long, precursor molecules
called pri-miRNAs, which enter the miRNA biogenesis pathway.
1.2.2.3 Processing of Pri-miRNAs by the microprocessor complex
Pri-miRNAs may range in size from a few hundred nucleotides up to several kilo-
bases in length. The pri-miRNAs form hairpin structures, which are cleaved in
Chapter 1. Introduction 7
the nucleus to form precursor miRNAs (pre-miRNAs). This cleavage is depen-
dent on the RNase III nuclease, DROSHA (Lee et al., 2003). RNase III proteins
are endonucleases specific to double stranded RNA. They cleave the RNA helix
producing characteristic 2nt 3’ overhangs. DROSHA’s status as an RNase III
nuclease, its involvement in pre-rRNA processing, and the fact it localises pre-
dominantly to the nucleus made it a good candidate as a nuclear processor of
pri-miRNAs. Lee et al. (2003) immunoprecipitated DROSHA and found it had
the capacity to process pre-miRNA from pri-miRNA in vitro. Similarly, deple-
tion of Drosha by siRNA resulted in a build-up of pri-miRNAs and a reduction
in pre-miRNAs.
Characterisation of native complexes containing DROSHA (Denli et al., 2004)
showed it to be a component of a 500 kDa complex termed the microprocessor
complex. The complex was shown to include another protein, which was dubbed
PASHA (partner of Drosha). PASHA is equivalent to vertebrate DGCR8 (DiGe-
orge syndrome critical region gene 8), and functions within the microprocessor
complex to stably bind the pri-miRNA and act as a molecular ruler to determine
the precise cleavage site for generation of pre-miRNAs (Han et al., 2006) (Figure
1.2 ).
1.2.2.4 Nuclear export of pre-miRNAs by Exportin-5
The pre-miRNAs that are generated by the microprocessor complex form short
hairpins of approximately 70 nucleotides in length that are transported from the
nucleus to the cytoplasm. Export of pre-miRNAs is dependent on Exportin-5
(XPO5), a RanGTP-dependent dsRNA-binding protein. Competition experi-
ments showed that export of labelled pre-miRNAs could be inhibited by the
presence of unlabelled competitor pre-miRNAs, but that export can be rescued
by the addition of exogenous XPO5. Conversely, a reduction in cellular levels
of XPO5 by RNAi resulted in a reduction in mature miRNA levels (Lund et al.,
2004). It is thought that the spatial separation of the nucleases DROSHA and
DICER in the nucleus and cytoplasm respectively, allows their sequential action;
XPO5 may play a role between these two functions to make sure pre-miRNAs ex-
ported from the nucleus are of high integrity (Wang et al., 2011). This is because
XPO5 recognises the pre-miRNA independently of its sequence or loop structure
but requires a defined length of double-stranded stem and 2nt 3’ overhangs for
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Figure 1.2 – The role of DGCR8 in the microprocessor. DGCR8 is thought to bind
more favourably to the junction between the rigid stem structure of the pri-miRNA and
the flexible 5’ and 3’ single stranded segments than between regions of the stem and the
more constrained loop structure. Correct binding of DGCR8 is thought to result in correct
positioning of DROSHA so that the cleavage site of the RNA stem loop will occur ~11 bp up
the stem, resulting in an ~70 nucleotide long pre-miRNA hairpin. Thus, DGCR8 acts with
structural features of pri-miRNAs to promote their accurate processing into pre-miRNAs
by the microprocessor complex. From Seitz & Zamore, 2006.
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successful binding (Lund et al., 2004, Zeng & Cullen, 2004). Thus, only correctly
processed miRNAs will be exported into the cytoplasm where they are processed
to double-stranded miRNA molecules by a second endonuclease called DICER.
1.2.2.5 Processing of pre-miRNAs by Dicer and TRBP
In the cytoplasm another RNase III enzyme, DICER, acts with its partner TRBP
(TAR RNA-binding protein) to process pre-miRNA into mature double stranded
miRNA with characteristic 2nt 3’ overhangs (Hutvagner et al., 2001, Chendri-
mada et al., 2005). DICER processing is required for production of mature siR-
NAs as well as miRNAs (Bernstein et al., 2001). Grishok et al. first showed
the involvement of Dicer in the miRNA pathway in C. elegans ; the progeny
of animals treated with Dicer siRNA exhibited accumulation of the long forms
(~70nt) of the miRNAs lin-4 and let-7, while the levels of short forms (~22nt)
were reduced (Grishok et al., 2001). DICER contains an NH2-terminal DEXH-
box ATP-dependent RNA helicase domain, a PAZ domain, tandem RNAse III
motifs, and a COOH-terminal dsRNA-binding domain (Hutvagner et al., 2001).
TRBP has three double-stranded RNA-binding domains and is required for the
recruitment of AGO2 to the small interfering RNA (siRNA) bound by DICER
(Chendrimada et al., 2005). DICER processing results in formation of mature
miRNAs, but DICER processing is not always required because recently non-
canonical pathways of miRNA biogenesis have been described.
1.2.2.6 Non-canonical pathways of miRNA processing
Some miRNAs are generated by non-canonical biogenesis pathways (Figure 1.3 ).
For example, intronic miRNAs (called mirtrons) may form a stem-loop structure
where the 3’ end of the stem-loop precursor is coincident with the 3’ splice site.
This structure is cleaved by nuclear pre-mRNA splicing rather than DROSHA/DGCR8
processing (Okamura et al., 2007, Ruby et al., 2007). Additionally, there is ev-
idence of miRNA processing in the absence of Dicer. The level of miR-451 ex-
pression is not affected by loss of Dicer, but is reduced in AGO2 mutants. In-
vestigation of this revealed that pre-miR-451 is not processed by Dicer, but is
loaded into AGO and is cleaved by the AGO2 catalytic centre to generate an in-
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termediate 3’ end, which is then further trimmed (Cheloufi et al., 2010, Cifuentes
et al., 2010).
1.2.2.7 Regulation of miRNA biogenesis
miRNAs are post-transcriptional regulators of gene expression, but they are also
the subject of regulation themselves, both directly and through regulation of
their associated proteins. miRNAs are regulated at the transcriptional level, dur-
ing their biogenesis, through RNA editing of their nucleotide sequence, at the
functional level, through the cellular localisation of the miRNA and through reg-
ulation of their decay (reviewed in Krol et al., 2010b). As an example, the miRNA
let-7 is regulated by LIN28 protein at multiple stages of its biogenesis. Let-7 is
regulated during processing by the microprocessor complex, during DICER pro-
cessing and through polyuridylation and subsequent degradation (Viswananthan
et al., 2008, Newman et al., 2008, Rybak et al., 2008, Heo et al., 2008). Other
examples of regulation of miRNA expression are described below.
Regulation of miRNA expression can occur at the transcriptional level. Most
miRNAs are transcribed by RNA polymerase II although there is evidence for
transcription of some human miRNAs by RNA polymerase III (Borchert et al.,
2006). Both RNA polymerases recognised different sequence elements resulting
in a large variety of regulatory options. Expression of selected miRNAs is under
the control of transcription factors such as C-MYC (O’Donnell et al., 2005) and
dependent on the methylation status of the miRNA promoter region (Saito et al.,
2006). Differential expression of proteins involved in miRNA biogenesis also con-
tributes to regulation of miRNA expression. This includes regulation of stability
of the key RISC component AGO. For example, AGO is hydroxylated at proline
700 by the type I collagen prolyl-4-hydroxylase (C-P4H(I)), which increases pro-
tein stability and facilitates AGO localisation to P-bodies (Qi et al., 2008). As
can be seen the generation of mature miRNAs is subject to numerous regulatory
mechanisms.
1.2.2.8 Mature miRNAs
The mature miRNA is a short double-stranded RNA molecule of between 20
and 24 nucleotides in length. Processed miRNAs generally have a longer half-
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Figure 1.3 – Non-canonical miRNA biogenesis. During canonical miRNA processing,
miRNAs reach their mature form after two RNAse III-mediated cleavage events involving
the DROSHA-DGCR8 complex in the nucleus and the DICER-TRBP complex in the cy-
toplasm. In some cases, miRNAs are encoded within short introns (miRtrons) and are pro-
cessed into pre-miRNA form by the splicing apparatus, thereby bypassing the DROSHA-
DGCR8 processing step (Ruby et al., 2007). In other cases, AGO2, which has endonuclease
activity, can support DICER processing by cleaving the 3’ arm of the pre-miRNA hairpin
(Diederichs & Haber, 2007). This generates an additional processing intermediate called
AGO2-cleaved precursor miRNA (ac-pre-miRNA). In addition, processing of miR-451 re-
quires AGO2 cleavage but not DICER cleavage (Cheloufi et al., 2010, Cifuentes et al.,
2010). Thus, miRNAs can be generated in a Drosha-independent and Dicer -independent
manner. Figure from Krol et al. (2010b).
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life than the average mRNA molecule. For example, the half-life of miR-223
was determined to be approximately 25 hours whereas the concentration of an
mRNA derived from the same precursor transcript, NGFR, decreased 10-fold in 24
hours (Baccarini et al., 2011). Despite this there are probably mechanisms, as yet
unknown, which regulate turnover of miRNAs because some show rapid decreases
in expression upon certain stimuli (Pedersen et al., 2007, Krol et al., 2010a). For
example, expression of interferon beta, a protein produced in host cells in response
to the presence of pathogens, leads to rapid reduction in expression of miR-122,
a miRNA that has been shown to be essential for hepatitis C virus replication
(Pedersen et al., 2007).
Once mature miRNAs have been synthesised they are generally localised to the
cytoplasm but a distinct hexanucleotide terminal motif on hsa-miR-29b results in
its localisation to the nucleus (Hwang et al., 2007). This suggests that miRNAs
contain cis-regulatory motifs and is interesting because there is evidence that
miRNAs could have a function in the nucleus as regulators of gene transcription
(Place et al., 2008). Kinetic analysis of miRNA expression showed that miRNAs
regulate multiple mRNAs during their lifetime; an individual miRNA is thought
to regulate at least two target transcripts before it is degraded (Baccarini et al.,
2011). Target regulation limits miRNA recycling because it promotes posttran-
scriptional modifications to the 3’ end of the miRNA, which results in modulation
of miRNA stability (Baccarini et al., 2011).
1.2.3 Interaction of miRNAs with target transcripts
1.2.3.1 miRNAs and the RISC complex
The complex responsible for targeting miRNAs (and also other small RNA molecules
such as siRNAs) is known as the RNA-induced silencing complex (RISC). The
term RISC was first coined by Hammond et al. (2000) in a paper showing degra-
dation of specific mRNAs in Drosophila cells after transfection of double stranded
RNAs (dsRNAs). The researchers reasoned that this degradation was due to se-
quence specific nuclease activity, as non-specific mRNAs were not degraded.
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1.2.3.2 Components of the RISC complex
ARGONAUTE proteins All RISC complexes characterised so far contain
at least one ARGONAUTE (AGO) protein, which are the core effectors of the
miRNA pathway. The AGO protein family has multiple members, all of which
are involved in dsRNA gene silencing (Czech & Hannon, 2011). The number of
AGO paralogs present varies from only one in S. pombe (Verdel et al., 2004),
to over twenty in C. elegans (Carmell et al., 2002). Mouse and human genomes
encode four AGO proteins and mouse ES cells that are deficient for AGO1-4
are completely defective in miRNA silencing (Su et al., 2009). Proteins within
the AGO family have a PAZ domain and a PIWI domain (Rand et al., 2004).
The PAZ domain binds RNA with the specific 2-nucleotide 3’ overhang that is
characteristic of short RNA duplexes. The PIWI domain has been shown to
mediate protein-protein interactions between AGO and Dicer (Tahbaz et al.,
2004) and constitutes the catalytic domain of the enzyme (Liu et al., 2004).
The structure of AGO is shown in Figure 1.4. The four mouse AGO proteins
are ubiquitously expressed and share significant sequence homology. However,
only AGO2 is capable of ‘slicer’ activity, catalysing the cleavage of the miRNA
target (Liu et al., 2004). Purified AGO proteins precipitate with single stranded
miRNAs (Meister et al, 2004), which suggests that the double-stranded mature
miRNA is either unwound by an as yet unidentified helicase or that one strand
may be cleaved by the ‘Slicer’ activity of AGO2 (Matranga et al., 2005). The
guide strand is retained by AGO because of a lower thermodynamic stability at
the 5’end, while the other strand (referred to as miRNA*) is degraded (Schwarz
et al., 2003).
Other components of the RISC complex Other proteins that associate
with the RISC complex in Drosophila include a protein with five staphylococ-
cal/micrococcal nuclease domains called Tudor-SN (Caudy et al., 2003), Fragile
X-related protein and Vasa intronic gene (VIG) (Caudy et al., 2002). The RISC
complex allows the recruitment of the miRNA to mRNA targets through target
recognition by perfect or imperfect complementarity between RNA sequences,
and facilitates processing of the mRNA.
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Figure 1.4 – The structure of Argonaute proteins. Song et al. (2004) identified the crystal
structure of AGO protein from the archaebacterium Pyrococcus furiosis and presented a
model for siRNA-guided mRNA cleavage by AGO. (a) shows the 3’ potion of an siRNA
(purple) and the 5’ end of the mRNA stand (green), which were placed by superimposing
the PAZ domains from PfAGO and hAGO1. The view is similar to that seen in (b), which
is a schematic depiction of the model proposed by Song et al. for siRNA-guided mRNA
cleavage. The siRNA (pale green) is localised with its 3’ end in the PAZ cleft. The rest
of the siRNA lies in the AGO groove. The mRNA comes in between the N-terminal and
PAZ domains and out between the PAZ and MID domains. The active site is in the PIWI
domain and cleaves the mRNA opposite the middle of the siRNA guide. The MID-PIWI
domains have been crystallised from eukaryotic AGO1 protein (from Neurospora crassa)
and show similar domain orientation to those in prokaryotic AGO proteins suggesting a
conserved mode of binding with the RNA substrate. (Boland et al., 2011). Figure adapted
from Song et al. (2004).
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1.2.3.3 Factors important for target recognition
The most important region of the miRNA for target recognition is nucleotides
2-7 from the 5’ end, termed the ‘seed region’. In most cases this region pairs
perfectly with the mRNA target (Bartel, 2009). Different types of seeds have
been characterised depending on the extent of the binding within this region and
whether there is binding at position 8 or an adenine complementary to position
1 of the miRNA. Although supplementary binding at the 3’ end of the miRNA
has been assumed, there is little evidence to directly support its frequent function
(Doench and Sharp, 2004). However, 3’ compensatory binding is thought to play
a role in situations where seed pairing is compromised, for example by a bulge or
mismatch in the seed region (Yekta et al., 2004).
1.2.3.4 The miRNA ‘seed’ region
The seed region was first identified as being important in miRNA targeting
through computational prediction of miRNA targets followed by experimental
verification of some predicted targets (Stark et al., 2003). Stark et al. observed
that the few animal miRNA-target duplexes that had been verified previously con-
tained mismatches, gaps and G:U basepairs at different positions. Even allowing
for G:U basepairs, the longest continuous sequence alignments were between 8 and
10 nucleotides in length. They developed a computer based screening strategy
for predicting miRNA targets, which predicted all known miRNA-mRNA target
duplexes. Six novel predicted miRNA targets were verified experimentally. Com-
parison of the features of the five previously identified miRNA targets, and the
six newly validated targets revealed that all target sites shared perfect sequence
identity with nucleotides 2-8 of the miRNA. Soon after, Lewis et al. made a
similar discovery and called the region most important for targeting the ‘miRNA
seed’ (Lewis et al., 2003).
1.2.4 Mechanisms of miRNA function
miRNA regulation of target mRNA is thought to occur through translation re-
pression and/or mRNA destabilisation. Translational repression of target mRNAs
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has been reported to occur in a number of ways: through inhibition of transla-
tional initiation or elongation, co-translational protein degradation and also pre-
mature termination of translation. Methods of mRNA regulation by miRNAs are
summarised in Figure 1.5.
1.2.4.1 The mechanism of miRNA function in plants and animals
It was thought that, in animals, miRNAs functioned primarily through transla-
tional repression whereas in plants miRNAs acted almost entirely through mRNA
degradation. These differences arose because plant miRNAs show near perfect
complementarity with their mRNA targets, while in animals the base pairing is
generally much less extensive. More recent data has shown that this functional
distinction is not correct and miRNAs can induce mRNA degradation in animals
and translation repression in plants (Behm-Ansmant et al., 2006, Brodersen et
al., 2008). The question of which one of these mechanisms acts predominantly
is still under debate (reviewed in Huntzinger & Isaurralde, 2011). However, the
consensus still stands that the method of regulation is dependent on the degree of
mismatch between the guide miRNA and its target mRNA; miRNAs with near
perfect complementarity to target mRNAs guide mRNA cleavage, while those
with a large number of mismatches inhibit translation.
1.2.4.2 Translational inhibition
Translational inhibition was first recognised as a potential route for miRNA func-
tion due to findings in C. elegans ; miRNA-regulated mRNA levels were not sub-
stantially changed, but levels of the encoded protein were reduced (Olsen et al.,
1999). In addition, the mRNAs were found to be associated with ribosomes that
could go on to perform translational elongation in vitro. Since then, further evi-
dence has emerged that miRNAs function through translational inhibition after
protein synthesis has been initiated (Petersen et al., 2006). Studies have also
shown evidence of inhibition of protein synthesis at the initiation stage through
impaired cap recognition (Pillai et al., 2005, Humphreys et al., 2005).
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Figure 1.5 – Mechanisms of miRNA function. Schematic showing various proposed mech-
anisms of miRNA function. Target mRNA is shown as a violet line, miRNA is shown as
thick red line associated with RISC complex, the blue hexagon represents the translation
initiation complex and the orange circles represent ribosomes. (a) Perfect complementar-
ity between miRNA and target mRNA leads to cleavage of the mRNA by the catalytic
site within the PIWI domain of AGO proteins followed by mRNA degradation. Imperfect
complementarity between miRNA and mRNA leads to inhibition of translation initiation
(b) or inhibition of translation elongation/termination and promotion of ribosome drop-off
(c). There is also evidence that regulation can occur through recruitment of a proteolytic
enzyme to degrade emerging polypeptides (d) and deadenylation followed by degradation
of the mRNA target (e). Figure from Lewis & Steel (2010).
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1.2.4.3 Localisation of miRNA targets to P-bodies
A relationship between miRNA-mediated regulation and cytoplasmic P-bodies
has also been proposed. AGO proteins localise to P-bodies along with repressed
mRNAs, which localise in a miRNA dependant manner (Pillai et al., 2005). The
P-bodies contain a range of enzymes involved in mRNA turnover and so a model
was suggested in which RISC binding to mRNA results in delivery to a P-body
where the mRNA comes into contact with enzymes responsible for deadenylation
and decapping or is held in stasis. Stasis could potentially be achieved due to
the absence of ribosomes within P-bodies. However, it is now considered that P-
bodies are a consequence, rather than a cause of miRNA-mediate gene silencing
because silencing can occur in cells devoid of functional P-bodies (Eulalio et al.,
2007).
1.2.4.4 miRNA-mediated destabilisation of target transcripts
While it was originally thought that animal miRNAs functioned mainly through
translational inhibition, it is now known that destabilisation of target mRNAs
is a common result of miRNA target recognition. The first evidence of this was
through transfection of a miRNA into cells that did not normally express the
specific miRNA. Twelve hours after transfection a significant decrease (between
1.5 and 3.6-fold) was observed in the levels of many mRNAs, most of which had
potential target sites for the miRNA (Lim et al., 2005). Multiple further studies
have made the same observation (including Sebach et al., 2008, Baek et al., 2008,
Guo et al., 2010). The majority of this mRNA degradation is thought to occur
through miRNAs directing their targets to the 5’ to 3’ mRNA decay pathway
where mRNAs are deadenylated by the CAF1-CCR4-NOT deadenylase complex
and then decapped by DCP2 (Rehwinkel et al., 2005, Behm-Ansmant et al., 2006).
Although miRNAs can direct endonucleolytic cleavage of fully complementary
targets, this seems to be a rare occurrence in animals. Only two examples of such
‘Slicing’ have been published: miR-196 mediated cleavage of HOXB8 mRNA and
miR-127 and miR-136 mediated cleavage of retrotransposon-like 1 (rtl1) mRNA
(Yekta et al., 2004, Davis et al., 2005).
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1.2.4.5 Promotion of transcription
There is evidence to suggest that miRNAs may also act to promote gene tran-
scription. Transfection of miR-373 or pre-miR-373 into mammalian cells was
shown to increase the levels of E-cadherin expression, which contained a miR-373
target site in its promoter region (Place et al., 2008). Additionally, design and in-
troduction of synthetic dsRNAs complementary to regions within gene promoters
was shown to result in sequence-specific and long term induction of the targeted
gene (Li et al., 2006, Janowski et al., 2007). However, although it has been shown
that miRNA-mediated activation of gene transcription is sequence dependent and
requires functional Dicer and AGO2 there is, as yet, no suggested mechanism for
this novel miRNA function.
1.2.5 miRNAs and disease
miRNAs have been shown to have roles in many, if not all, biological processes
including apotosis, cell signalling, organogenesis and development. Soon after
their discovery, miRNAs were linked with human health and shown to have roles
in neurological diseases, immunity, viral and endocrine diseases and in cancer.
1.2.5.1 miRNAs in neurological disorders
The neurological disorder most frequently associated with miRNAs is fragile X
syndrome, which is the most common inherited mental retardation disease. This
syndrome is caused by mutations that prevent production of fragile X mental re-
tardation protein (FMRP), an RNA-binding protein that is thought to regulate
the expression of numerous genes at the protein synthesis level. The mechanism
by which FMRP does this is not yet known. FMRP normally forms ribonucle-
oprotein complexes and can interact with the RISC complex as well as directly
with miRNAs (Caudy et al., 2002, Jin et al., 2004). In Drosophila, AGO1 is es-
sential for FMRP function (Jin et al., 2004). These findings suggest that FMRP
may regulate gene expression through an RNAi-related mechanism.
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1.2.5.2 miRNAs and the immune system
Many roles for miRNAs in the immune system have been documented predom-
inantly involving the miRNAs miR-146a and miR-155. These miRNAs are
strongly upregulated in response to lipopolysaccharide (LPS) stimulation of the
immune system (Tili et al., 2007, Nahid et al., 2009). miR-146a is induced by the
immune system regulator NF-KB and directly regulates expression of TRAF6 and
IRAK1, which are upstream of NF-KB in this immune system cascade of gene ex-
pression (Taganov et al., 2006). Therefore miR-146a creates a negative-feedback
loop that controls the NF-KB mediated response to LPS stimulation.
1.2.5.3 miRNAs and cancer
Most research of miRNAs in disease has been in the field of cancer. The first
evidence for a correlation between miRNAs and cancer was the observation that
miRNAs are frequently located in Cancer-Associated Genomic Regions (CAGRs)
(Calin et al., 2004). Work following on from this has revealed that miRNA
expression profiles in tumours are significantly different from those in healthy
tissue (Lu et al., 2005). Multiple studies have made similar findings and have
led to lists of miRNAs that are thought to be mainly oncogenic and those that
are thought to act as tumour suppressors. Among the miRNAs associated with
cancer are the miR-15a-16 cluster, which is deleted or downregulated in chronic
lymphocytic leukaemia (Calin et al., 2002), miR-17 and miR-21, which show
upregulation in colon, lung, stomach, prostrate and pancreatic tumours (Volinia
et al., 2005) and the miR-17-92a cluster of miRNAs. The overexpression of
the miR-17-92a cluster has been frequently associated with solid tumours or in
haematological malignancies (reviewed in Olive et al., 2010). Conditional knock
out of miR-17-92a showed that expression of miR-17-92a is required to suppress
apoptosis in MYC-driven B-cell lymphomas (Mu et al., 2009). Interestingly,
miR-17-92a is a direct transcriptional target of C-MYC and both C-MYC and
the miR-17-92a cluster are expressed at high levels in ES cells, which are thought
to share similar proliferative properties with cancer cells (Thomson et al., 2004,
Kim et al., 2010a).
Chapter 1. Introduction 21
1.2.5.4 miRNAs in viruses
miRNAs are encoded within the genomes of some viruses. Viruses were first
shown to express miRNAs in 2004, when five miRNAs were produced in human
B cells after infection with the Epstein-Barr virus (EBV), a g-herpesvirus (Pfeffer
et al., 2004). Since then, miRNAs have been discovered in all herpesviruses ex-
amined. However, other unrelated DNA viruses seem to contain only one or two
miRNAs, or none at all, and viruses with an RNA genome have been reported to
lack miRNAs altogether (Cullen, 2009). Interestingly, there is evidence of viral
miRNAs that are functional orthologs of eukaryotic miRNAs. For example, func-
tional orthologs of miR-155 exists in Karposi’s sarcoma-associated herpesvirus
(KSHV) (Gottwein et al., 2007, Skalsky et al., 2007) and in Marek’s Disease Virus
(MDV) (Zhao et al., 2009) and are capable of regulating common targets with
miR-155.
Currently, it is thought that viral miRNAs may serve two major functions. One
function is the inhibition of cellular factors that are produced as a result of viral
infection. For example, EBV miR-BART5 inhibits expression of PUMA, an an-
tiviral factor that promotes cell apoptosis (Choy et al., 2008). A second function
is the inhibition of viral proteins, including key early regulatory proteins. This
may be required for latency of viral infections. During latency, herpes simplex
virus (HSV-1) produces high levels of miRNAs that down regulate expression of
ICP0 and ICP4, two immediate-early transactivators that are thought to play
key roles in productive HSV-1 infection (Umbach et al., 2008). Viral miRNAs
may be key for the oncogenic capabilities of some herpesviruses such as KSHV
and MDV. Indeed, deletion of the six-miRNA cluster 1 from the genome of MDV
abolished the oncogenicity of the virus (Zhao et al., 2011), which appeared to be
primarily due to loss of the MDV functional ortholog of miR-155, miR-M4.
1.2.5.5 miRNAs as therapeutics
Expression patterns of miRNAs associated with specific diseases, particularly
human cancers, have led to the theory that miRNAs may be used as biomarkers
for disease (Trang et al., 2009). Additionally, manipulation of miRNA expression
may present a useful therapeutic approach. The future of miRNA research into
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human disease will undoubtedly reveal more conditions with a miRNA component
and may lead to novel biomarkers and therapeutics for disease.
1.2.6 Other small RNA molecules
1.2.6.1 siRNAs
As well as miRNAs, other classes of small RNA molecules are also found in mam-
malian cells. These are the endogenous small interfering RNAs (siRNAs) and
Piwi-interacting RNAs (piRNAs) (Watanabe et al., 2006). siRNAs are derived
from long double stranded RNA molecules or long hairpin molecules, which are
processed by Dicer to generate short RNA duplexes of ~21nt in length. As for
miRNAs, one strand of the siRNA associates with the RISC complex targeting
it to mRNAs with sequence complementarity to the siRNA. However, in contrast
to miRNAs, siRNAs bind with perfect sequence complementarity to their tar-
get mRNAs resulting in cleavage of the target transcript (Zamore et al., 2000).
The finding that introduction of double-stranded (dsRNA) complementary to en-
dogenous mRNA transcripts resulted in specific and potent suppression of gene
expression has resulted in its used as a valuable research tool (Fire et al., 1998).
Thus far, endogenous siRNAs have only been detected in abundance in mouse
oocytes and ES cells (Tam et al., 2008, Watanabe et al., 2008, Babiarz et al.,
2008). In mammals, these small RNAs are often encoded within pseudogenes
and proposed functions are the regulation of the source-genes of the pseudogenes
as well as regulation of retrotransposon expression (Tam et al., 2008, Watanabe
et al., 2008).
1.2.6.2 piRNAs
The piRNAs differ from both miRNAs and siRNAs in that they do not require
Dicer for their processing. These short RNA molecules are between 25 and 32 nt
in length and are expressed predominantly in the germline in mammals (Girard
et al., 2006). piRNAs are characterised by their interaction with PIWI proteins,
which are a distinct family of AGO proteins, although the mechanisms of piRNA
biogenesis and function are poorly understood (Klattenhoff & Theurkauf, 2008).
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Studies in mice implicate these small RNA molecules in germline development,
silencing of transposons and maintenance of germline DNA integrity in mammals
(Kuramochi-Miyagawa et al., 2004, Carmell et al., 2007).
1.2.7 Summary
While much is now known about the biogenesis, regulation and function of miR-
NAs there are still key questions to be answered. There is still disagreement,
for example, about whether miRNA destabilisation or translational suppression
is the major mode of miRNA function. The significance and functional details
of non-canonical pathways of miRNA biogenesis need to be determined, as does
the emerging concept of regulation of expression of miRNAs themselves. Addi-
tionally, we are far from elucidating the biological functions of the large number
of individual miRNAs that have been discovered in the last decade.
1.3 Early mouse development
1.3.1 Fertilisation and onset of cleavage
Mammalian development begins when the meiotic cycle of the oocyte, which was
suspended in metaphase of the second meiotic division, is reactivated by calcium
release into the oocyte as a result of sperm entry (Swann, 1990). This occurs
in the oviduct as the ovulated oocyte travels from the ovary to the uterus. Ap-
proximately 24 hours after completing meiosis the first cleavage event occurs.
At the 2-cell stage the mouse embryo begins zygotic transcription, and this pro-
duces proteins that drive future cleavage events and further development (Piko &
Clegg, 1982). The first cleavage event is meridional, but then rotational cleavage
occurs; this means that during the second cleavage one blastomere divides merid-
ionally, and the other divides equatorially (Gulyas, 1975). In contrast to some
other embryos, the cells in mammalian embryos do not all divide synchronously
so embryos frequently contain odd numbers of cells.
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1.3.2 The morula stage embryo
After the third cleavage event the blastomeres are loosely packed, but during the
8-cell stage compaction occurs. Changes in the distribution of cell surface proteins
such as E-cadherin cause the cells to form a tight ball, which is stabilised by tight
junctions between the outside cells of the embryo (Fleming et al., 2001). Cells
within the embryo contain gap junctions allowing the passage of small molecules.
Formation of tight junctions results in deformation of the round shape of the
blastomeres and formation of the morula embryo. At this stage the first obvious
differentiation event begins to occur. Most of the external cells of the morula will
produce trophoblast lineages, while the majority of the internal cells will form the
inner cell mass (ICM). It is the inner cell mass from which ES cells are derived.
By the 64-cell stage the trophectoderm and ICM are completely distinct, and
neither are capable of contributing cells to the alternative layer (Fleming, 1987).
1.3.3 Trophectoderm differentiation
1.3.3.1 Reciprocal Inhibition of Oct4 and Cdx2
Cells of the inner cell mass express the transcription factor octamer-binding pro-
tein 4 (Oct4 ) and cells of the trophectoderm express the homeobox transcription
factor caudal type homeobox 2 (Cdx2 ) (Figure 1.6 ). Cdx2 is thought to be a key
regulator of trophectoderm differentiation, as a loss-of-function Cdx2 mutation
results in defects in trophoblast differentiation (Strumpf et al., 2005). In studies
using mouse ES cells it was found that the TE is specified as a result of recip-
rocal inhibition between Oct4 and Cdx2 (Niwa et al., 2005). This produces an
Oct4 -positive, Cdx2 -negative compartment and an Oct4 -negative, Cdx2 -positive
compartment in the early embryo that will become ICM and TE respectively.
1.3.3.2 Tead4 in trophectoderm specification
The Oct4 -Cdx2 reciprocal-inhibition model requires a slight asymmetry to be
introduced to the system. Recently, it has been shown that this asymmetry is
introduced to the system via activation of Tead4, a transcriptional effector of
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the Hippo-YAP signalling pathway, in the outer cells of the embryo. Tead4 -
null mutants arrest prior to expression of Cdx2 and do not form a blastocoel
(Nishioka et al., 2008). This suggested that Tead4 is upstream of Cdx2 in the
hierarchy of TE specifying genes. However, TEAD4 is ubiquitously expressed in
the early embryo. Although TEAD4 is expressed in the inner and outer cells of
the early embryo, its coactivator, YAP, is restricted to the nuclei of outer cells. In
inner cells YAP is phosphorylated by LATS, a component of the Hippo signalling
pathway, which results in the cytoplasmic localisation of YAP (Nishioka et al.,
2009). YAP is found to be cytoplasmic only in cells with a high degree of cell-cell
contact that are internal to cell aggregates. This model provides evidence for
position-dependent TEAD4 activity and cell fate specification. in vitro, ES cells
induced to missexpress TEAD4 differentiate into TE lineages and can be induced
to form TS-like cells when grown in TS cell culture conditions (Nishioka et al.,
2009). After the TE has been specified, the TE cells secrete fluid into the internal
portion of the embryo. This creates the blastocoel cavity, and the embryo is now
described as a blastocyst.
1.3.4 Differentiation of the primitive endoderm
The second lineage specification event, which occurs in the pre-implantation blas-
tocyst embryo, is the segregation of the epiblast and the primitive endoderm. The
epiblast gives rise to the embryo itself whereas the primitive endoderm gives rise
to extra-embryonic structures, which support growth of the embryo and are in-
volved in embryonic patterning. While specification of the trophectoderm and
ICM is driven by cell position, the opposite seems to be true for specification
of the primitive endoderm: cell fate predetermines cell position. Specification
of the primitive endoderm is thought to begin at E3.5 with a ‘salt and pepper’
mosaic pattern of expression of the epiblast-specific transcription factor Nanog,
and the essential master-regulator of primitive endoderm, Gata6 (Figure 1.6 ).
This means that cells within the late ICM express Nanog or Gata6 exclusively
(Chazaud et al., 2006). Lineage tracing revealed that the descendants of indi-
vidual E3.5 ICM cells contribute to epiblast or primitive endoderm lineages, but
never both (Chazaud et al., 2006). This showed that at E3.5 the fate of ICM cells
has already been determined and led to a model of epiblast/primitive endoderm
formation in which an initial mosaic of lineage progenitors at E3.5 are sorted
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Figure 1.6 – Molecular players in the formation of the first lineages in the mouse embryo.
Four lineage-specific transcription factors, Oct4, Cdx2, Nanog and Gata6, are important
for specification of the first three lineages in the mouse embryo: the trophectoderm (TE),
the primitive endoderm and the epiblast. Oct4 is expressed in all blastomeres throughout
the early cleavage stages. At the blastocyst stage, Oct4 is downregulated in the outer TE
cells through inhibition by Cdx2. The expression of Cdx2 is stochastic during cleavage
and becomes restricted to outer cells by the blastocyst stage through a position-dependent
mechanism. Nanog and Gata6 are expressed in all cells until the early blastocyst stage.
Nanog expression is then restricted to a subpopulation of ICM cells through inhibition
by Cdx2 and Grb2-dependent signaling, while Gata6 expression is maintained by Grb2-
dependent signaling. By the late blastocyst stage cells of the ICM will express either Nanog
or Gata6. Through a process of cell sorting and relocation, cells positive for Gata6 or
Nanog will be located to appropriate locations within the ICM and will generate primitive
endoderm and epiblast, respectively. Figure from Rossant & Tam (2009).
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and relocated to appropriate locations within the ICM by E4.5 (Rossant and
Tam, 2009). Active signalling through a GRB2 (growth receptor bound protein
2)-dependent mechanism is important for primitive endoderm formation because
in the absence of GRB2, no primitive endoderm forms and all cells of the ICM
express Nanog (Chazaud et al., 2006).
1.3.5 Implantation of the embryo
As the embryo moves through the oviduct the surrounding zona pellucida pre-
vents it from adhering to the oviduct walls; however, on reaching the uterus, the
embryo must ‘hatch’ from the zona pellucida to allow implantation in the uterus
wall. A small hole is lysed in the zona and the mouse embryo is extruded and is
able to implant into the uterine wall. This occurs at approximately E4.5. Implan-
tation occurs as a result of apposition of the mural trophectoderm to the uterine
epithelium. The decidual response occurs in the area immediately surrounding
the point of embryo attachment and leads to formation of the maternal com-
ponent of the placenta, which is composed of maternal vasculature and uterine
decidual cells. The embryonic component of the placenta is comprised of layers
of differentiated trophoblast cells (extraembryonic ectoderm of the chorion) and
fetal vascular system of mesoderm (allantois) origin (Rinkenberger et al., 1997,
Rossant and Cross, 2001).
1.3.6 Gastrulation
The post-implantation blastocyst is composed of trophectoderm, primitive endo-
derm and epiblast lineages. The epiblast contains all the cells that will go on
to form the components of the embryo proper. The three primary germlayers
–endoderm, ectoderm and mesoderm – are produced as a result of gastrulation.
Gastrulation begins at the embryonic/extraembryonic junction with formation of
the primitive streak, which progresses distally through the embryo. Although the
signals that initiate gastrulation at a specific point are not known, the secreted
factors, Nodal and Wnt3 are essential for this process (Conlon et al., 1994, Liu et
al., 1999). The most anterior portion of the primitive streak becomes the node.
Cells migrate individually through the primitive streak and are patterned ac-
cording to differential gene expression along the length of the streak. Mesoderm
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Figure 1.7 – Lineages of tissues constituting the mouse embryo. Blue boxes – all tis-
sues that will give rise to the embryo proper and extraembryonic cells. Orange boxes –
extraembryonic tissues.
and endoderm cells migrate through the primitive streak whereas cells migrating
through the node will become notochord. Expression of the T-box transcription
factor, Brachyury, is essential for normal morphogenetic mesoderm movements
during gastrulation (Wilson et al., 1995). Fate maps have been generated for the
gastrulating embryo by labelling individual cells of the epiblast (Lawson et al.,
1991). Figure 1.7 shows the origins of the early tissue lineages of the mouse.
1.4 Mouse embryonic stem cells
Embryonic stem (ES) cells are pluripotent stem cell lines that are derived from
the inner cell mass (ICM) of blastocyst stage embryos. They have two remark-
able properties: the ability to self-renew indefinitely, and the ability to produce
cells belonging to the three major tissue germlayers: endoderm, mesoderm and
ectoderm (Figure 1.8 ). This is demonstrated by the generation of chimeric mice;
ES cells will integrate fully into the developing embryo, and can contribute to all
tissues including the production of functional gametes. ES cells are also amenable
to genome engineering; this property can be used in combination with their con-
tribution to the germline to introduce mutations into lines of mice.
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Figure 1.8 – Mouse embryonic stem cells. Mouse ES cells are derived from the inner
cell mass of blastocyst stage embryos. If grown in the appropriate conditions ES cells will
self-renew indefinitely. They also have the ability to differentiate into cells belonging to
the three germ lineages in vivo and in vitro.
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The incredible properties of ES cells have resulted in a large research effort to
try to understand the mechanisms governing the pluripotency and differentiation
of these cells. ES cells not only have the potential to provide study systems
for development and disease, but may one day lead to therapeutic treatments for
degenerative diseases such as Alzheimer’s and Parkinson’s disease. ES cells can be
induced to differentiate in vitro, mimicking early developmental transitions such
as trophectoderm differentiation, primitive endoderm differentiation and germ
layer differentiation. In this way ES cells provide excellent model systems for the
study of early developmental events in vitro.
1.4.1 Origins and culture of mouse ES cells
1.4.1.1 Embryonal carcinoma cells
The discovery and maintenance of ES cells was made possible by prior work on ter-
atocarcinomas and the embryonal carcinoma (EC) cells derived from teratomas.
In 1970 it was found that by grafting mouse epiblast cells onto a permissive host
site a tumour consisting of many different cell types could be created (Solter
et al., 1970). These teratocarcinomas contained cells belonging to each tissue
germlayer, and an undifferentiated component that could be maintained by serial
transplantation. Cells derived from this undifferentiated component were termed
EC cells (Evans, 1972). While these cells could contribute to embryogenesis and
form chimaeric embryos, their genetic constitution was compromised and most
EC cells show restricted developmental potential (Martin, 1980). However, study
of EC cells laid the foundations for the study of ES cells, which were first re-
ported in 1981 (Evans & Kaufman, 1981; Martin, 1981). A key finding was
that co-culture of EC cells with mitotically-inactivated fibroblast cells led to ef-
ficient establishment of EC cultures with a high differentiative capacity (Martin
& Evans, 1975).
1.4.1.2 Feeder-dependent ES cell culture
The basic protocol for ES cell derivation is now relatively straightforward (Robert-
son, 1987): Blastocyst stage embryos (either intact or after immunosurgical iso-
lation of the ICM) are placed onto a layer of mitotically inactive feeder cells in
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culture. After several days of culture, epiblast outgrowths become apparent and
can be disaggregated and transferred to fresh cultures containing feeder cells.
Colonies develop and are assessed, and undifferentiated ones are dissociated and
replated. If secondary undifferentiated colonies arise, then these can generally be
expanded and cultured as ES cells. It was reasoned that the fibroblast cells were
producing some critical factor for ES cell maintenance, hence the term ‘feeder
cells’ (Figure 1.9a). ES cells can be neither derived nor maintained in the pres-
ence of media supplemented with serum alone.
1.4.1.3 Culture of ES cells in serum and Lif
The requirement for a feeder layer was abrogated through culture of ES cells in
conditioned media, confirming that the fibroblast cells were producing a trophic
factor that supported self-renewal (Smith & Hooper, 1983; Smith & Hooper,
1987). Further investigation showed that addition of the cytokine, leukaemia
inhibitory factor (LIF), was sufficient to sustain ES cell self-renewal in the absence
of a feeder later (Smith et al., 1988, Williams et al., 1988) (Figure 1.9b). Binding
of Lif to its receptor initiates heterodimerisation of the Lif receptor with the
gp130 receptor (Yoshida et al., 1994). Downstream of this receptor two signalling
cascades are initiated; activation of STAT3 (signal transducer and activator of
transcription 3) by JAK (janus kinase) (Lutticken et al., 1994), and stimulation
of the RAS-ERK mitogen-activated protein kinase cascade (Takahashi-Tezuka et
al., 1998).
The role of STAT3 STAT3 activation is thought to be essential for the self-
renewal of ES cells grown in serum + Lif conditions because ES cells expressing a
dominant interfering mutant of STAT3 could not be isolated (Niwa et al., 1998).
Furthermore, inducing expression of the dominant interfering form of STAT3
in ES cells abrogated self-renewal and promoted differentiation. Lif/STAT3 are
thought to control ES cell self-renewal and pluripotency in part through a MYC-
dependent mechanism. Mouse ES cells express high levels of the MYC transcrip-
tion factor and constitutive expression of stable MYC results in Lif independent
self-renewal and pluripotency (Cartwright et al., 2005).
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1.4.1.4 Serum-free culture of ES cells
Lif and BMP A conclusion that STAT3 activation is the only requirement
for ES cell propagation is premature, because the addition of serum to culture
medium may be fulfilling other requirements. Therefore a key goal was to re-
move serum from ES cell culture in order to grow the cells in completely defined
conditions. ES cells can be grown in medium containing serum substitute supple-
mented with Lif but only at high densities. Colony formation from single cells is
not possible in these conditions (Ying et al., 2003). In the absence of serum, neu-
ral differentiation is only partly inhibited by the presence of Lif and self-renewal
is attenuated. A breakthrough came when it was shown that addition of the
anti-neural factor BMP4 in combination with Lif was sufficient to support ES
cell self-renewal in the serum-free media N2B27 (Ying et al., 2003) (Figure 1.9c).
The BMP4 pathway signals through SMAD 1, 5 and 8 induce expression of ID
proteins, which suppress differentiation. Constitutive expression of ID1, 2 or 3 is
sufficient to replace the requirement for BMP or serum (Ying et al., 2003).
Culture of ES cells in the presence of small molecule inhibitors More
recently, it has been shown that ES cells do not require extrinsic factors for
self-renewal or maintenance of their pluripotent state (Ying et al., 2008) (Figure
1.9d). Small molecule inhibition of the ERK signalling cascade and GSK3B
allowed propagation of mouse ES cells with a similar proliferation rate to cells
grown in serum with Lif. Expression of pluripotency markers was maintained
and colonies could be grown from single cells. ES cells could be derived in the
inhibitor medium and, crucially, contributed to tissues from all three germ layers
in chimaeric mice as well as showing germline transmission of their genome.
The inhibitor medium works through addition of small molecule inhibitors of Fgf
receptor tyrosine kinases (SU5402) and mitogen activated protein/extracellular
signal-regulated kinase (ERK) kinase (MEK) (PD184352), which together inhibit
pro-differentiation signalling via mitogen-activated protein kinase. These two
inhibitors can be replaced by a single, more potent, MEK inhibitor (PD0325901).
Additional inhibition of GSK3B by CHIR99021 is thought to improve growth
and viability of the ES cell cultures. The fact that ES cells can maintain their
pluripotency and ability to self-renew in the absence of extrinsic stimuli suggests
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that they may represent a primitive ‘ground state’, which is self-maintaining if
shielded from differentiation stimuli.
1.4.2 Pluripotency of mouse ES cells
1.4.2.1 Intrinsic determinants
Oct4 The embryonic stem cell state is maintained by expression of a network of
key transcription factors with Oct4, Sox2 and Nanog at its core. Oct4 (octamer-
binding transcription factor 4), also known as POU5f1 (POU domain, class 5,
transcription factor 1), is a homeodomain transcription factor, which is expressed
in pluripotent cells of the early embryo, germ cells and embryonic stem cells
(Okamoto et al., 1990, Rosner et al., 1990, Scholer et al., 1990). Oct4 is required
for maintenance of the pluripotent cell population in the early embryo and its
absence is thought to cause differentiation along the trophoblast lineage (Nichols
et al., 1998).
Sox2 The SRY-related HMG-box (SOX) family of transcription factors are
involved in the regulation of embryonic development and cell fate and have a
single HMG DNA-binding domain. Sox2 is developmentally regulated (Wiebe et
al., 2000), expressed in the pluripotent lineage of the early mouse embryo and
its down-regulation correlates with a commitment to differentiate (Avilion et al.,
2003). If Sox2 is removed from ES cells, as in the Sox2 -inducible null ES cell
line generated by Masui et al., the cells differentiate, and the majority become
trophectoderm-like cells as assessed by expression of trophectoderm marker genes
(Masui et al., 2007).
Nanog Nanog was added to the core transcriptional network of ES cells in
2003 following its discovery by Chambers et al. (2003) and Mitsui et al. (2003).
The homeobox transcription factor is expressed in the inner cells of a compacted
morula and blastocyst as well as in early germ cells and ES cells. Nanog is key
for early cell fate specification because its ablation causes early pluripotent cells
to adopt a differentiated parietal/visceral endoderm fate (Mitsui et al., 2003).
Additionally, Nanog overexpression allows self-renewal of ES cells independent
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Figure 1.9 – Summary of ES cell culture conditions. Mouse ES cells were initially grown
on a layer of mouse embryonic fibroblast cells in the presence of serum (+ Feeders +
Serum) and maintained ES cells in a undifferentiated state through the presence of un-
defined factors from serum and produced by feeder cells. The cytokine Lif can substitute
for the presence of feeder layer through activation of STAT3, which is thought to inhibit
pro-differentiation signalling downstream of Erk (+ Serum + Lif). ES cells can be grown
in serum-free conditions by addition of the Lif cytokine and bone morphogenic proteins
(Bmps), which activate the Smad pathway and induce expression of Inhibitor of Differenti-
ation (Id) proteins (N2B27 +Lif + Bmp). ES cells can be grown in the absence of extrinsic
factors through growth in serum-free conditions with the addition of small molecule in-
hibitors of the Erk signalling pathway and of GSK3B (N2B27 + inhibitors).
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of Lif stimulation of STAT3 (Mitsui et al., 2003 & Chambers et al., 2003) and
reduces the differentiation potential of the ES cells (Chambers et al., 2003).
1.4.2.2 Transcriptional regulation by pluripotency factors
ChIp analysis has shown that Oct4, Sox2 and Nanog show extensive co-binding of
the same regions of the mouse genome (Chen et al., 2008, Marson et al., 2008). In
addition to these three core pluripotency factors, are multiple other transcription
factors that are important in maintaining ES cell identity, including SMAD1,
STAT3 and TCF3, the downstream effectors of signalling pathways triggered by
BMP, Lif and Wnt, respectively. SMAD1, STAT3 and TCF3 were found to co-
occupy promoter regions with Oct4 and Nanog, linking extracellular signalling
with the core transcriptional network of ES cells (Chen et al., 2008, Cole et al.,
2008).
The key pluripotency factors bind to the promoters of a large number of genes,
many of which are transcription factors (Loh et al., 2006). In this way they may
initiate cascades of downstream regulatory events from upstream events. Oct4
can also regulate expression of other target genes through its positive regulation of
histone modifiers, including Jmjd1a and Jmjd2c, which prevent the accumulation
of repressive methylation at the promoters of genes maintaining pluripotency (Loh
et al., 2007). Indeed the chromatin of mouse ES cells has hallmarks of highly
active chromatin including a higher-order structure (Meshorer & Misteli, 2006),
which may prove essential for maintenance of pluripotency.
1.4.3 Other pluripotent cell types
1.4.3.1 EpiSCs
The epiblast will go on to form all the cells of the embryo proper, and is a distinct
entity from the inner cell mass, which forms the epiblast and primitive endoderm
lineages. Cells derived from the epiblast are termed epiblast stem cells (EpiSCs)
and require different culture conditions from ES cells, which are derived from the
ICM (Brons et al., 2007, Tesar et al., 2007). These cells are ‘primed’ pluripotent
stem cells because they retain the ability to form teratomas in nude mice but not
Chapter 1. Introduction 36
the ability to form chimaeric embryos. EpiSCs also differ from ES cells in that
they express some genes normally expressed by the pre-gastrulation epiblast that
are expressed at low levels in ES cells such as Fgf5, and lack expression of some
ES cell associated genes such as Rex1 (Brons et al., 2007).
1.4.3.2 iPS cells
ES cells retain the potential to differentiate into any tissue of the three germ
lineages if grown in the appropriate conditions. This property is lost as cells dif-
ferentiate down a particular lineage. However, seminal work by Yamanaka’s labo-
ratory showed that it is possible to take differentiated cells and convert them back
into a pluripotent state (Takahashi & Yamanaka, 2006). The so-called induced
pluripotent stem (iPS) cells show similar characteristics to ES cells and have the
ability to contribute to chimaeric animals and transmit their genome through
the germline. Since the first iPS cells were generated from mice in 2006 many
laboratories have used the technology to attempt generation of iPS cells from
different species (Martins-Taylor & Xu, 2010). Different technical approaches are
now available but the basic principle remains the same: A combination of defined
factors, which may include Oct4, Sox2, C-MYC, Klf4, Nanog and Lin28, are intro-
duced into somatic cells by retroviral or adenoviral transduction or transfection
of expression vectors. Outgrowing colonies are picked, expanded and assessed for
expression of pluripotency genes before being subjected to tests of their develop-
mental potential.
The observation that differentiated cells can be reprogrammed to a pluripotent
state is perhaps not surprising, given that a nucleus from a somatic cell can be
reprogrammed by its nuclear transfer into an enucleated oocyte (Wilmut et al.,
1997) and that cell fusion of embryonic germ cells with somatic cells results in
pluripotent cells that can contribute to the three germ layers in chimaeric embryos
(Tada et al., 1997). Nevertheless, transcription factor induced reprogramming is
the best evidence so far of the plasticity of cells in response to changes in their
transcriptional regulators. Furthermore, this method can be used to generate
pluripotent cells from human somatic cells, which could be used to generate
patient-specific cells for tissue repair or replacement thus avoiding immunological
rejection and ethical issues associated with alternate sources of pluripotent cells.
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1.4.3.3 Similarities between iPS cells and ES cells
There are numerous studies that claim that iPS cells and ES cells are morpho-
logically, functionally and molecularly equivalent but also a substantial number
of studies claiming molecular differences between both mouse and human iPS
cells and ES cells (reviewed in Plath & Lowry, 2011). Notably, two groups have
shown that the DNA methylation pattern of the original cell persists in iPS cells
and that this affects their ability to differentiate down particular lineages (Polo
et al., 2010, Kim et al., 2010c). Therefore, although the potential of iPS cells
as sources of clinically relevant populations of differentiated cells is unparalleled,
current problems with reprogramming mean that ES cell research is equally as
relevant with the advent of iPS cells as it was before.
1.4.4 Differentiation of mouse ES cells
1.4.4.1 in vitro differentiation
The potential of ES cells to form any tissue from the three germ lineages has
tremendous potential for the study of development and disease, testing of ther-
apeutics and generation of clinically relevant populations of cells. ES cell dif-
ferentiation into multiple cell types has been demonstrated in vitro through the
formation of three-dimensional aggregates called embryoid bodies, through mono-
layer culture on extracellular matrix proteins and through culture of ES cells on
supportive stromal layers (Murry & Keller, 2008). However, although multiple
cell types may terminally differentiate from ES cells, it is believed that ES cells
only have the capacity to directly differentiate into three cell types: the primitive
ectoderm, the primitive endoderm and the trophectoderm (Niwa H., 2010).
Many methods of differentiating ES cells involve the supplementation of culture
media with fetal calf serum, which is a poorly defined combination of factors
with batch-to-batch variation. This had led to problems with reproduction of
differentiation protocols but advances including the use of serum-free media with
specific inducers are beginning to address this issue (Murry & Keller, 2008).
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1.4.4.2 Heterogeneity of ES cell cultures
Even in defined differentiation conditions, however, not all ES cells will differen-
tiate down the lineage of choice (Lowell et al., 2006). While the reason behind
this is not completely clear, it is known that individual ES cells within a culture
show distinct expression patterns of a small number of genes. Nanog expression
is heterogeneous in ES cells (Singh et al., 2007) as is expression of Gata6, Rex1
and Stella (Singh et al., 2007, Toyooka et al., 2008, Hayashi et al., 2008b). This
heterogeneity does not represent distinct stable cell populations because isolated
positive and negative populations will regain heterogeneous expression after a pe-
riod of culture. However, positive or negative populations show different differen-
tiation potential, suggesting that ES cells can oscillate between states predisposed
to self-renewal (naïve) or differentiation into a particular lineage (primed).
1.4.4.3 Signalling pathways controlling ES cell differentiation
It has already been mentioned that suppression of the ERK signalling pathway
(in combination with GSK3B inhibition) permits self-renewal of ES cells in the
absence of extrinsic stimuli. This is thought to be because signalling through
FGF/ERK initiates differentiation of ES cells (Kunath et al., 2007, Stavridis et
al., 2007). In this way ES cells can be said to inherently drive differentiation,
because they produce FGF4, which activates autocrine ERK signalling. Tradi-
tional culture of ES cells in Lif and serum/BMP4 is thought to counterbalance
the pro-differentiative autocrine FGF4/ERK signal by inhibiting differentiation
downstream of ERK signalling (Ying et al., 2008).
1.4.4.4 A new theory of differentiation
Traditionally, it has been thought that ES cell pluripotency genes must be down
regulated in order for an ES cell to differentiate. Recently, a new theory of pluripo-
tency has been proposed. A review by Loh and Lim (2011) introduced the concept
that rather than existing as a stable ‘ground’ state, the pluripotent state is a re-
sult of competition between different pluripotency factors that each have lineage-
specifying actions. This theory is supported by a paper from Ramanathan’s lab-
oratory, which claims that Oct4 and Sox2 orchestrate germ layer fate selection
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with Oct4 supressing neuroectodermal differentiation and promoting mesendo-
dermal differentiation, and Sox2 inhibiting mesendodermal differentiation while
promoting neuroectodermal differentiation (Thomson et al., 2011). The concept
of pluripotency as an unstable battlefield rather than a stable self-maintaining
state needs further investigation but may help to explain how pluripotency is
maintained in the early embryo in the presence of pro-differentiation signalling.
1.4.4.5 The relationship between mouse ES cells and the early embryo
Cells of the early embryo express similar pluripotency markers to ES cells in
culture and show heterogeneous expression of Nanog and Gata6, which is also seen
in ES cells (Singh et al., 2007). One major anomaly between traditional mouse
ES cell culture and the early embryo, is that while activation of STAT3 (induced
through Lif signalling) is required for maintenance of ES cells in culture, lif null
mice develop normally (Stewart et al., 1992) and STAT3 null embryos do not
arrest until after implantation having formed normal preimplantation blastocysts
(Takeda et al., 1997). However, although gp130 null embryos can proceed through
early embryogenesis, they cannot maintain a pluripotent cell population during
diapause (Nichols et al., 2001). This suggests that activation of STAT3 is required
for in vivo maintenance of the pluripotent cell population during developmental
arrest and provides a physiological rationale for the responsiveness of mouse ES
cells to signalling via gp130 cytokines.
Early mouse embryos can be cultured in the presence of the MEK inhibitor,
PD0325901, and behave in a similar manner to cultured cells grown in these
conditions, with homogeneous expression of Nanog and loss of paternal X chro-
mosome inactivation in XX embryos (Nichols et al., 2009). Cells of the embryo
grown in the presence of the MEK inhibitor maintain pluripotency as assessed by
formation of germline-competent chimaeras and are amenable to efficient deriva-
tion of ES cell clones from single cells. The authors concluded that mouse ES
cells are in the same state as naïve epiblast and intrinsic self-replication is not an
adaptation to culture.
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1.4.5 Mouse ES cells as models of early differentiation and
development
Mouse ES cells are amenable to genetic manipulation and can therefore be used
as a tool to study gene function through generation of knockout mouse lines. In
addition to this, their similarity with cells of the early mouse embryo and ability
to differentiate in culture mean that ES cells are an excellent model system for
the study of molecular mechanisms underpinning cell fate transitions. Below
is an account of in vitro differentiation systems for ES cells that model early
developmental transitions.
1.4.5.1 Trophectoderm differentiation from ES cells
As ES cells are derived from the ICM and do not contribute efficiently to trophec-
todermal lineages following injection into blastocysts (Beddington & Robertson,
1989), it was originally considered that ES cells could not generate trophecto-
derm directly. However, it is now known that ES cells can be induced to form
trophoblast stem (TS) cells in culture through manipulation of specific transcrip-
tion factors (Niwa, 2010) including the ES cell master regulator Oct4 (Niwa et
al., 2000) or the homeobox gene Cdx2 (Niwa et al., 2005, Hay et al., 2004).
Trophectoderm differentiation can be induced in the ZHBTc4 ES cell system
(Niwa et al., 2000) by the rapid downregulation of Oct4 expression, described
in section 3.1.1. Upon rapid Oct4 downregulation, several trophoblast-associated
genes are upregulated, including the transcription factors Cdx2 and Eomes (Niwa
et al., 2000). Missexpression in ES cells of both Cdx2 and Eomes induces the ex-
pression of other trophoblast-associated genes such as placental cadherin (Cdh3 )
(Niwa et al., 2005). In particular, missexpression of Cdx2 leads to TE differenti-
ation, where TS cells can be derived that will contribute to the placental lineage
in vivo. In summary, although the ICM and TE differentiate prior to the point
of ES cells isolation from the ICM, ES cells retain the ability to differentiate
into trophoblast lineages and can be induced to do so by manipulation of key
transcription factors.
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1.4.5.2 Primitive endoderm differentiation
Differentiation into primitive endoderm can be initiated in 3D aggregates of ES
cells called embryoid bodies (EBs) where it forms as a layer on the EB sur-
face. EBs loosely mimic early embryonic development and the similarities are
clear when comparing Gata6 knockout embryos, which do not form primitive
endoderm, and EBs generated from Gata6 knockout ES cells, which mimic this
phenotype (Capo-Chichi et al., 2005, Cai et al., 2008). Primitive endoderm cells
from embryos can be maintained in vitro as extraembryonic endoderm (XEN)
cells (Kunath et al., 2005) and XEN-like cells can be induced directly from ES
cells by forced expression of Gata4 or Gata6 (Fujikura et al., 2002).
1.4.5.3 Primitive ectoderm differentiation
Primitive ectoderm can be formed from ES cells in EB culture, in which cells in
the interior of the structure form pluripotent epithelium equivalent to primitive
ectoderm and express the primitive ectoderm marker Fgf5 (Haub & Goldfarb,
1991, Hebert et al., 1991). Monolayer culture of ES cells in the absence of Lif
also leads to Fgf5 upregulation, suggesting that a proportion of these cells ac-
quire a primitive ectoderm like state. Crucially, upregulation of Fgf5 expression
always occurs prior to differentiation of various embryonic lineages but not ex-
traembryonic lineages. This means than in order for ES cells to differentiate
into embryonic lineages it is thought that they must first go through a primitive
ectoderm-like state, recapitulating what is seen in the early embryo (Niwa, 2010,
Shimozaki et al., 2003).
1.4.5.4 Germ layer differentiation
In the early embryo, the three germ layers are produced from primitive ectoderm
during the process of gastrulation. Although it has been known for a long time
that cells belonging to the three germ lineages can be formed during EB differen-
tiation (Doetschman et al., 1985), it was only shown recently that a gastrulation-
like process can occur in EBs (ten Berge et al., 2008). Embryoid bodies were
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Figure 1.10 – ES cells as models of developmental transitions. Three cell types can be
derived from late blastocyst embryos and propagated in vitro: trophoblast stem (TS) cells,
embryonic stem (ES) cells and extra-embryonic endoderm (XEN) cells. ES cells can be
induced to differentiate into TS cells or XEN cells in vitro by genetic manipulation. They
can also form embryoid bodies, which generate cells belonging to the three germ lineages.
Figure adapted from Niwa (2010).
shown to exhibit anterior-posterior polarity and formation of a primitive streak-
like region, which was dependent on local activation of the Wnt signalling pathway
(ten Berge et al., 2008).
1.4.5.5 ES cells provide an ideal system to model early developmental
transitions
The study of early mammalian developmental transitions is hampered by the fact
that development occurs in utero. However, the derivation and culture of em-
bryonic cells in vitro provides an ideal opportunity to study the factors involved
in developmental processes. As detailed above, cells representing the three earli-
est mouse lineages, the TE, the ICM and the extraembryonic endoderm, can be
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maintained in culture, retain properties of the tissue of origin, and can be rein-
troduced to an early embryo and contribute solely to the tissue of origin. ES cells
are similar to cells of the ICM, retain pluripotency in culture and can be induced
to differentiate, mimicking early developmental processes in vitro. ES cells can be
induced to differentiate into cell types representative of the TE and extraembry-
onic endoderm (Figure 1.10 ), and differentiated cells will contribute exclusively
to these lineages upon introduction to an embryo (Shimosato et al., 2007, Niwa et
al., 2005). Additionally, ES cells can be induced to form embryoid bodies (Figure
1.10 ), which recapitulate aspects of embryonic development in vitro. Together,
these findings show that ES cells provide an ideal model system for the study of
factors involved in the regulation of early developmental decisions.
1.4.6 Summary
While much is now understood about the transcription factor network and sig-
nalling pathways underpinning the pluripotent state, the details of how this state
is maintained are still to be confirmed. However, it has been shown that ES cells
share similar properties with pluripotent cells of the early embryo and can be
used as excellent model systems of early developmental events.
1.5 miRNAs in developmental transitions
miRNAs were first discovered in C. elegans, as regulators of developmental tran-
sitions. Since then these small molecules have been shown to have roles in many
physiological processes, including essential functions for the correct development
of multiple species (Wienholds et al., 2003, Lee et al., 1993, Reinhart et al., 2000,
Brennecke et al., 2003, Bernstein et al., 2003, Wang et al., 2007). This section
will introduce the modes of regulation by which miRNAs may operate during
development, as well as what is currently known about the roles of miRNAs in
early mammalian development and ES cells.
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1.5.1 miRNAs regulate developmental processes
miRNAs act through several modes of regulation during development including
developmental switches, adding robustness to developmental programs and regu-
lating proliferation and apoptosis. Some examples of the role of miRNAs during
development are mentioned below.
1.5.1.1 miRNAs as developmental switches
In the nematode worm C. elegans the first discovered miRNA, lin-4, is an example
of a miRNA acting as a developmental switch. If lin-4 is lost C. elegans cannot
undergo the transition from the first to the second larval stage (Lee et al., 1993).
Cell lineage patterns normally specific for the first larval stage are reiterated at
later larval stages, with the animals going through additional larval moults. This
phenotype is due to the loss of repression of lin-14, a direct target of lin-4, which
is normally down regulated during the first larval stage.
miRNAs are also required for the developmental switch from neurogenesis to gli-
ogenesis in the developing spinal cord of the mouse (Zheng et al., 2010). Neural
and glial cells are produced sequentially from ventricular neural progenitor cells
in the developing CNS and a key question is how the switch from neurogenesis to
gliogenesis is controlled. Zheng et al. generated Olig1Cre-mediated conditional
Dicer -/- mice, which were deficient for miRNA processing in the ventral neuroep-
ithelium. Astrogliogenesis and oligodendrogenesis was severely disrupted in the
conditional Dicer -/- mice but neural patterning and motor neuron development
was not affected. This suggests that miRNAs are required for the developmental
switch from neurogenesis to gliogenesis.
1.5.1.2 miRNAs add robustness to developmental programs
It is thought that miRNAs are predominantly involved in increasing the robust-
ness of developmental decisions, rather than directly regulating them. For exam-
ple the miR-430 family are required in the zebrafish embryo during the process
of activation of zygotic transcription. In these embryos the miR-430 family are
expressed at high levels coincident with the start of zygotic gene expression. If
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these embryos are depleted for miRNAs, brain defects result, but these defects can
be rescued by the injection of miR-430 (Giraldez et al., 2005). Several hundred
transcripts are regulated by miR-430, a large proportion of which are maternal
transcripts (Giraldez et al., 2006). This suggests that miR-430 is required to ac-
celerate the clearance of maternal transcripts at the start of zygotic transcription
adding robustness to the material to zygotic transition.
1.5.1.3 miRNAs regulate proliferation and apoptosis
Other processes essential for correct development are also regulated by miRNAs
including proliferation and apoptosis. An example of miRNA-regulation of apop-
tosis is seen in Drosophila embryos that lack the miRNA bantam are small and
die as early pupae (Brennecke et al., 2003). Normally, bantam is thought to pro-
mote tissue growth by regulating the proapoptotic gene hid, which contains five
bantam target sites in its 3’ UTR. Hid expression induced apoptosis, but Hid -
induced apoptosis could be suppressed by introduction of bantam showing that
at least part of the phenotype of the bantam mutant is due to loss of regulation
of Hid expression. miRNAs are known to play roles in regulating proliferation
through involvement in cell cycle regulation (Wang et al., 2008) and through
regulating the switch between proliferation and differentiation (Yi et al., 2008).
1.5.1.4 miRNAs are essential for embryonic development
The requirement of miRNAs for correct development is widely conserved and
is exemplified by the creation of mutants that are negative for components of
the miRNA-processing pathway. Dicer1-null zebrafish arrest at day 10 of devel-
opment (Wienholds et al., 2003), correct development timing in the nematode
worm C. elegans depends upon the expression of miRNAs lin-4 and let-7 (Lee et
al., 1993, Reinhart et al., 2000) and the Drosophila miRNA bantam controls cell
proliferation during fruit fly development (Brennecke et al., 2003).
miRNAs are also essential for early mammalian development. Dicer -/- murine
embryos are reported to arrest around E7.5, when the embryo is undergoing
gastrulation (Bernstein et al., 2003) (Figure 1.11 ) and DGCR8-/- embryos are
reported to arrest prior to E6.5, the point at which gastrulation commences (Wang
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Figure 1.11 – Dicer-/- and wt embryos. Bernstein et al. (2003) disrupted the Dicer
gene in mice. Homozygous null embryos arrested at approximately E7.5. (a) Typical E7.5
wt and mutant embryos. Mutant embryos appear small and morphologically abnormal
although embryonic-extraembryonic regions are distinguishable. (b) In situ hybridisation
for brachyury, a marker of the primitive streak, showed that mutant embryos did not express
brachyury. (c) In situ hybridisation for Oct4 showed that staining was much reduced in
mutant embryos. Figure from Bernstein et al. (2003).
et al., 2007). In situ hybridisation showed reduced Oct4 expression in Dicer -/-
embryos compared to wt embryos and no detectable expression of Brachyury.
The authors concluded that Dicer -/- embryos exhibited a loss of stem cells and
a failure to specify the primitive streak. The exact reason for developmental
arrest of miRNA-deficient embryos is not known but both Dicer -/- and DGCR8-/-
embryos are fully resorbed by E10 with only evidence of implantation remaining.
1.5.2 miRNAs in early mouse development
miRNAs are expressed in mouse embryos in a spatial and temporal fashion
(Wheeler et al., 2006, Mineno et al., 2006, Takada et al., 2006). Loss of the
miRNA processing enzymes Dicer1 and DGCR8 demonstrate that the global
miRNA population is essential for mammalian development (Bernstein et al.,
2003, Wang et al., 2007) and more recent work has shown that they are involved
in multiple processes during early mouse development.
1.5.2.1 miRNAs in early lineage specification and gastrulation
miRNAs are involved in developmental processes as early as gametogenesis. Mice
deficient for Dicer1 have primordial germ cells (PGCs) with reduced proliferation
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rates and have retarded spermatogenesis (Hayashi et al., 2008a). In contrast to
their essential role in murine spermatogenesis, miRNAs do not appear to function
during oogenesis. Indeed, oocytes deficient for DGCR8 have no phenotype and
show no change in mRNA levels relative to wild type oocytes (Suh et al., 2010).
Spruce et al. (2010) performed a comprehensive analysis of early mouse embryos
with zygotic loss of Dicer. Such embryos showed initial specification of the epi-
blast with strong expression of Oct4 and Cripto. Expression of markers of the
primitive streak, Eomes (which is also a trophectoderm marker), Brachyury and
Nodal, showed that gastrulation was initiated but delayed in mutant embryos.
Additionally, markers of definitive endoderm were either drastically reduced or
lost in the majority of mutant embryos. Overall, the results showed that Dicer -/-
embryos could form an epiblast and initiate gastrulation but that progression of
patterning was abnormal (Spruce et al., 2010). A large caveat remains with this
data however, because the embryos were deficient for zygotic Dicer, but contribu-
tion of miRNAs generated by maternal Dicer could not be excluded. In fact, the
authors found similar levels of miR-291-3p, miR-295 and miR-291-5p in mutant
and wild type blastocysts. Therefore the authors could not determine if miRNAs
have a role in specification of the first lineages of the blastocyst. Additionally,
the findings of Spruce et al. disagreed with those of Bernstein et al. (mentioned
above) who found that Dicer -/- embryos exhibited loss of the stem cell population
and an inability to specify the primitive streak (Bernstein et al., 2003).
1.5.2.2 miRNA knockout mice
The generation of mice deficient for miRNA clusters has provided insight into
the role of specific miRNAs during mouse development. Deficiency for the miR-
290-295 cluster of miRNAs results in high incidences of embryonic lethality, with
homozygous null embryos showing general developmental delays or partial or
complete localisation outwith the yolk sac (Medeiros et al., 2011). However, a
proportion of homozygous null mice reach birth and are viable, although female
mice are infertile. This shows that while this miRNA cluster is important for
correct development, it is not essential. Mice homozygous null for the miR-17-
92 cluster of miRNAs die shortly after birth with lung hypoplasia, ventricular
septal defects and a reduction in the number of pre-B cells in fetal livers (Ventura
et al., 2008). Interestingly, while ablation of the miR-106b-25 or miR-106a-363
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clusters had no obvious phenotypic effect, embryos lacking both the miR-17-92
and miR-106b-25 clusters or all three miRNA clusters had a much more severe
phenotype than the miR-17-92 knockout alone and died midgestation. Together,
these results show that miRNAs play essential roles during mouse embryonic
development.
1.5.3 miRNAs in ES cells
1.5.3.1 Expression of miRNAs in ES cells
miRNA expression was first assessed in mouse ES cells in 2003 when Phillip
Sharp’s laboratory cloned short 20-26nt RNAs from undifferentiated and differ-
entiated ES cells (Houbaviy et al., 2003). They found miRNAs associated with
the undifferentiated and differentiated states including the miR-290-295 family,
which were highly expressed in undifferentiated mouse ES cells. Since then, an-
other study has shown that the miR-290-295 cluster made up between 23% and
29% of miRNA sequences from mouse ES cells, the largest proportion attributed
to a single miRNA cluster (Calabrese et al., 2007). Although the miR-290-295
cluster are expressed at very high levels in mouse ES cells, they are not found in
human ES cells (Suh et al., 2004). However, human ES cells express high levels of
the miR-371-373 and miR-302-367 cluster miRNAs, which are sequence related
to miR-290-295 (Suh et al., 2004). Despite the early arrest of miRNA-deficient
embryos, Dicer -/- and DGCR8-/- ES cells can be maintained in vitro (Murchison
et al., 2005, Kanellopoulou et al., 2005, Wang et al., 2007). These cells express
markers of pluripotency and replicate indefinitely but show defects in rate of
growth and differentiation capacity.
1.5.3.2 The phenotype of Dicer -/- ES cells
Dicer is an RNAse III enzyme that is involved in miRNA and siRNA biogenesis.
Dicer -/- ES cells have been generated by two independent laboratories (Murchi-
son et al., 2005, Kanellopoulou et al., 2007) and are deficient for miRNAs and
siRNAs. Murchison et al. generated conditional Dicer -/- ES cells and made the
observation that their proliferation rate was slower than that of WT ES cells.
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This was attributed to an alteration of the cell cycle, which showed an increase
in cells in G1 and G0 phases and a corresponding decrease of cells in G2 and M
phase. The authors reported that the Dicer -/- ES cells expressed ES cell marker
genes including Oct4, but showed an increase in transcripts derived from hete-
rochromatic repeats. Kanellopoulou et al. also generated Dicer -/- ES cells and
reported that they expressed the ES cell marker Oct4 at comparable levels to
WT ES cells, but proliferated more slowly and were defective in epigenetic si-
lencing of centromeric repeat sequences similar to the findings of Murchison et al.
Kanellopoulou et al. also investigated the differentiation potential of the Dicer -/-
ES cells. They found that embryoid body induced differentiation of Dicer -/- ES
cells showed severe defects. There was little morphological evidence of differenti-
ation and no expression of differentiation markers of the three germ lineages was
detectable.
1.5.3.3 The phenotype of DGCR8-/- ES cells
DGCR8 is a component of the microprocessor complex, which is involved in
miRNA biogenesis (Figure 1.2 ). Removal of DGCR8 from mouse ES cells re-
sulted in viable cells that did not express canonical miRNAs (Wang et al., 2007).
DGCR8-/- ES cells have provided an excellent model for elucidating the function
of miRNAs in ES cells because individual miRNAs can be reintroduced to these
cells and the effect, if any, on the phenotype of the cells can be assessed. In this
way miRNAs controlling proliferation have been determined. DGCR8-/- ES cells
show a reduction in proliferation rate, which is associated with accumulation of
the cells in the G1 phase of the cell cycle (Wang et al., 2008). Wang and oth-
ers used a screen to test the effects of re-introducing 461 individual miRNAs on
proliferation of the DGCR8-/- ES cells. They identified 14 different miRNAs that
rescued the proliferation defect (Wang et al., 2008). These miRNAs belonged
to three families: the miR-290, the miR-302 and the miR-17-92a clusters of
miRNAs, which are all highly expressed in ES cells and down-regulated upon dif-
ferentiation. Collectively, these miRNAs were termed ESCC (for ESC-specific cell
cycle regulating) miRNAs. These findings suggest that a major role for miRNAs
in ES cells is to ensure rapid cell cycle progression. The miRNAs achieve this,
at least in part, by inhibiting inhibitors of the CyclinE/CDK2 pathway (p21cip,
Rbl2 and Lats2 ), which regulates the G1/S transition (Wang et al., 2008). The
phenotype of miRNA-deficient ES cells is discussed in more detail in section 5.1.1.
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1.5.4 The role of miRNAs in ES cell differentiation
1.5.4.1 The let-7 family of miRNAs
Profiling of miRNAs during ES cell differentiation has revealed specific miR-
NAs that increase in expression during differentiation (Krichevsky et al., 2006,
Ivey et al., 2008). One family of miRNAs that is strongly associated with ES
cell differentiation is the let-7 family (Viswanathan et al., 2008). DGCR8-/- ES
cells are reported to show an inability to silence self-renewal when induced to
differentiate, but introduction of let-7 miRNAs is sufficient to rescue this defect
(Melton et al., 2010). Interestingly, while mature let-7g is not found in undifferen-
tiated ES cells, the pri-let7g transcript is readily detectable (Viswanathan et al.,
2008). Viswananthan et al. (2008) determined that a protein highly expressed in
ES cells, LIN28, interacted with pri-miR-let7g and inhibited its cleavage by the
microprocessor complex. Additionally, LIN28 also regulates expression of let-7
miRNAs by binding to pre-let7 and promoting its polyuridylation targeting it for
degradation (Heo et al., 2008). LIN28 is expressed highly in undifferentiated ES
cells and its expression decreases during differentiation. This allows expression
of mature let-7 miRNAs to increase and inhibit self-renewal genes adding a layer
of robustness to the differentiation switch.
1.5.4.2 miRNA regulation of pluripotency genes
There are examples of miRNAs that directly regulate key ES cell pluripotency
genes such as Oct4, Sox2 and Nanog during differentiation. Upon retinoic acid
induced differentiation of mouse ES cells, miR-134, miR-296 and miR-470 are
up-regulated. miR-470 directly regulates expression of Nanog and Oct4, miR-
296 directly regulates expression of Nanog and miR-134 directly regulates Sox2
expression (Tay et al., 2008a). Another study showed that expression of Sox2
and Klf4 is down regulated by miR-200c in mouse ES cells, but did not confirm
a direct interaction (Wellner et al., 2009). In human ES cells miR-145 has been
shown to target Oct4, Sox2 and Klf4 during ES cell differentiation and this
interaction is part of a negative feedback loop because the miR-145 promoter is
bound and repressed by Oct4 in human ES cells (Xu et al., 2009).
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1.5.4.3 miRNA regulation of epigenetics in ES cells
Characterisation of Dicer -/- ES cells also showed that expression of the de novo
DNA methytransferase genes Dnmt3a, Dnmt3b and Dnmt3l were significantly
down regulated in the Dicer -/- cells (Sinkkonen et al., 2008), but that this could
be rescued by expression of miR-290 family miRNAs. Oct4 silencing in differ-
entiating Dicer -/- ES cells was accompanied by the accumulation of repressive
histone marks but not by DNA methylation, which indicated an inability to sta-
bly repress Oct4. Introduction of Dnmts or the miR-290 cluster rescued the
defective Oct4 promoter methylation indicating a requirement for these miRNAs
for stable repression of pluripotency genes during differentiation.
1.5.5 The role of miRNAs in reprogramming
As well as roles in differentiation, miRNA have also been shown to have roles in
the process of de-differentiation, or reprogramming. Introduction of the embry-
onic stem cell specific miRNAs miR-291-3p, miR-294 and miR-295 along with
retroviruses expressing Oct4, Sox2 and Klf4 enhanced reprogramming in the ab-
sence of C-MYC (Judson et al., 2009). C-MYC binds the promoter of these
miRNAs, which may suggest that the requirement for C-MYC to increase the
efficiency of reprogramming is mediated through these miRNAs. Reports have
also shown that overexpression of miR-302 can reprogram human cancer cells (Li
et al., 2008) and human hair follicle cells (Li et al., 2010) into an iPS cell-like
state.
Recently, it was reported that it is possible to reprogram mouse and human so-
matic cells to pluripotency using miRNAs alone (Anokye-Danso et al., 2011).
Anokye-Danso and others expressed the miR-302-367 miRNA cluster in mouse
embryonic fibroblasts and human foreskin and dermal fibroblasts and observed
that reprogrammed iPS cell colonies were generated. These clones showed char-
acteristics of iPS cells reprogrammed by the original 4-factor approach including
teratoma formation and generation of chimaeric mice. If reproducible, this has
immense potential for iPS cell research because it abrogates the need for in-
troduction of pluripotency transcription factors and because the miRNAs show
high species conservation, which may make this approach readily usable in other
species.
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1.5.6 Summary
Proper embryonic development is dependent on accurate spatial and temporal
regulation of gene expression. miRNAs regulate gene expression post-transcriptionally,
and are essential for proper embryonic development. miRNA deficient ES cells
have been generated and shown to be viable although the cells show defects in pro-
liferation and differentiation. The miRNA-deficient ES cells provide an excellent
system for the investigation of miRNA regulation of developmental processes.
1.6 Aims and Objectives
Mammalian development is a complex series of developmental transitions, which
relies on accurate spatial and temporal regulation of gene expression. miRNAs
regulate gene expression post-transcriptionally through inhibition of translation
and/or mRNA degradation. The overall aim of this project was to investigate the
role of miRNAs in regulating developmental processes. An initial objective was
to establish whether miRNAs were dynamically regulated in a cell based model
of an early developmental transition and whether differentially expressed miR-
NAs, if any, could be functionally associated with the developmental process. In
order to explore the roles of miRNAs during an early developmental transition,
an embryonic stem (ES) cell model of trophectoderm differentiation was used. In
this model system the expression of the key ES cell regulatory gene, Oct4, can
be conditionally repressed, which induces the ES cells to differentiate down the
trophectoderm lineage. Identification of miRNA target transcripts remains a key
goal of miRNA research. Therefore, having established a role for specific miR-
NAs in developmental transitions, a further objective was to assess the reliability
of current sequence-based and experimental methods of miRNA-mRNA target
identification. In order to investigate the general role of miRNAs in regulating
developmental processes, the final objective was to compare the differentiation





2.1.1 Chemicals and Equipment
All chemicals were of molecular biology or analytical grade and were obtained
from a variety of manufacturers: Sigma, Fluka, Fisher Scientific, BDH, Fisons
and Electran. All commercial reagents and chemicals were stored according to the
manufacturer’s instructions. All water used for the preparation of solutions was
double distilled, deionised (Purite Select Analyst) and sterilised by autoclaving
(121°C, 15-20 minutes) except when working with RNA and during the PAR-
CLIP method. In these cases, deionised sterile nuclease-free water from Ambion
was used. Radioisotopes (EasyTides Adenoside 5’-triphosphate-[g-32P]-) were
obtained from Perkin-Elmer. Work with radioisotopes was carried out within a
designated area of the laboratory. All solutions and microcentrifuge tubes used
for experiments involving RNA and/or PCR were autoclaved twice (121°C, 15-20
minutes). Filter tips (Art or Greiner) were used for all cell and molecular biology
work and designated tips and pipettes kept for RNA and/or PCR work. Pipettes
and working area were treated with RNAse-Zap (Ambion) prior to work involving
RNA.
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2.1.2 Reagents
2.1.2.1 LNA oligonucleotides
miRNA inhibition and detection was achieved using RNA oligonucleotides with
approximately every third RNA nucleotide replaced by an LNA-modified DNA
nucleotide (capitals). Sequences below:













Table 2.1 – Sequences of LNA oligonucleotides.
2.1.2.2 miRNA precursors
Exogenous miRNA expression was achieved using Pre-miR miRNA Precursors
from Ambion:
mmu-miR-467a* stem-loop sequence: CCUGUGUGCAUAAGUGCGCGCAU-
GUAUAUG CGUGUAUAUUUUAUGCAUAUACAUACACA CACCUACACA-
CACAUGCACACAGA CA
mmu-miR-210 stem-loop sequence: ACCCGGCAGUGCCUCCAGGCGCAGGGCAGCC
CCUGCCCACCGCACACUGCGCUGCCCCAGACCCACUGUGCGUGUGACAGCG-
GCU GAUCUGUGCCUGGGCAGCGCGACCC
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2.1.2.3 siRNA oligonucleotides
Specific mRNA knockdown was achieved using siRNA oligonucleotides (Dharma-
con). Sequences below:
siRNA targetting Oct4 : AAGGAUGUGGUUCGAGUAUGG
siRNA targetting EGFP : AAGAACGGCAUCAA GGUGAAC
2.1.2.4 QPCR Primers




























Table 2.2 – QPCR primer sequences.
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2.1.2.5 Antibodies for western analysis
Protein levels were assessed by western blot analysis using the following antibod-
ies:
Oct4 - Santa Cruz sc5279 (1:1000); ActB – Sigma Aldrich A5441 (1:5000); DGCR8
– ProteinTech 10996-1-AP (1:1000); Ago2 – WAKO BioProducts 014-2202 (1:1000);
pSTAT3 – Cell Signalling Technologies 9134S (1:1000); STAT3 – Transduction
Laboratories 610190 (1:1000); pAKT - Cell Signalling Technologies 4060S (1:1000);
AKT - Cell Signalling Technologies 4685 (1:1000); pERK - Cell Signalling Tech-
nologies 4377S (1:1000); ERK – Transduction Laboratories 61014 (1:1000); pGSK3B
- Cell Signalling Technologies 9336S (1:1000); GSK3B - Cell Signalling Technolo-
gies 9315S (1:1000).
Secondary antibodies were used at 1:2000 dilutions: Horse-anti-mouse IgG (HRP-
linked) Cell Signalling Technologies 7076S Goat-anti-rabbit IgG (HRP-linked)
Cell Signalling Technologies 7074S
2.1.2.6 Antibodies for immunohistochemistry analysis
Protein expression was visualised by immunohistochemistry using the following
antibodies: Oct4 - Santa Cruz sc5279 (1:200); Nanog - Abcam ab80892 (1:200);
Nestin - DSHB Rat-401 (1:20); Tuj1 - Covance mms-435P (1:500); E-cadherin
– Takara ECCD-2 (1:200). Secondary antibodies were Invitrogen Alexa Fluor
dye conjugated antibodies raised in donkey or goat corresponding to appropriate
antibody isotypes. Secondary antibodies were used at a 1:2000 dilution.
2.2 General Methodology
2.2.1 Cell Culture Techniques
2.2.1.1 Embryonic Stem Cell Culture
ES cells were cultured at 37°C (5% CO2) in GMEM supplemented with 10% fetal
calf serum, 2mM L-Glutamine, 1x non-essential amino acids, 1mM sodium pyru-
vate, 100uM ß-Mercaptoethanol and Lif. Lif was synthesised in the laboratory
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and its efficacy was determined by titration against commercial Lif before use
(performed by Linda Sutherland). ES cells were cultured on gelatin-coated tissue
culture treated plastic, media was replaced every 24 hours and cells were passaged
every 48 hours or when 80% confluency was reached. TVP was used to dissociate
ES cell cultures for passaging. For growth in serum-free conditions, ES cells were
first grown in standard ES cell media, cells were washed twice with 1 x PBS and
then N2B27 (Ying & Smith, 2003) or 2i media was added to cultures. 2i media
was made up fresh for each usage by addition of PD0325901 and CHIR99021
to N2B27 media to final concentrations of 1uM and 3uM, respectively. When
necessary, cells were counted using a haemocytometer before being diluted to an
appropriate concentration for plating. ES cells were passaged a maximum of 50
times. Vials containing ES cells were frozen in 10% DMSO, 50% FCS in ES cell
media at -80°C for 1 week, and then transferred to -150°C for long-term storage.
2.2.1.2 Differentiation of ZHBTc4 ES cells
5x105 ZHBTc4 ES cells were transferred to gelatin-coated T25 tissue culture flasks
in standard ES cell culture media. 24 hours later the media was removed and
replaced with standard ES cell media or ES cell media containing 1mg/ml doxycy-
cline. ZHBTc4 ES cells were grown in the presence or absence of doxycycline for
up to 96 hours with the media being replaced with fresh media (with or without
1µg/ml doxycycline) every 24 hours. Protein and RNA samples were taken every
24 hours.
2.2.1.3 Derivation of mouse embryonic fibroblasts
MEFs were derived from E12.5 and E13.5 C57/Bl6 x CBA/Ca F1 hybrid mouse
embryos. Embryos were washed in PBS with 2x Penicillin:streptomycin and inter-
nal organs were removed using forceps. Embryos were washed twice in PBS with
2x Pencillin:Streptomycin. Single embryos were placed in 7ml bijous containing
2 mls of TVP and were cut into small pieces using scissors. Bijous containing
embryos were incubated for 5 minutes at 37°C and then vortexed thoroughly.
This process was repeated to obtain a cloudy suspension. 3 mls of MEF media
(GMEM supplemented with 10% fetal calf serum, 2mM L-Glutamine, 1x non-
essential amino acids, 1mM sodium pyruvate and 100uM ß-Mercaptoethanol)
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was added to the bijou to stop the trypsinisation reaction and bijous were vor-
texed. Bijous were left to stand until any remaining pieces of tissue had sunk to
the bottom of the bijous. The top 3 mls of media was then removed from the
bijou and transferred to a gelatinised T75 tissue culture flask containing 12 mls
of MEF media. Cultures were incubated overnight at 37°C in 5% CO2. After 24
hours dead cells were removed from the flask by replacing the media with fresh
MEF media. When the cultures were 70-80% confluent, cells were trypsinised and
resuspended in 10% DMSO, 50% FCS in MEF media. 2 vials of cells per T75
flask were frozen at -80°C and transferred to -150°C one week later for long-term
storage.
2.2.1.4 Fibroblast Cell Culture
3T3 cells and mouse embryonic fibroblasts (MEFs) were grown at 37°C (5% CO2)
in GMEM supplemented with 10% fetal calf serum, 2mM L-Glutamine, 1x non-
essential amino acids, 1mM sodium pyruvate and 100uM ß-Mercaptoethanol.
Cells were grown on gelatin-coated tissue culture-treated plastic. Media was
replaced every 24 (3T3 cells) or 48 (MEFs) hours and cultures were passaged
when 80% confluency was reached (approximately every 48 hours for 3T3 cells
and every 72-96 hours for MEFs). When necessary, cells were counted using a
haemocytometer before being diluted to an appropriate concentration for plating.
3T3 cell stocks were frozen in 10% DMSO, 50% FCS in MEF media at -80°C for 1
week, and then transferred to -150°C for long-term storage. For MEFs to be used
as feeder cells, cells were grown to 70-80% confluency, trypsinised, resuspended in
MEF media in a 50ml centrifuge tube and irradiated (using a GammaCell 1000
Elite) with a 50 Gray dose. Cells were then counted and plated at a density of
1.5x105 per T25.
2.2.1.5 Culture of Embryoid Bodies
For formation of embryoid bodies (EBs) 1x106 ES cells were transferred to a
single well of a 6-well Ultra-Low Attachment® Plate (Corning®) in GMEM
supplemented with 10% fetal calf serum, 2mM L-Glutamine, 1x non-essential
amino acids, 1mM sodium pyruvate and 100uM ß-Mercaptoethanol. Media was
removed and replaced with fresh EB media every 48 hours. After 8 days in
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suspension culture 10 EBs were transferred to a single well of a 6-well gelatin-
coated tissue culture-treated plastic plate. EBs adhered to the surface of the plate
and were grown for a further 8 days. Media was removed and replaced with fresh
EB media every 48 hours. Samples were taken at the start of the experiment
(time 0), day 4, day 8, day 12 and day 16 of culture. For RNA analysis, EBs
media was replaced with 1xPBS, and then 1xPBS was removed and replaced with
1ml RNA-Bee (AMS Biotechnology), which lysed the EBs.
2.2.1.6 Transfection of ES cells and 3T3 cells
ES cells and 3T3s were transfected using the transfection reagents Lipofectamine™
2000 (Invitrogen) or Lipofectamine™ LTX (Invitrogen). Both transfection reagents
were used according to the manufacturer’s instructions. Briefly, cells were cul-
tured in 6-well plates or 96-well plates for 24 hours and the media was removed
approximately 1 hour prior to transfection and replaced with 1ml of media in
6-well plates or 100µl of media in 96-well plates. DNA/RNA for transfection was
diluted in Opti-MEM® (Invitrogen), followed by dilution of Lipofectamine 2000
or Lipofectamine LTX in Opti-MEM and incubation at room temperature for 5
minutes. An equal volume of Optimem plus Lipofectamine was added to each
tube of diluted DNA/RNA and incubated at room temperature for at least 30
minutes. An appropriate volume of transfection mix was added per well of cells.
Plates of transfected cells were incubated at 37ºC (5% CO2) overnight for a max-
imum of 18 hours. Reactions were stopped by removal of media and replacement
with fresh media.
MiRNA knockdown miRNA expression was inhibited using between 37.5nM
and 150nM of complementary RNA oligonucleotide with approximately every
third RNA nucleotide replaced by an LNA-modified DNA nucleotide (from Ex-
iqon or Sigma-Proligo). Transfections were carried out as described above.
MiRNA Overexpression miRNAs were overexpressed in cells by transfection
of between 30nM and 200nM pre-miR miRNA precursors (Ambion). Transfec-
tions were carried out as described above.
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SiRNA Knockdown For siRNA knockdown 1x105 cells were transferred to
each well of a 6-well plate. After 24 hours, media was removed and replaced
with 1ml of fresh media. Cells were transfected using the Lipofectamine™ 2000
(Invitrogen) reagent with 100ng/ml siRNA targeting Oct4 or EGFP (control).
Transfections were carried out as described above. Transfections were repeated
24 hours later using the same protocol. Samples were lysed for RNA (in 1ml
RNA-Bee) 72 hours after the first transfection.
2.2.1.7 Cell proliferation assays
The reduction of MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bro-
mide) to formazan was monitored using the Vybrant® MTT Cell Proliferation
Assay Kit (Molecular Probes) as described in the manufacturer’s instructions. For
analysis of cell proliferation after miRNA knockdown, 1x103 ES cells or 0.5x103
3T3 cells were transferred to each well of a gelatin-coated tissue culture-treated
96-well plate. After 24 hours, media was replaced with 100µl of fresh media
and cells were transfected overnight with LNA oligonucleotides complementary
to various miRNAs using 1ml per well of Lipofectamine LTX. Transfection reac-
tions were stopped after a maximum of 18 hours by removal of the media and
replacement with fresh media. The following afternoon, or 24 or 48 hours later,
the media was replaced with 100ml phenol-red-free media and 10ml of 12mM MTT
stock solution per well. Reactions were incubated at 37°C for either 1 hour (ES
cells) or 2 hours (3T3 cells). Then 100 ml of SDS::HCL solution was added to
each well and the contents mixed thoroughly by pipette. Reactions were incu-
bated overnight at 37°C in a humidified chamber. After a maximum time of 18
hours the contents of the wells were mixed by pipette and the absorbance of each
well at 570nm was recorded by a 96-well Multiscan Ascent plate reader (Thermo
Electron Corporation, Thermo Scientific). Background readings were subtracted
and results were normalised to control values.
The CyQUANT Direct Cell Proliferation Assay Kit (Invitrogen) was used to
assay cell proliferation according to the manufacturer’s instructions. For analysis
of cell proliferation after miRNA knockdown, 1x103 ES cells were transferred to
each well of a gelatin-coated tissue culture-treated 96-well plate. After 24 hours,
media was replaced with 100µl of fresh media and cells were transfected overnight
with LNA oligonucleotides complementary to various miRNAs using 1ml per well
Chapter 2. Materials and Methods 61
of Lipofectamine LTX. Transfection reactions were stopped after a maximum of 18
hours by removal of the media and replacement with fresh media. The following
afternoon, or 24 or 48 hours later, the media was replaced with 100ml media and
100ml of 2x detection reagent per well. Reactions were incubated at 37°C for 1
hour and the absorbance at 485nm of the contents of each well was recorded by
a 96-well Multiscan Ascent plate reader (Thermo Electron Corporation, Thermo
Scientific). Background readings were subtracted and results were normalised to
control values.
2.2.1.8 Cell Counting by Haemocytometer
Haemocytometers were cleaned with 70% ethanol before coverslips were moist-
ened and affixed to the haemocytometer using gentle pressure until Newton’s
rings could be observed (this ensures that the chamber is of the correct depth).
The suspension of cells for counting was mixed thoroughly and 10µl was pipetted
into the haemocytometer chamber. Using a hand tally counter, cells within the
3 corner squares (each made up of 16 squares) were counted. Cells within the
square and on the right hand and bottom boundary line were counted. The av-
erage number of cells in the 3 corner squares is equivalent to the number of cells
in the original suspension x104per ml.
2.2.1.9 Cell Counting by Nucleocounter
The Nucleocounter NC-100 (Chemometec) was used according to the manufac-
turer’s instructions. A representative cell sample was mixed with an equal volume
of reagent A-100 (lysis/disaggregation buffer) followed by regent B-100 (stabil-
ising buffer). Samples were loaded onto a Nucleocassette, which was placed in
the Nucleocounter for cell number analysis. For assessing the effect on cell num-
ber of miRNA inhibition, 2x105 cells were transferred to each well of a 6-well
gelatin-coated tissue culture-treated plate. After 24 hours, cells were transfected
overnight with 1µg/well LNA oligonucleotides using 5ml per well of Lipofectamine
LTX. After a further 24 hours, cells were removed from the plate by trypsinisation,
counted by nucleocounter and transferred to fresh 6-well plates (800000 ZHBTc4
ES cells or 700000 E14 ES cells/well) or to 96-well plates for MTT analysis and
Cyquant Analysis (1000 cells/well for ZHBTc4 ES cells only). After a further 48
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hours of culture, cells were removed from the plate and counted and MTT and
CYQUANT assays were performed. The remaining cells were lysed for RNA (in
1ml RNA-Bee) in order to confirm inhibition of miRNA expression.
2.2.1.10 Cell Imaging
Photographs of cells were taken using the Nikon Eclipse TE2000-U microscope.
Bright field photographs were captured using white light at an exposure of 10ms
and adjusted for white background. Photos for immunohistochemistry were cap-
tured using FITC (green, 515-555nm), Texas Red (red, 600-660nm) or UV (blue,
420nm) filters at an exposure of 100-800ms.
2.2.1.11 Neural Differentiation of mES cells
For neural differentiation 5x103 ES cells were transferred to each well of 20µg/ml
laminin-coated 4-well plates (plates were coated with laminin at 37ºC for at
least 2 hours) in N2B27 media (Ying & Smith, 2003) supplemented with 0.25µM
PD0325901 and 1.5µM CHIR99021 (custom synthesised by the Division of Signal
Transduction Therapy, University of Dundee). The media was changed every 48
hours. After 7 days the cells were fixed in 4% paraformaldehyde and immunohis-
tochemistry was used to visualise expression of proteins associated with neural
cells (protocol below).
2.2.1.12 Subcloning of DGCR8-/- ES cells
For subcloning 250 DGCR8-/- ES cells were transferred to 10cm2 gelatin-coated
tissue culture-treated plastic dishes and cultured in ES cell media. The media
was changed every 72-96 hours. After >30 days of culture colonies were scraped
and sucked into a p20 pipette and transferred to single wells of a 96-well gelatin-
coated tissue culture-treated plate. Clones were cultured in ES cell media and
cell numbers were expanded until there were sufficient cells for testing of miRNA-
deficiency.
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2.2.1.13 Genetic modification of mES cells
For generation of genetically modified ES cell lines, 5x106 ES cells were trans-
ferred to each well of a gelatin-coated tissue culture-treated 6-well plate and
cultured in ES cell media. 24 hours later cells were transfected overnight with
4µg/well of expression vector using Lipofectamine 2000 (Invitrogen). 48 hours
later transfected cells were trypsinised and transferred to 2 x gelatin-coated tissue
culture treated 10cm plates at different densities (3/4 and 1/4 of total cells) in
ES cell media. 48 hours later 0.5µg/ml puromycin was added to ES cell cultures
in ES cell media. Media plus 0.5µg/ml puromycin was replaced every 3-4 days.
12 days after the initial addition of puromycin, the puromycin concentration was
increased to 0.75µg/ml in ES cell media. 3 days later clones stably expressing the
EGFP expression vector were carefully transferred to single wells of 96-well plates
using a p20 pipette. 2 days later clones stably expressing the PCAGIP empty
vector were transferred to 96-well plates in the same manner. These clones were




Cells were lysed in RNA-Bee (AMS Biotechnology) for RNA extraction. Samples
were vortexed thoroughly and frozen in RNA-Bee at -80°C for future processing,
or processed directly as follows: 200µl of chloroform was added per 1ml of RNA-
Bee, samples were shaken vigorously for 30 seconds and then centrifuged at 4°C
for at least 15 minutes at 12,000xg. The aqueous phase was transferred to a fresh
1.5ml microcentrifuge tube and 0.7 volumes of isopropanol was added. Samples
were vortexed briefly then centrifuged at 4°C for at least 30 minutes at 12,000xg.
The supernatant was removed by pipette and 0.5ml of ice-cold 85% ethanol was
added to the microcentrifuge containing the RNA pellet. The sample was cen-
trifuged at 4°C for at least 10 minutes at 12,000xg. The supernatant was removed
by pipette and the microcentrifuge tube containing the RNA pellet was put in ice
with the lid open for 10 minutes in order for any residual ethanol to evaporate.
RNA pellets were resuspended in nuclease-free water by thorough vortexing and
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heating for 2 minutes at 65°C. For long-term storage RNA was precipitated with
0.1 volumes of sodium acetate pH5.2 and 2.5 volumes of 100% ethanol and stored
at -20°C.
2.2.2.2 Recovery of precipitated RNA
Samples containing precipitated RNA were vortexed thoroughly and a volume
of sample containing the desired quantity of RNA was removed to a fresh 0.5ml
microcentrifuge tube. The remaining stocks containing precipitated RNA were
returned to -20ºC storage and the decanted samples were centrifuged at 4°C for
at least 30 minutes at 12,000xg. The supernatant was removed by pipette and
500µl of ice-cold 85% ethanol was added to the microcentrifuge tube containing
the RNA pellet. The sample was centrifuged at 4°C for at least 10 minutes at
12,000xg. The supernatant was removed and by pipette and the microcentrifuge
tube containing the RNA pellet was put at 45°C with the lid open for 2 minutes
in order for any residual ethanol to evaporate. RNA pellets were resuspended in
the desired volume of nuclease-free water by thorough vortexing and heating for
2 minutes at 65°C.
2.2.2.3 Quantitative and qualitative analysis of RNA
The concentration of RNA in solution was quantitated using the Nanodrop spec-
trophotometer (ThemoScientific) according to the manufacturer’s instructions.
Sample pedestals were cleaned before use and nuclease-free water was used to set
the reference spectrum of the spectrophotometer. A 1µl volume of RNA sample
was pipetted onto the sample pedestal and the absorbance was read at the op-
timal path length (0.05mm – 1mm). A full spectral output was given showing
the concentration of RNA in solution and the presence of contaminants. The
quality of RNA within a sample was assessed using the Agilent Bioanalyser 2100
according to the manufacturer’s instructions. The Agilent RNA 6000 Nano Kit
was used to assess sample quality except in cases where low RNA concentrations
were expected, in which case the Agilent RNA 6000 Pico Kit was used.
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2.2.2.4 Northern analysis of miRNA levels
5mg of total RNA in nuclease-free water was mixed with an equal volume of 2x
TBE-Urea loading buffer (Invitrogen) up to a maximum sample volume of 30µl.
Samples were heated to 70ºC for 3 minutes in order to minimise the presence of
RNA secondary structures. Samples were pipetted into wells of a 15% TBE-Urea
Criterion polyacrylamide gel (Bio-Rad) and separated by gel electrophoresis in
1x TBE buffer at 125V for approximately 1.5 hours. The resulting gel and a
piece of Hybond™-N membrane (pre-wetted in 0.5 x TBE buffer) were placed
between pieces of filter paper soaked in 0.5 x TBE buffer. RNA was transferred
from the gel onto Hybond™-N membrane (Amersham) using the Bio-Rad semi-
dry transfer system (220mA for 1 hour). RNA was cross-linked to the membrane
(120mJ/cm2) using the UV Stratalinker 2400 (Stratagene).
For detection of specific miRNA molecules, membranes were pre-hybridised in
ULTRAhyb Oligo buffer (Ambion) at 42ºC for a least one hour and incubated
overnight at 42ºC with complementary radiolabelled LNA-modified oligonucleotides
in ULTRAhyb Oligo buffer (Ambion). Oligonucleotides were radiolabelled at the
5’ end with [P32]g-ATP using the mirVana Probe and Marker Kit (Ambion). Af-
ter removal of unbound oligonucleotide (2 x 15 minute washes in 2xSSC, 0.1%SDS
at 42°C), membranes were wrapped in saran wrap, placed in an exposure cassette
and exposed to photographic film (Kodak, Biomax MS film) at -80°C in the
presence of a MS intensifying screen (Kodak) for between 1 hour and 24 hours.
Photographic film was developed (Konica SRX-101A X-ograph machine) and the
resulting image was assessed for the presence of non-specific signals. Membranes
went through cycles of washes in 0.1xSSC, 0.1% SDS at increasing temperatures
followed by exposure to photographic film until non-specific signals were removed.
Different exposure times were used to get an optimum autoradiograph showing
expression of the specific miRNA. Membranes were washed in boiling 0.1% SDS
in order to remove any traces of radiolabelled oligonucleotide and could then be
pre-hybridised and incubated with a radiolabelled oligonucleotide complementary
to a different miRNA. Alternatively, membranes could be stored in saran wrap
at -20ºC indefinitely.
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2.2.2.5 Phosphorimager quantitation
To quantitate hybridised radiolabelled nucleic acid after northern analysis of
miRNA levels, membranes were exposed to phosphorimager screens at room
temperature for the required length of time. Phosphorimager screens were first
cleared by exposure on a light box for 5 minutes. To quantify the stored signal,
screens were scanned (BioRad Molecular Imager FX) and resulting data was anal-
ysed using Quantity One software. Values for miRNA expression were normalised
for variation in loading by correcting for control values (typically the spliceosome
RNA U6).
2.2.2.6 cDNA synthesis
Prior to cDNA synthesis, contaminating DNA was removed from RNA samples
using the DNA-free kit from Ambion according to the manufacturer’s instructions.
0.1 volumes of NaAc pH5.2 and 2.5 volumes of 100% ethanol were then added to
the sample and samples were transferred to -20ºC for at least 1 hour in order to
precipitate the RNA. Precipitated RNA was recovered (see above for protocol),
resuspended in nuclease-free water and quantitated by Nanodrop. Up to 52µg of
RNA was used for cDNA synthesis. cDNA was synthesised using the First-Strand
cDNA synthesis kit (GE Healthcare) according to the manufacturer’s instructions.
cDNA was aliquotted to avoid repeated freezing and thawing and stored at -20°C.
2.2.2.7 QPCR primer design and optimisation
Sequences for QPCR primers were either taken from publications or designed us-
ing Primer3 software (http://frodo.wi.mit.edu/primer3/) with the following cri-
teria: ~ 100 base pair product, ~20 nucleotide primer sequence, TM (melting
temperature) of  60°C, low primer complementarity, Max Poly-X (The max-
imum allowable length of a mononucleotide repeat, for example AAAA) = 3.
Primers were optimised by performing QPCR on a pool of cDNA samples from
undifferentiated and differentiated ES cell cultures over a 1x106 range of cDNA
concentrations. Primers were suitable for use if they amplified a single product
over >1000-fold range with 95-105% efficiency and a correlation of >0.95.
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2.2.2.8 QPCR analysis of gene expression
20-35ng of cDNA in 9.5µl nuclease-free H2O was amplified over 40 QPCR cycles
using the SYBR Green PCR Master Mix (Invitrogen) and 1.25µl of each 10uM
forward and reverse primer using a Stratagene lightcycler 3000P QPCR machine.
The PCR temperature cycles were set-up according to the manufacturer’s pro-
tocol. Samples containing no cDNA, H2O-only and RNA that had not been
reverse-transcribed were used as controls. MxPro software (Statagene) was used
for analysis of QPCR data. The fluorescence threshold was set at 0.01 (so that
amplification curves crossed the threshold during exponential PCR amplification
of product) and Ct values were normalised to b-Actin expression. miRNA qPCR
was performed using Taqman MicroRNA Assays (Applied Biosystems) according
to the manufacturers protocol using 10ng of total RNA in 5µl of nuclease-free H2O
for miRNA-specific cDNA synthesis and QPCR (using a Stratagene lightcycler
3000P QPCR machine). Duplicate cDNA-synthesis reactions were carried out for
each sample because normalisation to a housekeeping gene was not possible due
to the fact that the cDNA synthesis step, as well as the QPCR, were specific to
the miRNA being assayed.
2.2.2.9 MiRNA profiling
In order to profile miRNAs during the ES cell to trophoblast transition, ZHBTc4
ES cells were induced to differentiate by addition of doxycycline. ZHBTc4 ES
cells were also grown in the absence of doxycycline and therefore remained un-
differentiated. Samples were taken every 24 hours from the undifferentiated and
differentiated ES cells. miRNA libraries were generated from undifferentiated
ES cells at time 0, 24 hours and 48 hours, and from differentiated ES cells 24,
48 and 72 hours after addition of doxycycline. For miRNA profiling 5x106 ES
cells were transferred to T150 tissue culture flasks in 36mls of ES cell culture
media. Cells were grown for 24 hours in doxycycline-free media before doxycy-
cline was added to half of the flasks (10ng/ml). Cells were harvested at the point
of doxycycline addition (Time 0) and after 24, 48, 72 and 96 hours of growth
in media with or without doxycycline. RNA was extracted from ES cells us-
ing RNABee (AMS Biotechnology) according to the manufacturer’s instructions.
The quantity and quality of RNA was assessed using the Labtech Nanodrop ND-
1000 and the Agilent 2100 Bioanalyser RNA 6000 Nano Assay. RNA was stored
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at -20oC as ethanol precipitate. miRNA was isolated from total RNA by elec-
trophoresis using the FlashPAGE™ Fractionator from Ambion according to the
manufacturer’s instructions. Eluted miRNA was stored at -20oC as ethanol pre-
cipitate. MicroRNA libraries were generated essentially as described by Lau et al.
(2001). Briefly, RNA substrate and decade marker RNA were end labelled with
g-32P-dATP. An miRNA cloning linker (17.91x) was ligated to the 3’ ends of the
miRNA and the ligated products were gel purified. The 5’ end adaptor (17.92R)
was then ligated to the recovered material and the final ligation products were gel
purified and recovered. Ligated miRNAs were converted to cDNA using reverse
transcriptase and a primer designed to recognize the 3’ adaptor oligonucleotide
ligated to the miRNA (15.22). cDNA was amplified by PCR using primers (17.92
and 17.93D) designed to recognise the 5’ and 3’ adaptors ligated onto the ends of
the miRNA. The 5’ and 3’ PCR primers had BanI restriction sites at their 5’ and
3’ ends respectively. After PCR amplification, cDNA was digested with BanI re-
striction enzyme and the products were ligated using T4 DNA ligase. An adenine
nucleotide was added on to the 3’ ends of resulting concatemers using Taq poly-
merase and dATP. Products were ligated into a TOPO cloning vector (Invitrogen)
and transformed into chemically competent cells. Colonies were picked and sent
for sequencing by DNA sequencing services. miRNA profiling was carried out by
Tom Burdon and Derek McBride. Primer sequences are below:
17.91x pCTGTAGGCACCATCAAx (x:DMT-O-C3-CPG)
17.93R ATCGTaggcacctgaaa (RNA/DNA version, lowercase RNA)
15.22 ATTGATGGTGCCTAC
17.93D ATCGTAGGCACCTGAAA (DNA version, calcTm = 42°C)
17.92 ATTGATGGTGCCTACAG (calcTm = 40°C)
2.2.3 Protein Techniques
2.2.3.1 Protein extraction and quantitation
Cell pellets were lysed by addition of an equivalent volume of lysis buffer contain-
ing EDTA-free protease inhibitors (Roche). Lysates were incubated on ice for 10
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minutes then centrifuged at 13,000rpm for 15 minutes. Supernatant was retained
and protein quantity was determined using the Bio-Rad Protein Assay according
to the manufacturer’s instructions. Protein was stored at -80ºC in lysis buffer.
2.2.3.2 Western analysis for protein expression
A volume of protein sample containing 50µg of protein was combined with an
equivalent volume of 2x Laemmli Sample Buffer (Bio-Rad) and boiling the sam-
ple for 10 minutes denatured proteins. Samples were pipetted into the wells of
an 8-20% denaturing polyacrylamide gel (Bio-Rad) and separated by gel elec-
trophoresis at 115V for 1.5-2 hours. Filter papers were soaked in one of three
different buffers: Anode 1 buffer (18.1g Tris, 100ml MeOH, 400ml H2O), Anode 2
buffer (1.5g Tris, 100ml MeOH, 400ml H2O) or Cathode buffer (2.6g 6-amino-n-
hexanoic acid, 100ml MeOH, 400ml H20). A gel ‘sandwich’ was assembled on the
platinum anode surface of the Trans-Blot SD Semi-Dry Electrophorectic Transfer
Cell (Bio-Rad) comprising of: 2 x filter papers soaked in Anode 1 buffer, 2 x
filter papers soaked in Anode 2 buffer, PVDF membrane (GE Healthcare) pre-
wetted in methanol and soaked in Anode 2 buffer, the polyacrylamide gel soaked
in Anode 2 buffer, and finally 4 x filter papers soaked in cathode buffer. Proteins
were transferred from the gel onto a PVDF membrane at 90mA per gel for 90
minutes. Membranes were pre-incubated in 0.1% Tween (in 1 x PBS) containing
5% Marvel Milk powder, 3% BSA, and 1% serum corresponding to secondary
antibody host, and incubated overnight at 4ºC with primary antibody at the rec-
ommended concentration. Membranes were washed in 0.1% Tween (in 1 x PBS)
and incubated with HRP-conjugated secondary antibody at the recommended
concentration (generally 1:2000) for 2 hours. Membranes were again washed in
0.1 % Tween (in 1 x PBS). ECL reagents (GE Healthcare) and exposure to pho-
tographic film (Kodak, X-OMAT LS film, Cat: 8646770) were used to visualise
HRP activity in accordance with manufacturer’s instructions. Photographic films
were developed using the Konica SRX-101A X-ograph machine.
For Chapter 5 western analysis Cells were lysed in 1 x SDS loading buffer
(10% glycerol, 3% SDS, 62.5mM Tris HCL pH6.8, 0.005% Bromophenol Blue, 3%
Beta-mercaptoethanol) and exposed to sonication (Sonicator Ultrasonic Proces-
sor XL, Misonix) for 8 minutes. Equivalent sample volumes were pipetted into
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sample wells and separated by electrophoresis on a Novex NuPage 4-20% Bis-Tris
gel (Invitrogen) in 1 x MOPS SDS running buffer (Invitrogen). Hybond-ECL
membrane (GE Healthcare) was pre-wetted with dH2O for 10 min before being
soaked in cold transfer buffer (100ml 10X transfer buffer (29.3g Glycine, 58g Tris
and 18.8ml 20% SDS made up to 1l dH20), 200ml EtOH, 700ml dH20). Filter
papers and fiber pads were also soaked in cold transfer buffer and used to as-
semble a gel ‘sandwich’ within a transfer cassette: 1 x fibre pad, 2 x filter paper,
Bis-Tris gel, Hybond-ECL membrane, 2 x filter paper, 1 x fibre pad. Using a
wet transfer system (Criterion blotter, Bio-Rad) proteins were transferred from
the gel onto a Hybond-ECL membrane (GE Healthcare) at 90V for 75 minutes.
Membranes were pre-incubated in 5% Marvel Milk powder in TBST (80ml 25x
TBS (125g Tris, 400g NaCl, made up to 2L with H20, pH7.6), 2ml Tween 20
(Sigma), made up to 2L with H20), and incubated overnight at 4ºC with the
recommended primary antibody concentration in 5% BSA in TBST. Membranes
were washed with TBST (4 x 15 min) and then incubated with HRP-conjugated
secondary antibody at the recommended concentration (generally 1:2000) for 2
hours in 0.5% Marvel Milk in TBST. Membranes were washed with TBST (4 x
14 min). ECL reagents (Invitrogen) and exposure to photographic film (Amer-
sham Hyperfilm ECL) were used to visualise HRP activity in accordance with
manufacturer’s instructions. Photographic films were developed using the Konica
SRX-101A X-ograph machine.
2.2.3.3 Immunohistochemistry
5x104 cells were transferred to each well of a 4-well plate, grown for 24 hours and
then fixed in 4% paraformaldehyde (2 x PBS washes, then 15 minutes in 4% PFA
at room temperature, then 2 x PBS washes) and stored at 4°C in PBS. Plates were
washed (4 x 5 minute washes) with PBST (1 x PBS + 3% Triton), pre-hybridised
in 1% BSA, 10% serum (from secondary antibody host) in PBST, and incubated
with the suggested concentration of primary antibody in pre-hybridisation solu-
tion at 4°C overnight. Plates were washed (4 x 5 minute washes) with PBST
and incubated with fluorophore-conjugated secondary antibody (1:1000 dilution)
for at least 2 hours at room temperature in the dark. Plates were washed with
PBST (4 x 5 minute washes) and stained with DAPI (Invitrogen 1:5000 in PBST)
for 5 minutes at room temperature in the dark. Plates were washed with PBS
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(2 x 5 minute washes) and stored in PBS at 4°C in the dark. The presence of
fluorophore-conjugated antibodies was visualised by exposure to the appropriate
wavelength of light.
2.2.4 Bioinformatics
2.2.4.1 Bioinformatics analysis of miRNA profiling data
For bioinformatics analysis the UNIX operating system was used as a platform
to run programs written by Wilfrid Carre in Perl. The programs were used to
carry out the following processes: RNA sequences were ‘trimmed’ by removing
the 5’ and 3’ sequences that corresponded to the ligated adaptor sequences. The
remaining short-RNA sequences were catalogued and the frequency of occurrence
of individual sequences was calculated. Sequences from the profiling data were
compared with sequences present within miRBase to identify previously reported
miRNAs. Sequences were then matched against the mouse genome to identify
their genomic locations. Genomic sequences 10nt 5’ and 70nt 3’ or 70nt 5’ and
10nt 3’ of the identified short-RNA sequence were extracted and assessed for the
potential to form a hairpin structure by RNAfold.
2.2.4.2 Data analysis of miRNA profiling data
Using Excel, the number of times a miRNA was sequenced in each miRNA library
was normalised to the size of the library. Sequences that did not map to the
mouse genome were removed, as were sequences that were not predicted to form
a hairpin secondary structure by RNAfold. Sequences present in undifferentiated
and differentiating cells were compared in order to identify differentially expressed
miRNAs. Differentially expressed miRNAs were defined as miRNAs recorded
>10 instances that differed by >2-fold between amalgamated undifferentiated
and differentiated miRNA libraries.
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2.3 Detailed Methods
2.3.1 SILAC
The SILAC (stable isotope labelling of amino acids in cell culture) method relies
on metabolic incorporation of ‘heavy’ or ‘light’ isotopes of amino acids into newly
synthesised proteins in cell culture. The heavy amino acids contain substituted
stable isotopic nuclei (in this case 13C) while the light amino acids contain stan-
dard isotopic nuclei (12C). Two cell populations are grown in culture media that
is identical except that one of them contains light forms of a particular amino
acid and the other contains heavy forms. After a number of cell divisions, each
instance of the amino acid will be replaced by its isotope labelled analog. Cell
populations are then combined and proteins are extracted and prepared for mass
spectrometry analysis. Differential expression of proteins can be determined be-
cause the heavy labelled proteins have an m/z ratio that is slightly higher than
that of light labelled proteins.
In this experiment ZHBTc4 ES cells were grown in the presence of R0K0 (arginine
and lysine with 12C nuclei) or R6K6 (arginine and lysine with 13C nuclei). After
96 hours doxycycline was added to the R6K6 (or heavy) labelled population,
which made this population differentiate into trophectoderm. 48 hours later
equal numbers of undifferentiated R0K0 cells and differentiated R6K6 cells were
combined. Proteins were extracted and prepared for mass spectrometry analysis,
which allowed comparison of protein expression levels in the two cell populations.
A detailed SILAC method follows:
The necessary steps were taken to avoid keratin contamination during this pro-
tocol. Peptides tend to stick to plastic surfaces on storage so 1.5 ml Eppendorf
LoBind tubes (cat no. 2243108-1) were used throughout.
2.3.1.1 Cell Culture
SILAC ES cell media was prepared using pre-made DMEM media with standard
amino acids (R0K0) or heavy labelled amino acids (R6K6) from Dundee cell
products and supplemented as for standard ES cell media (10% dialysed fetal calf
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serum, 2mM L-Glutamine, 1x non-essential amino acids, 1mM sodium pyruvate,
100uM ß-Mercaptoethanol and Lif).
2x106 ES cells were transferred to a T25 flask containing either R0K0 or R6K6
ES cell media and the media was removed and replaced with fresh R0K0 or
R6K6 media after 24 hours. After 48 hours the cultures were 80% confluent.
TVP treatment (1 x PBS wash followed by 3 minutes in 0.8mls TVP at 37ºC)
was used to detach cells from the surface of the T25. 5ml of R0K0 or R6K6
media was added and cells were transferred to a 15 ml falcon tube, pelleted and
resuspended in 10ml of media for cell counting. 2x106 ES cells from each flask
were transferred to a fresh T25 flask containing R0K0 or R6K6 ES cell media.
ES cells were grown in R0K0 or R6K6 media for a further 48 hours and the media
was removed and replaced with fresh R0K0 or R6K6 media after 24 hours. After
48 hours the cultures were 80% confluent and 2x106 ES cells were transferred to
fresh T25 flasks as above. The R0K0 cultures continued to be grown in R0K0
and 1µg/ml doxycycline was added to the R6K6 cultures in R6K6 media. The
media was removed and replaced with fresh R0K0 media or R6K6 media with
1µg/ml doxycycline after 24 hours.
TVP treatment (1 x PBS wash followed by 3 minutes in 0.8mls TVP at 37ºC)
was used to detach cells from the surface of the T25. 5ml of R0K0 or R6K6
media was added and cells were transferred to a 15 ml falcon tube, pelleted and
resuspended in 10 ml of 1 x PBS for cell counting by nucleocounter. An equal
number (5x106) of cells from the two cell populations were added to a 15 ml falcon
tube, pelleted, washed with PBS, pelleted and resuspended in 100µl of T-Per
buffer (Pierce) and protease inhibitors (Roche). Samples were homogenised using
a glass homogenisor, sonicated (Clifton Ultrasonic Cleaner) and frozen at -80ºC.
Volumes of cell suspension from the two separate cell populations containing 1x106
cells were transferred to 1.5ml microcentrifuge tubes, centrifuged, resuspended in
100µl T-PER buffer with protease inhibitors and frozen at -80ºC. These samples
were later thawed and the protein was quantitated by Bio-Rad protein assay
according to the manufacturer’s instructions. This gave an indication of the
quantity of protein in the sample for SILAC analysis (approximately 0.5µg/µl).
The protein sample for SILAC analysis was thawed, homogenised with a glass
homogenisor, sonicated (Clifton Ultrasonic Cleaner) and centrifuged at 10,000xg
for 5 min. The supernatant was transferred to a fresh 1.5ml microcentrifuge tube
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and 25µl was taken for SILAC processing (this corresponded to approximately
125µg of protein). The remaining sample was frozen at -80ºC.
2.3.1.2 Reduction and Alkylation
The protein sample for SILAC analysis was reduced and alkylated by DTT/Iodoacetamide:
Disulphide linkages between cysteine residues were broken by addition of DTT
to a final concentration of 10 mM (BDH 443553B) and boiling of the sample for
1-2 min. Alkylation then prevented the disulphide bonds from re-forming. The
sample was alkylated by addition of iodoacetamide (Sigma I1149) to a final con-
centration of 50 mM followed by incubation at room temperature in the dark for
30 min. 2x Laemmli loading buffer (BD Biosciences) was added to the samples
and the samples were boiled at 85°C for 2 minutes.
2.3.1.3 Seperating proteins on gels and excising bands
Protein samples were separated by electrophoresis on a Novex 4-12% polyacry-
lamide gel (Invitrogen) at 125V for 90 minutes. The resulting gel was cut into 10
slices in a sterile 14cm tissue culture dish using a sterile scalpel. 5µl of the sample
was run on a second gel, which was stained using Blum’s silver stain (Blum et
al., 1987) and scanned between two pieces of acetate.
Working as quickly as possible, the gel slices were cut into smaller pieces using
sterile scapels and placed in 1.5 ml Lobind Eppendorf tubes (one slice per tube).
The fine end of a sterile P1000 pipette tip was fused using heat and used to mash
up the gel pieces within each microcentrifuge tube.
2.3.1.4 Digestion of band pieces
300 ml of dH2O was added to gel pieces for 15 min then 300 ml of CH3CN (Ace-
tonitrite; Sigma A3396) was added for a further 15 min. The supernatant was
removed by pipette and 300 ml of 20 mM NH4HCO3 (Sigma A6141) was added
to gel pieces for 15 min. The supernatant was removed and 300 ml of 20 mM
NH4HCO3/CH3CN (50:50 v/v) was added to the gel pieces for 15 min at which
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point the gel pieces shrank and appeared opaque. The supernatant was removed.
100 ml of CH3CN was added to dehydrate the gel pieces for 5 min. The gel pieces
shrank and appeared completely white. The supernatant was removed and the
band pieces were dried in a Speedvac (miVac DNA concentrator, Genevac) for 5
minutes.
50 ml/gel slice of 25 mg/ml modified trypsin (ABI) in 20 mM NH4HCO3 was
added to each sample. Gel pieces were rehydrated in trypsin digestion buffer for
30 min. If required, more NH4HCO3 was added in order to cover the gel pieces.
Samples were mixed gently, centrifuged to bring gel pieces to the bottom of the
microcentrifuge tubes and incubated at 37°C overnight (>16h).
2.3.1.5 Extraction of peptides
All gel extraction steps were performed at 30ºC on a shaking platform to ensure
complete extraction of peptides. An equal volume of CH3CN was added to the
digested peptides and the sample was incubated at 30°C for 30 minutes. The
supernatant (containing the peptides for analysis) was transferred to a fresh Ep-
pendorf LoBind tube. A volume of 1% formic acid (BDH cat No. 101155F) was
added to cover the gel pieces and samples were incubated for 20 minutes. The
supernatant (containing more peptides) was transferred to the tube containing
the peptides for analysis. A second wash with 1% formic acid was performed
and the supernatant (containing more peptides) was transferred to the tube con-
taining the peptides for analysis. 150 ml of CH3CN was added to the gel pieces
and incubated for 10 minutes. The gel pieces shrank and turned white. The
supernatant (containing more peptides) was transferred to the tube containing
the peptides for analysis. The peptides were stored at -80°C and sent to Dundee
Cell Products (http://www.dundeecellproducts.com/) for MS analysis.
2.3.2 PAR-CLIP
PAR-CLIP is a novel method that can be used to identify the binding sites of
cellular RNA-binding proteins (RBPs) including Ago2 (Hafner et al., 2010a &
2010b). This method relies on the incorporation of photoreactive ribonucleoside
analogs into RNA transcripts during cell culture. Irradiation of the cells by UV
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light at 365nm induces crosslinking of the photoreactive-nucleoside-labelled RNA
molecules to their interacting RBPs. The RBP (in this case Ago2) is immuno-
precipitated and co-immunoprecipited RNAs are isolated. The isolated RNA is
converted to cDNA, which is used to make DNA libraries for sequencing. A
detailed PAR-CLIP method follows:
Solutions can be made up in advance. Add protease inhibitors and DTT directly
before use.
2.3.2.1 Expanding Cells
ES cells were expanded in ES cell growth medium to obtain 100-400 x 106 cells
(approx. 10 x 10cm cell culture plates) at approximately 80% confluency. 14
hours before crosslinking 4-thiouridine (Sigma) was added to a final concentration
of 100 mM (1:10000 v/v of a 1 M 4-thiouridine stock solution - 260.27 mg 4-
thiouridine dissolved in 1 ml DMSO) directly to the cell culture medium. For the
miR-467a* expression experiment, 30nM pre-miR miRNA Precursor for mmu-
miR-467a* was transfected into 10 x 10cm plates of DGCR8-/- ES cells with
12.5µl Lipofectamine 2000 (Invitrogen) per plate according to the manufacturer’s
instructions. Lipofectamine 2000 alone was added to another 10 x 10cm plates
of DGCR8-/- ES cells.
2.3.2.2 UV-Crosslinking
Cells were washed once with 10 ml ice-cold PBS per plate and PBS was removed
completely. Plates of cells were placed on a tray with ice and irradiated uncov-
ered with 0.15 J/cm2 of 365 nm UV light in a Stratalinker 2400 (Stratagene).
Cells were scraped off plates with a cell scraper in 1 ml ice-cold PBS per plate,
transferred to 15 ml centrifugation tubes (cells from replicate plates were added
to 1 x 15ml tube) and collected by centrifugation at 1000 x g for 5 min at 4°C.
The supernatant was discarded. 100 x 106 ES cells (10 x 10 cm plates) yielded
approx. 1 ml of wet cell pellet. Cells pellets were shock-frozen in liquid nitrogen
and stored at -80°C. Cell pellets can be stored like this for at least 12 months.
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2.3.2.3 Cell lysis and RNaseT1 digest
The cell pellet was resuspended in 3 volumes of 1x NP40 lysis buffer (50 mM
HEPES, pH 7.5, 150 mM KCl, 2 mM EDTA, 1 mM NaF, 0.5% (v/v) NP40, 0.5
mM DTT, Roche complete EDTA-free protease inhibitor cocktail) and incubated
on ice for 10 min. Cell lysates were cleared of unbroken cells and debris firstly by
centrifugation at 13,000 x g for 15 min at 4°C, and then by filtering through a 0.2
mm membrane syringe filter (Pall Acrodisc or equivalent). RNase T1 (Fermentas,
1000 U/ml) was added to a final concentration of 1 U/ml and samples were incu-
bated in a water bath for 15 min at 22°C. Reactions were subsequently cooled for
5 min on ice before proceeding.
2.3.2.4 Immunoprecipitation and recovery of crosslinked target RNA
fragments
For immunoprecipitation, 10 ml of Dynabeads Protein G magnetic particles (In-
vitrogen) were transferred per ml of cell lysate (for a typical experiment it should
be approx. 40-50 ml of beads) to a 1.5 ml microfuge tube. Beads were washed
twice with 1 ml of citrate-phosphate buffer (4.7 g/l citric acid, 9.2 g/l Na2HPO4,
pH 5.0) and resuspended in twice the volume of citrate-phosphate buffer relative
to the original volume of bead suspension. 12.5 mg (12.5µl) of mouse anti-Ago2
monoclonal antibody (Wako) was added per ml of bead suspension (for a final
mass of 1µg per pulldown assuming 80µl of beads/pulldown) and incubated on a
rotating wheel for 40 min at room temperature. Beads were washed twice in 1
ml of citrate-phosphate buffer to remove unbound antibody before being resus-
pended in twice the volume of citrate-phosphate buffer relative to the original
volume of bead suspension.
20 ml of freshly prepared antibody-conjugated magnetic beads were added per
ml of partial RNase T1 treated cell lysate and samples were incubated in 15 ml
centrifugation tubes on a rotating wheel for 1 h at 4°C. Magnetic beads were col-
lected on a magnetic particle collector for 15 ml centrifugation tubes (Invitrogen)
and transferred to 1.5 ml microfuge tubes, then washed 3 times in 1 ml of IP
wash buffer (50 mM HEPES-KOH, pH 7.5, 300 mM KCl, 0.05% (v/v) NP40, 0.5
mM DTT, Roche complete EDTA-free protease inhibitor cocktail). A magnetic
particle collector for 1.5 ml tubes (Invitrogen) was used to separate the beads
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from the supernatant according to the manufacturer’s instructions. RNaseT1
(Fermentas, 1000 U/ml) was added to a final concentration of 100 U/ml and sam-
ples were incubated in a water bath for 15 min at 22 °C and cooled subsequently
on ice for 5 min. Beads were washed 3 times in 1 ml of high-salt wash buffer
(50 mM HEPES-KOH, pH 7.5, 500 mM KCl, 0.05% (v/v) NP40, 0.5 mM DTT,
Roche complete EDTA-free protease inhibitor cocktail) then resuspended in 1
volume of dephosphorylation buffer (50 mM Tris-HCl, pH 7.9, 100 mM NaCl, 10
mM MgCl2, 1 mM DTT). Calf intestinal alkaline phosphatase (CIAP, NEB) was
added to a final concentration of 0.5 U/ml, and the suspension was incubated for
10 min at 37°C. Beads were washed twice in 1 ml of phosphatase wash buffer (50
mM Tris-HCl, pH 7.5, 20 mM EGTA, 0.5% (v/v) NP40) then twice in polynu-
cleotide kinase (PNK) buffer without DTT (50 mM Tris-HCl, pH 7.5, 50 mM
NaCl, 10 mM MgCl2). Beads were resuspended in one original bead volume of
PNK buffer (50 mM Tris-HCl, pH 7.5, 50 mM NaCl, 10 mM MgCl2, 5 mM DTT).
U-32P-ATP was added to the bead suspension to a final concentration of 0.5
mCi/ml and T4 PNK (NEB) was added to a final concentration of 1 U/ml. Samples
were incubated for 30 min at 37°C. Non-radioactive ATP (Sigma) was added to
obtain a final concentration of 100 mM and samples were incubated for another
5 min at 37°C. Beads were washed 5 times with 800 ml of PNK buffer without
DTT and resuspended in 70 ml of SDS-PAGE loading buffer (10% glycerol (v/v),
50 mM Tris-HCl, pH 6.8, 2 mM EDTA, 2% SDS (w/v), 100 mM DTT, 0.1%
bromophenol blue).
The radiolabeled suspension was incubated for 5 min in a heat block at 95°C
to denature and release the immunoprecipitated RBP with crosslinked RNA and
vortexed. Magnetic beads were removed on the separator and the supernatant
was transferred to a clean 1.5 ml microfuge tube. 40ul of the supernatant was
pipetted into wells of a Novex Bis-Tris 4-12% (Invitrogen) precast polyacrylamide
gel and run at 200 V for 55 min. The gel was removed from the plastic casing and
laid on a pre-developed photographic film. Glo-gos (Agilent Technologies) were
used to facilitate the alignment of the gel to the film. The gel and photographic
film were wrapped in plastic film (e.g. Saran wrap) and exposed to Kodak MS
film overnight with an intensifying screen at -80°C in an exposure cassette. The
gel was aligned with the film and slices corresponding to the expected size of
RBP (Ago2, approx 100 kDa) were cut out using sterile scalpels. Gel slices were
transferred to D-Tube Dialyzer Midi Tubes with 800 ml 1x SDS running buffer.
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The crosslinked RNA-RBP complex was electroeluted in 1x SDS running buffer
at 100 V for 2 h according to the instructions of the manufacturer.
The electroeluate (800µl) was pipetted from the Dialyzer Midi Tubes into 2.0 ml
microcentrifuge tube tubes. An equal volume of 2x Proteinase K Buffer (100 mM
Tris-HCl, pH 7.5, 150 mM NaCl, 12.5 mM EDTA, 2% (w/v) SDS) was added
to the electroeluate followed by the addition of Proteinase K (Roche) to a final
concentration of 1.2 mg/ml. Samples were incubated for 30 min at 55°C. RNA was
recovered by acidic phenol/chloroform (125:24, pH 4.7) followed by a chloroform
extraction. At this stage it was necessary to split the sample between multiple
1.5ml microcentrifuge tubes because sample volumes became too large for single
tubes to be used. RNA was precipitated overnight with 2.5 volumes of 100%
ethanol, 0.1 volume of Sodium Acetate and 1 ml of glycogen (10mg/ml stock).
RNA was recovered and resuspended in 6µl dH2O for downstream analysis.
2.3.2.5 Small RNA Library Preparation
Small RNA libraries were prepared by following the ‘Small RNA v1.5 Sample
Preparation Guide’ (Illumina). Briefly, 5’and 3’ adaptor molecules were ligated
onto the PAR-CLIP recovered RNA. RNA was precipitated, recovered, reverse
transcribed and PCR amplified using primers designed to amplify across the
ligated adaptors with Ban1 sites at their termini. The resulting DNA was con-
catemerised, separated on a 10% TBE PAGE gel (Novex, Invitrogen) and visu-
alised by SYBR Gold (Invitrogen) staining of the gel. Bands corresponding to
the insert sequence and ligated adaptors (93bp and above) were cut out from
the gel and DNA was eluted overnight then precipitated. DNA was recovered
from precipitate and ligated into a pGEM-T Easy Vector (Promega) according to
the manufacturer’s instructions. JM109 Competent Cells (Promega) were trans-
formed according to the manufacturer’s instructions and cells were plated on
ampicillin/XGAL/IPTG LB Agar plates and grown overnight at 37°C. Colonies
were picked and grown overnight at 37°C (225-250rpm) in 2mls of LB Broth with
100µg/ml ampicillin. Plasmid DNA was recovered by Miniprep (QIAPrep Spin






miRNAs have been shown to be very important in early mammalian develop-
ment. Deleting the canonical miRNA-processing pathway in murine embryos
leads to early embryonic lethality: Dicer1 null murine embryos arrest develop-
ment prior to E7.5 (Bernstein et al., 2003) and DGCR8 knockout embryos arrest
development prior to E6.5 (Wang et al., 2007). It is therefore likely that miRNAs
are involved in regulating individual developmental transitions. A developmental
transition is defined here as the transformation of a cell into a different cell state
with a concomitant effect on the developmental potential of the cell. In order
to investigate what role, if any, that miRNAs play in individual developmental
transitions, we wished to: (i) determine if miRNAs are differentially represented
during developmental transitions, and (ii) determine if any differentially repre-
sented miRNAs play functional roles in the developmental process. In order to
answer this question miRNA expression was evaluated through generation and
sequencing of miRNA libraries (miRNA profiling) in a cell-based model of an
early developmental transition. An in vitro model of a developmental transition
was used rather than in vivo miRNA profiling in order to reduce the complexity
of the system being examined and to identify miRNAs that were directly asso-
ciated with a single developmental process. The ZHBTc4 ES cell system was
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chosen not only because it models the earliest obvious differentiation event in
the early embryo – that of trophoblast differentiation, but also because this is
a regulated system that allows reproducible, homogeneous differentiation of the
cultured cells.
3.1.1 The ZHBTc4 model system
Oct4 is a transcription factor that is a known master-regulator of ES cell differen-
tiation; it is expressed at high levels in embryonic stem cells and is downregulated
upon ES cell differentiation (Okamoto et al., 1990, Rosner et al., 1990, Scholer et
al., 1990). Hitoshi Niwa and others have investigated the effect of missexpress-
ing Oct4 in mouse ES cells by generating genetically modified ES cell lines. In
one of these lines, the ZHBTc4 ES cell line, both endogenous Oct4 alleles have
been inactivated and the cells carry a conditional Oct4 transgene, which is reg-
ulated by tetracycline (Niwa et al., 2000). In standard culture conditions, the
ZHBTc4 ES cells express Oct4 at approximately 60% of normal levels, however,
in the presence of tetracycline, the Oct4 transgene is completely repressed and
the cells rapidly lose all Oct4 expression. Loss of Oct4 expression leads to rapid
differentiation of the ZHBTc4 ES cells. On the basis of the morphological changes
and because two trophoblast-associated genes, Hand1 and Cdx2, are upregulated,
Niwa et al. reported that the cells differentiated into trophectoderm on downreg-
ulation of Oct4. Furthermore, when the resulting differentiated cells are grown
in trophoblast stem cell conditions (Tanaka et al., 1998), trophoblast stem cells
are generated that can be passaged repeatedly and are capable of differentiating
into trophoblast subtypes upon removal of FGF4.
Since the original publication, ZHBTc4 ES cells have been used to study Oct4
involvement in ES cell differentiation (Hay et al., 2004), ES cell cycle control
(Lee et al., 2010), ES cell survival under stress conditions (Guo et al., 2008) and
germ cell specification (Okamura et al., 2008). This cell line has also been used
to investigate the capacity of the two human Oct4 isoforms to confer self-renewal
in mouse ES cells (Lee et al., 2006), and the tumorigenicity of the translocation
products EWS-Oct4 and EWS-Oct4B (Lee et al., 2007, Kim et al., 2010d).
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3.1.2 The role of miRNAs during ES cell differentiation
Maintenance of ES cells relies on suppression of the MAPK signalling pathway
or pro-differentiation signals downstream of it, while differentiation of ES cells
requires activation of ERK1/2 by FGF4 (Ying et al., 2008). Differentiation of ES
cells is associated with a loss of pluripotency characterised by down-regulation of
the ES cell master regulators Oct4 and Sox2 (Nichols et al., 1998, Avilion et al.,
2003), with obvious changes in morphology and proliferation rate, and with alter-
ation to signalling status, fate potential, dependence on growth factors and cell
cycle regulation. Differentiation associated changes to the cell cycle include the
establishment of a G1 phase, which is largely absent in the rapidly proliferating
ES cell (Savatier et al., 1994), and a decrease in the rate of cell cycle progression.
It is possible that the cell-cycle properties of ES cells may be functionally impor-
tant for pluripotency and that acquisition of G1/S regulation may be necessary
for differentiation to occur (Burdon et al., 2002). It is hypothesised that miRNAs
could be regulating any aspect, or multiple aspects of the differentiation process.
3.2 Aims of Chapter 3
Using the ZHBTc4 ES cell model system, the primary aims of this chapter were to
determine if miRNAs were differentially represented in a model of trophectoderm
differentiation and if differentially represented miRNAs, if any, were functionally
associated with elements of the developmental process.
3.3 Results
Prior to the project start, the ZHBTc4 ES cell system was initially characterised
and culture samples for miRNA profiling prepared by T. Burdon. RNA extraction
and miRNA library preparation was carried out by D. McBride. DNA sequencing
was performed commercially by DNA Sequencing Services (Dundee). Programmes
used for analysis of miRNA sequence data were written and tested by W. Carre.
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3.3.1 Characterisation of the ZHBTc4 model system
To ensure that our in vitro system represented an appropriate model of tro-
phoblast differentiation, the original characterisation of the ZHBTc4 system was
repeated and extended. In the ZHBTc4 ES cell culture system (Niwa et al., 2000)
Oct4 is expressed from a doxycycline-regulated transgene as illustrated in Figure
3.1a. In this system, both endogenous copies of Oct4 have been disrupted and
addition of doxycycline switches off the Oct4 transgene, which results in rapid
differentiation of the cells. Using protein samples previously prepared by T. Bur-
don, the expression of OCT4 in undifferentiated and differentiated ZHBTc4 ES
cells was investigated. Protein samples from ZHBTc4 ES cells that had been
cultured without doxycycline or in the presence of doxycycline for 12, 24, 48, 72
and 96 hours were used for western analysis of OCT4 expression. As can be seen
in Figure 3.1b, in untreated cells OCT4 protein levels increase slightly between
plating (T0) and 12 hours in culture, and thereafter similar OCT4 protein lev-
els are maintained for up to 96 hours. In contrast, in doxycycline treated cells,
OCT4 protein levels decrease dramatically to undetectable levels in as little as
12 hours following addition of doxycycline. This means that both suppression
of the transgene by doxycycline and the turnover rate of the transgenic protein
is extremely rapid in these cells. However, it must be noted that the changes
observed in OCT4 protein expression arise from analysis of a single experiment
and are therefore not definitive.
ZHBTc4 ES cells were grown without doxycycline or with the addition of doxy-
cycline for up to 96 hours in order to assess their morphology (Figure 3.2 ). Cells
grown without doxycycline remained ES cell-like in their morphology, growing
very tightly with large nuclei. The cells grown in the presence of doxycycline for
24 hours appeared ES cell-like. After a further 24 hours with doxycycline, cells
within colonies became more tightly associated before spreading out and taking
on a very different appearance. The boundaries between cells were difficult to
distinguish. At the edges of colonies cells appeared very large with flattened mor-
phology and clear to granular cytoplasm. With increasing time, in doxycycline
treated cultures the proportion of these large granular cells increased although
it is worth noting that even 96 hours after addition of doxycycline there were
still colonies of cells with an ES-like morphology. A greater number of float-
ing, dead cells were observed in the cultures grown without doxycycline. This
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Figure 3.1 – Characterisation of ZHBTc4 ES cell system. (a) Schematic diagram illus-
trating the doxycycline-regulated Oct4 transgene present in ZHBTc4 ES cells. (b) Western
analysis of OCT4 expression in ZHBTc4 ES cells at time of plating (Time 0) and ZHBTc4
ES cells grown without doxycycline (- dox) or in the presence of 1mg/ml doxycycline (+dox)
for 12, 24, 48, 72 or 96 hours. Western membrane was re-probed for b-ACTIN expression
to estimate protein-loading levels in individual lanes (loading control), n=1. (c) ZHBTc4
ES cells were grown without doxycycline or with doxycycline for 24, 48, 72 and 96 hours
and cells were harvested, dissociated and counted by nucleocounter at each timepoint.
Time 0 shows the number of cells initially plated (50,000). N=3, error bars show standard
deviation.
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Figure 3.2 – Morphology of untreated and doxycycline-treated ZHBTc4 ES cells. ZHBTc4
ES cells were grown without doxycycline (- doxycycline) or in the presence of 1mg/ml
doxycycline (+ doxycycline) for up to 96 hours and bright-field photographs (x100 magni-
fication) were taken every 24 hours.
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Table 3.1 – Panel of genes used as markers of ES cells and trophoblast lineages
may be explained by the fact that the undifferentiated cultures proliferated more
rapidly and became over-confluent. To quantitate the difference in growth rates
between undifferentiated cells and those induced to differentiate by the addition
of doxycycline, cell counts were performed on untreated and doxycycline treated
cultures at various timepoints after plating (T0). Figure 3.1c shows that cells
grown in the absence of doxycycline proliferate more quickly than cells grown
with doxycycline. This is to be expected as ES cells proliferate more rapidly than
differentiated cells due to differences in the ES cell cycle, in which G1 control is
reduced or absent (Savatier et al., 1994).
It has been reported that addition of doxycycline to ZHBTc4 ES cells results in
upregulation of TE marker genes, including Cdx2 and Hand1. To get a more
complete picture of the differentiation of these cells, QPCR assays were designed
and optimised for a panel of ES cell and TE marker genes (Table 3.1 ). Primer
optimisation was carried out on pooled cDNA derived from undifferentiated and
differentiated ES cell cultures. Optimisation QPCR was performed on a series of
10-fold cDNA dilutions over a 1x106 fold range. Primers were considered suitable
for use if they amplified a single product over >1000-fold range with an efficiency
between 95-105% and a ‘goodness of fit’ (RSq) of >0.95. Primer sequences can be
found in Materials and Methods, Table 3.2 shows the amplification efficiencies,
’goodness of fit’ (RSq) and amplification range for each primer pair. Appendix A
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Table 3.2 – Optimisation details for QPCR primers used in Chapter 3
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Figure 3.3 – Analysis of gene expression in undifferentiated and differentiated ZHBTc4
ES cells. ZHBTc4 ES cells were grown without doxycycline or in the presence of 1mg/ml
doxycyline for 24 or 48 hours. RNA was extracted from untreated and doxycycline-treated
cell cultures, DNAse treated and used to generate cDNA for QPCR analysis of expression
of ES cell marker genes (a) and trophoblast marker genes (b). QPCR Ct values were
normalised to b-Actin expression. Untreated cultures are represented by a value of 1.0
and results show gene expression in doxycycline treated cultures relative to non-treated
cultures at each timepoint. N=1.
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contains details of all primer pair optimisations. Gene expression was examined
by QPCR 24 and 48 hours after addition of doxycycline in treated cultures as
well as untreated cultures at identical timepoints (Figure 3.3a & b). Addition
of doxycycline resulted in decreased expression of markers of pluripotency (Oct4,
Sox2, Nanog) and increased expression of known markers of trophectoderm lin-
eages (Cdx2, Eomes, Hand1, Mash2, Id2 ). Interestingly Esrrß was designed as a
marker of trophectoderm differentiation because mice deficient for this protein ex-
hibit placental defects (Luo et al., 1997), but its expression pattern suggested that
higher levels were associated with undifferentiated ES cells. Conclusions about
expression of pluripotency and trophectoderm marker genes in the ZHBTc4 ES
cell system are preliminary because they arise from a single experimental analysis.
3.3.2 miRNA profiling during the ES:trophoblast transition
The ZHBTc4 system was used to profile miRNAs present in ES cells and TE cells
in order to identify miRNAs present in this cell type and those that were differ-
entially regulated as a result of the transition of ES cells into trophoblast. For
miRNA profiling analysis, T. Burdon carried out the tissue culture, D. McBride
prepared the miRNA libraries and W. Carré wrote Bioinformatics programs for
analysis of the miRNA profiling output. RNA was extracted from cultures grown
with or without doxycycline for 0, 12, 24, 48, 72 and 96 hours. For the generation
of miRNA libraries, the miRNA fraction was purified from total-RNA collected
from the 0, 24 and 48 hour timepoints of undifferentiated culture samples, and
from total-RNA collected from the 24, 48 and 72 hour timepoints of differentiat-
ing culture samples (Figure 3.4a). The resulting miRNA populations were cloned
and sequenced as illustrated in Figure 3.4a. The bioinformatics programs per-
formed the following functions: individual short RNA sequences were extracted
from vector sequence and linker sequences; extracted sequences were searched in
miRBase to identify homology with known miRNAs; results were combined and
the data was sorted to show the number of times each miRNA was sequenced
from the different libraries; the mouse genome was searched for homology to
short RNA sequences and if a match was found, a portion of the upstream and
downstream DNA sequence was extracted and analysed for the ability to form a
hairpin structure.
200 clones were sequenced from each of the six different libraries, which resulted
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Figure 3.4 – miRNA profiling in undifferentiated and differentiated ZHBTc4 ES cells. (a)
Schematic illustration of miRNA profiling method. ZHBTc4 ES cells were grown either
without doxycycline (- DOX) or in the presence of 1mg/ml doxycycline (+ DOX) for 12,
24, 48, 72 or 96 hours. RNA was extracted from the starting population of undifferenti-
ated ZHBTc4 ES cells (Time 0) and the timepoints indicated. MiRNAs were purified from
the timepoints shown in red boxes. Following miRNA purification, RNA was converted to
cDNA, concatemerised, cloned and sequenced. (b) Pie chart showing the proportions of to-
tal miRNA sequences that represent previously known mouse miRNAs, novel miRNAs and
candidate novel miRNAs. (c) Bar chart showing the number of miRNAs with equivalent
representation in undifferentiated and differentiated miRNA libraries and the number of
miRNAs represented at higher levels in undifferentiated ZHBTc4 ES cells or differentiated
cells.
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in a total of 5683 individual short-RNA sequences. Individual library clones
encoded concatemerised sequences representing an average of 4/5 miRNA se-
quences per clone. Bioinformatics analysis revealed that 461 different individual
sequences had been identified, of which 160 had been previously been recorded
as mouse miRNAs. Of the remaining 301 sequences, which are potentially novel
miRNAs, 86 map to the published mouse genome and of these, 31 map in a region
that folds appropriately into a hairpin structure as defined by RNA-fold (Figure
3.4b). These 31 sequences are likely to represent novel miRNAs. The remaining
270 sequences that do not match a region in the mouse genome or fold into a
hairpin structure are ‘candidate’ miRNA sequences. Full miRNA profiling data
is available in Appendix B.
3.3.3 Analysis of miRNA profiling results
Differentially represented miRNAs were defined as miRNAs recorded >10 in-
stances and differing by >2-fold between undifferentiated and differentiated cul-
tures. By the criteria adopted, 19 miRNAs were differentially regulated as a
result of trophoblast induction (Figure 3.4c & Table 3.3 ). Of these, the levels of
12 miRNAs increased and the levels of 7 miRNAs decreased as a result of differ-
entiation. Increases in representation ranged from 2-fold to 11-fold and decreases
in representation ranged from 2-fold to 8-fold. Most of the differentially repre-
sented miRNAs were previously known, but one miRNA that was observed to be
represented more highly in differentiated libraries than undifferentiated libraries,
mES2, was novel. mES2 was represented at 5-fold higher levels in differentiated
libraries compared to undifferentiated libraries and was encoded within intron 10
of Sfmbt2. This suggests that mES2 is a novel miRNA that is part of the Sfmbt2
miRNA cluster.
To confirm that the profiling data reflected gene expression, a subset of the dif-
ferentially represented miRNAs was selected for northern analysis. RNA from
ZHBTc4 ES cells grown without doxycycline or in the presence of doxycycline
for various lengths of time was used for miRNA northern analysis of miR-30C,
miR-669b, mES2 and miR-467a* expression (Figure 3.5a). Phosphoimager anal-
ysis of miRNA northern membranes was used to quantitate miRNA expression
in undifferentiated and differentiated ZHBTc4 ES cells (Figure 3.5b).
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Table 3.3 – miRNAs identified as being differentially represented during trophectoderm
differentiation of ZHBTc4 ES cells. The total number of times a miRNA was sequenced
is shown for differentially represented miRNAs in ZHBTc4 ES cell cultures grown with-
out doxycycline (‘Undifferentiated’ column) or with doxycycline (‘Differentiated’ column).
The total number of sequencing events is pooled from 3 undifferentiated libraries and 3
differentiated libraries after normalisation for library size. ‘Fold Change’ is the ratio (to
the nearest whole number) of the number of sequencing events in differentiated libraries
compared to undifferentiated libraries. The genomic location column shows if the miRNA
is intergenic or encoded within a protein-coding gene.
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Figure 3.5 – Expression analysis of miRNAs in undifferentiated and differentiated
ZHBTc4 ES cell cultures. (a) Total RNA (5mg) from ZHBTc4 ES cells at the time of
plating (T0) or ZHBTc4 ES cells grown without doxycycline (-dox) or in the presence
of 1mg/ml doxycycline (+dox) for 24, 48, 72 or 96 hours was used for miRNA northern
analysis. Expression of miR-30C, miR-669b, miR-467a*, the novel miRNA, mES2, and
the spliceosomal RNA, U6, is shown. (b) miRNA northern membranes were exposed to
a phosphoimager screen for quantitation of expression of each miRNA. Values for each
sample were normalised against values obtained for U6 and then calculated relative to the
T0 sample. N=1.
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Expression of miR-30C was observed to increase at 48 and 72 hours in undifferen-
tiated ZHBTc4 ES cells. In differentiated cultures however, miR-30C expression
decreased gradually from 24 hours to 96 hours after addition of doxycycline. The
overall miRNA profiling showed a 3-fold decrease in representation of miR-30C
in differentiated ZHBTc4 libraries compared to undifferentiated libraries. Phos-
phoimager quantitation showed an approximately 2-fold decrease in expression
at 48 hours and a 3-fold decrease in expression at 72 and 96 hours.
Expression of miR-669b was observed to increase at 24, 48 and 72 hours in un-
differentiated ZHBTc4 ES cells relative to expression at T0. In differentiated
cultures, miR-669b expression was higher than in undifferentiated cultures at all
timepoints. Differences in expression levels between undifferentiated and differ-
entiated samples at different timepoints varied between approximately 1.4 and
2.6-fold. For comparison, overall miRNA-profiling analysis showed 2-fold higher
representation of miR-669b in differentiated libraries compared to undifferenti-
ated libraries.
Expression of the novel miRNA, mES2 was seen to stay at approximately constant
levels in undifferentiated ZHBTc4 ES cells. However, in differentiated cultures
mES2 expression was lower in differentiated samples compared to undifferentiated
samples at all timepoints with a dramatic difference in expression levels observed
72 hours after doxycycline addition. The miRNA profiling data showed a 5-fold
decrease in representation of mES2 in differentiated ZHBTc4 libraries compared
to undifferentiated libraries. Phosphoimager quantitation showed a decrease in
expression of between approximately 45-fold (at 72 hours) and 1.75-fold (at 96
hours).
Expression of miR-467a* was observed to stay at an approximately constant level
in undifferentiated ZHBTc4 ES cells relative to expression at T0. In differentiated
cultures, miR-467a* expression was higher than in undifferentiated cultures at all
timepoints and showed an increase in expression from 24 hours to 72 hours after
addition of doxycycline. Differences in expression levels between undifferentiated
and differentiated samples at each timepoint varied between approximately 1.4-
fold at 24 hours and 3-fold at 72 hours. miRNA-profiling analysis showed 11-
fold higher representation of miR-467a* in differentiated libraries compared to
undifferentiated libraries.
Analysis of expression of several miRNAs predicted to be differentially represented
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by the miRNA-profiling data confirmed differential expression as predicted by
the profiling data. Furthermore, for three out of four miRNAs the differences
in expression levels observed between undifferentiated and differentiated samples
were broadly similar to the differences in representation levels from the miRNA
profiling data. However, while the expression analysis described here appears to
support the miRNA profiling data, it must be noted that these data are from a
single experimental analysis and are therefore not definitive.
3.3.4 Analysis of binding of miRNA promoters by ES cell
transcription factors
The possibility that differentially represented miRNAs identified in this study
may be known to be regulated by factors important in the self-renewal of ES cells
was investigated. In a study investigating how the key transcriptional regulators
of ES cells regulate miRNA gene expression, Marson et al. identified miRNA
promoters that contained binding sites for Oct4, Sox2, Nanog and Tcf3, as well
as miRNA promoters that bind SUZ12 and carry the H3K27me3 chromatin marks
associated with repressed genes (Marson et al., 2008). The Marson et al. dataset
was examined to determine whether the promoters of differentially represented
miRNAs identified in this study were bound by these key transcription factors
(Table 3.4 ).
Of the 7 miRNAs that decreased in representation on differentiation, 6 have bind-
ing sites for Oct4 within their promoter regions and of these 4 are bound by all
4 transcription factors analysed. This suggests that expression of these miRNAs
may be directly regulated by key ES cell transcription factors. In addition, the
Sfmbt2 gene promoter region contained predicted binding sites for repressor pro-
teins, consistent with the observation that the representation of 8 of the miRNAs
encoded within this cluster is lower in ES cells than in differentiated cultures.
Oct4 and Sox2 bound two of the miRNAs that were upregulated during differen-
tiation. These transcription factors can act as repressors as well as activators of
transcription depending on context so perhaps these miRNAs are being repressed
by Oct4 and Sox2 in ES cells.
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Table 3.4 – Binding of miRNA promoters by ES cell factors. Table shows if the promoters
of differentially represented miRNAs are bound by ES cell factors (Oct4, Sox2, Nanog and
Tcf3 ) or the polycomb group protein (SUZ12) or modified by the repressive chromatin mark
H2K27H3. Data from the miRNA profiling analysis was matched to promoter binding data
from Marson et al. (2008). MiRNAs encoded in more than one genomic location (eg. miR-
30C ) are listed using miRBase designation and promoter-binding data for each location is
shown.
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3.3.5 Expression analysis of genes containing differentially
represented miRNAs
Several of the differentially represented miRNAs were encoded within introns of
others genes (see Table 3.3 ). In the majority of such cases it is generally thought
that the miRNA is transcribed as part of the mRNA transcript (Baskerville &
Bartel, 2005) although there are cases where separate miRNA transcripts are en-
coded within introns. It might be expected that the genes containing differentially
represented miRNAs would be differentially expressed during the ES-trophoblast
transition. In order to examine this possibility ZHBTc4 ES cells were grown
in the presence of doxycycline for various lengths of time and RNA was ex-
tracted, DNAse treated and converted to cDNA. QPCR analysis was performed
on cDNA from differentiating ZHBTc4 ES cells in order to analyse the expression
of genes containing differentially represented miRNAs. QPCR analysis was also
performed on undifferentiated cells from corresponding timepoints to the differ-
entiating cells. This analysis was performed as a single experiment and therefore
conclusions drawn from the results are preliminary.
Expression of Sfmbt2 (which contains a large cluster of miRNAs including miR-
467a* and miR-669b) gradually increased throughout the 96-hour period of tro-
phectoderm differentiation, reaching levels that were 10-fold higher in differ-
entiated ZHBTc4 ES cultures than in undifferentiated cultures (Figure 3.6a).
miRNA-profiling analysis showed differential representation of miRNAs from the
Sfmbt2 cluster, which varied between, 2-fold and 11-fold.
The expression level of C77370 (which encodes miR-672 ) decreased rapidly on
differentiation, falling approximately 30-fold over the 48 hours following addition
of doxycycline to ZHBTc4 ES cells (Figure 3.6b). This is a more dramatic de-
crease in expression than was observed for miR-672, which was 8-fold lower in
differentiated cells compared to undifferentiated cells according to the miRNA-
profiling data. C77370 is an expressed sequence, which is believed to be protein
coding, but the function of which is not known.
Expression of Odz4 (which encodes miR-708 ) also decreased during trophecto-
derm differentiation, falling approximately 10-fold during the first 72 hours of dif-
ferentiation (Figure 3.6c). The level of miR-708 was 4-fold lower in differentiated
libraries compared to undifferentiated libraries according to the miRNA-profiling
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Figure 3.6 – Expression analysis of genes containing miRNAs. RNA was harvested from
ZHBTc4 ES cells (T0) and ZHBTc4 ES cells that were grown in the presence of 1mg/ml
doxycycline for 24, 48, 72 or 96 hours. RNA was DNAse treated, converted to cDNA and
used for QPCR analysis of expression of Sfmbt2 (a), C77370 (b), Odz4 (c) and Nfyc (d) in
differentiating ZHBTc4 ES cells. QPCR Ct values were normalised to b-Actin expression
and expression is shown relative to the expression in ZHBTc4 ES cells (T0). N=1.
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data. Odz4 (also known as Ten4 ) is a member of a transmembrane protein fam-
ily that have the ability to form homo and heterodimers and may be involved in
intercellular signalling during development (Feng et al., 2002, Tucker & Chiquet-
Ehrismann, 2006). Odz4 is expressed during development and is essential for
mouse gastrulation (Lossie et al., 2005).
The patterns of expression of Sfmbt2, C77370 and Odz4 mirrored the represen-
tation patterns seen for the miRNAs encoded within them although the extent of
the differential expression varied. In contrast, Nfyc (which is thought to contain
miR-30C ) was not differentially expressed (Figure 3.6d). miR-30C was con-
firmed as being differentially expressed by miRNA northern analysis (see Figure
3.5a & b) so the results from the expression analyses do not agree. The disagree-
ment between the expression patterns of Nfyc and miR-30C may be explained
by the fact that miR-30C is found at two different locations within the mouse
genome, one within Nfyc and the other in an intergenic region. The differential
expression seen here suggests that the miR-30C that is detected is expressed
from the location on Chromosome 1 rather than within the Nfyc gene on Chro-
mosome 4. Alternatively, miR-30C may have its own promoter and be processed
as a separate transcript to Nfyc. Nfyc encodes one subunit of a trimeric complex
forming a highly conserved transcription factor and has been shown to suppress
expression of the developmentally important hox gene egl-5 in C. elegans (Sinha
et al., 1996, Deng et al., 2007). The finding that genes encoding miRNAs follow
the same pattern as the miRNA means that more information can be extracted
from miRNA profiling than the representation of the miRNAs themselves. These
types of analyses may not only identify differentially represented miRNAs, but
differentially expressed protein-coding genes as well.
3.3.6 Expression analysis of Sfmbt2
Of the 12 miRNAs upregulated on differentiation, 8 are contained within a single
multi-miRNA cluster located in intron 10 of the Polycomb group gene, Sfmbt2
(Scm (sex comb on midleg)-like with four mbt (malignant brain tumour repeat)
domains 2) (Figure 3.7a).
Figure 3.6a shows that Sfmbt2 expression mirrors that of the miRNA cluster
contained within it. Sfmbt2 expression increased during trophoblast differentia-
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tion of ZHBTc4 ES cells. In order to confirm that upregulation of Sfmbt2 was
associated with a reduction in Oct4 expression and also to assess the effect of
an alternate method of Oct4 depletion on expression of ES cell and TE marker
genes, gene expression was examined after siRNA knockdown of Oct4 expres-
sion in CGR8 ES cells (the parental line of ZHBTc4 ES cells). As a control for
the transfection procedure, cells were treated with an siRNA against EGFP and
expression of marker genes was analysed. RNA available in the laboratory (pre-
pared by T. Burdon) was DNAse treated and used to generate cDNA for QPCR
analysis of gene expression.
Figure 3.7 - Schematic diagram of Sfmbt2 and encoded miRNA cluster and expression analysis
of Sfmbt2 (continued on next page).
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Figure 3.7 – Schematic diagram of Sfmbt2 and encoded miRNA cluster and expression
analysis of Sfmbt2. (a) Schematic diagram of Sfmbt2 gene showing introns as blue bars and
exons as grey bars. The Sfmbt2 miRNA cluster is encoded in intron 10 and is composed of
71 miRNAs belonging to 4 miRNA families. (b-c) CGR8 ES cell cultures (b) or ZHBTc4
and E14 ES cell cultures (c) were transfected with siRNAs designed to target Oct4 or EGFP
(control). 72 hours after transfection RNA was extracted, DNAse treated, converted to
cDNA and used for QPCR analysis of gene expression. QPCR Ct values were normalised
to b-Actin levels and expression is shown relative to expression of cultures transfected with
siRNA targeting EGFP. N=1. (d) RNA from the embryonic or extra-embryonic (placenta)
compartments of E13, E15 and E18 mouse embryos was DNAse treated, converted to cDNA
and used for QPCR analysis of Sfmbt2 expression. QPCR Ct values were normalised to b-
Actin levels and expression in each extra-embryonic sample is shown relative to expression
in the corresponding embryonic sample. N=1. (e) E14 ES cells (T0) were used to form
embryoid bodies and RNA was extracted after 4, 8, 12 or 16 days of differentiation (Day
4, Day 8, Day 12, Day 16). RNA was DNAse treated, converted to cDNA and used for
QPCR analysis of Sfmbt2 expression. QPCR Ct values were normalised to b-Actin and
expression at each timepoint of EB differentiation is shown relative to expression at T0.
N=1.
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Oct4 levels were reduced by >50% following siRNA knockdown of Oct4 (Figure
3.7b). The decrease in Oct4 expression after siRNA knockdown of Oct4 is not
as dramatic as that seen in the ZHBTc4 ES cell system. This is to be expected
because not every cell will be transfected with siRNA targeting Oct4 and also
because the transcription of Oct4 has not been prevented in these cells, as it
is in the doxycycline-treated ZHBTc4 ES cell cultures. Following inhibition of
Oct4 expression by siRNA, ES cell marker genes decreased in expression and,
Cdx2, Hand1 and Mash2 marker genes increased in expression (Figure 3.7b)
similar to gene expression in doxycycline-treated ZHBTc4 ES cell cultures. The
downregulation of ES cell markers is not as dramatic as in the ZHBTc4 ES cell
system and neither is the upregulation of Cdx2, Eomes and Id2. Interestingly the
increase in the level of Hand1, a marker of trophoblast giant cells, is dramatically
greater after siRNA knockdown of Oct4 than in the ZHBTc4 system. While
this is difficult to rationalise in the context of trophectoderm differentiation, it
should be noted that Hand1 is not only a factor that promotes trophoblast giant
cell differentiation, but is also involved in the differentiation of extra-embryonic
mesoderm and during heart development (Firulli et al., 1998). Additionally, the
siRNA knockdown samples were analysed 72 hours after Oct4 knockdown but the
ZHBTc4 ES cell samples were analysed 24 and 48 hours after knockdown. This
may also account for a higher level of Hand1, which is a marker of later trophoblast
differentiation. Overall, these data show that changes in gene expression after
knockdown of Oct4 expression in ES cells are broadly similar following siRNA
knockdown in wt ES cells or doxycycline addition to the ZHBTc4 ES cell system.
However, it must be pointed out that these data arise from a single experimental
replicate and experimental repeats would be required to render conclusions about
gene expression definitive.
The expression of Sfmbt2 increased after siRNA knockdown of Oct4 expression
compared to knockdown of EGFP expression. In order to confirm that upreg-
ulation of Sfmbt2 was associated with a reduction in Oct4 expression, Sfmbt2
expression was examined in two different ES cell lines after siRNA knockdown of
Oct4 expression compared to siRNA knockdown of EGFP expression. ES cells
were plated and grown for 24 hours followed by two overnight transfections (24
hours apart) with siRNAs predicted to target Oct4 or EGFP. 72 hours after the
initial transfection, RNA samples were harvested, DNAse treated and used to
generate cDNA for QPCR analysis of Sfmbt2 expression. It was observed that
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Sfmbt2 expression increased following Oct4 knockdown by siRNA relative to a
control knockdown. This effect was observed in both ES cell lines (Figure 3.7c)
although data was from a single experiment in each cell line so conclusions are
not definitive. These data suggest that Sfmbt2 expression increases as a result of
Oct4 downregulation in the ZHBTc4 ES cell system and after siRNA knockdown
of Oct4 expression. This effect could be due to direct regulation of Sfmbt2 by
Oct4 as there is a putative Oct4 binding site within the promoter of Sfmbt2 (Loh
et al., 2006).
To assess if Sfmbt2 (and by association its encoded miRNA cluster) is associated
with the TE in vivo its expression was assessed in mouse embryos. TE contributes
to the placenta so, using material available within the laboratory, Sfmbt2 expres-
sion was assessed in placentas and associated embryos (Figure 3.7d). Embryos
and placentas were collected from pregnant mice at E13, E15 and E18 and RNA
was extracted by S. Butterwith and stored as an ethanol precipitate. RNA was
recovered from precipitate, DNAse treated and used to generate cDNA. QPCR
analysis of Sfmbt2 expression was performed on cDNA generated from embryos
and associated placentas. As can be seen from Figure 3.7d, at E13, E15 and E18
Sfmbt2 is expressed between 10 and 50 fold higher in placental tissue than in
embryonic tissue. It is likely then that Sfmbt2 and its encoded miRNA cluster
are functionally associated with TE in early development although because these
data arise from a single experiment this conclusion is not definitive.
To investigate if Sfmbt2 upregulation is a general feature of differentiation or if it
is specific to TE differentiation the expression of Sfmbt2 was investigated during
embryoid body differentiation of E14 ES cells. E14 ES cells were plated in serum
media without the addition of Lif in non-adherent culture conditions to stimulate
EB formation and were grown in non-adherent culture conditions for 8 days. On
day 8 of differentiation EBs were transferred to adherent culture conditions and
cultured for a further 8 days. RNA was extracted from undifferentiated ES cells
(Time 0) and on days 4, 8, 12 and 16 of differentiation. RNA was DNAse treated
and used to generate cDNA for QPCR analysis of Sfmbt2 expression. Expression
of Sfmbt2 remained broadly similar during embryoid body differentiation of E14
ES cells (Figure 3.7e). Because embryoid bodies do not readily differentiate into
TE lineages (Weitzer, 2008) this finding suggests that the upregulation of Sfmbt2
is specific to TE differentiation. Further experimental repeats would be required
to confirm this preliminary conclusion.
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3.3.7 Expression analysis of miR-92a and related miRNAs
Members of the miR-17-92a cluster and the sequence-related miR-106-363 cluster
of miRNAs were more highly represented in ES cells than in trophoblast cells.
miR-92a is encoded within both clusters (Figure 3.8a) and is related in sequence
to miR-25 and miR-363 (Figure 3.8b), sharing an identical seed sequence with
these miRNAs. Of the 3 differentially represented miRNAs encoded within these
clusters, miR-92a was the one most frequently recorded in our profiling analysis.
To confirm that miR-92a was differentially expressed during trophectoderm dif-
ferentiation of ZHBTc4 ES cells, miRNA northern analysis was performed. RNA
from ZHBTc4 ES cells grown without doxycycline or in the presence of doxycy-
cline for various lengths of time was used for miRNA northern analysis of miR-
92a expression and analysis of expression of the related miRNAs, miR-25 and
miR-363 (Figure 3.9a). Phosphoimager analysis of miRNA northern membranes
was used to quantitate miRNA expression in undifferentiated and differentiated
ZHBTc4 ES cells (Figure 3.9b). Expression of miR-92a remained broadly similar
in undifferentiated ZHBTc4 ES cells. In differentiated cultures however, miR-92a
expression was consistently lower in differentiated cultures compared to undiffer-
entiated cultures. The miRNA profiling showed a 2-fold decrease in expression
of miR-92a in differentiated ZHBTc4 libraries compared to undifferentiated li-
braries. Phosphoimager quantitation showed an approximately 2-fold decrease in
expression at 48 hours and 96 hours after addition of doxycycline, which is con-
sistent with the fold change in representation calculated from the profiling data.
Analysis of miR-25 expression revealed that it is also differentially expressed in
the ZHBTc4 ES cell system although it did not meet the arbitrary criteria that
were defined for differentially represented miRNAs (Figure 3.9a & b). miR-25
expression was similar in undifferentiated ZHBTc4 ES cells at T0, 24 and 48
hours, but showed an increase in expression at 72 and 96 hours. In differenti-
ated cultures, expression of miR-25 was lower than expression in undifferentiated
cultures at each timepoint. Variation in expression levels varied between approx-
imately 1.3-fold and 2-fold. miR-363 was expressed at very low levels consistent
with the fact that it was not detected in the miRNA profiling analysis (Figure
3.9a). Although these observations are supported by the findings of the miRNA
profiling analysis, it must be noted that they arise from a single experimental
replicate and have the potential to be misleading.
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Figure 3.8 – Diagram of the miR-17-92a cluster and related miRNA clusters. (a) Diagrams
of the miR-17-92a cluster on chromosome 14 and related clusters miR-106a-363 and miR-
106b-25 on chromosomes X and 5, respectively. Each miRNA sequence is represented by
an arrow. miRNAs with identical seed sequences (nucleotides 2-8 from the 5’ end of the
miRNA) are shown as the same colour. (b) Mature miRNA sequences of miR-92a, miR-25
and miR-363. The seed sequence is highlighted in red.
In an attempt to gain some insight into the function of these miRNAs, expression
was analysed in a variety of adult tissues. The expression of miR-92a, miR-25
and miR-363 was assessed in adult mouse tissues using RNA available in the
laboratory (prepared by D. McBride). RNA was recovered from precipitate and
used for miRNA northern analysis of expression of miR-92a, miR-25 and miR-
363. miRNA northern analysis showed that miR-92a has variable expression in
the tissues of the mouse (Figure 3.10a & b). miR-92a is expressed in all tissues
examined but has particularly high levels of expression in thymus, spleen, bone
marrow and lung. miR-25 has a more restricted pattern of expression and is
expressed most highly in heart, spleen, lung and bone marrow. The differences
in expression patterns can most readily be explained by the fact that miR-25
and miR-92a are expressed from different genomic locations. In contrast to miR-
92a and miR-25, expression of miR-363 was only detected in thymus by miRNA
northern analysis under the conditions employed here. Experimental repeats
would be required in order to make conclusions about the expression patterns of
these miRNAs definitive.
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Figure 3.9 – Expression analysis of miR-92a and related miRNAs in undifferentiated and
differentiated ZHBTc4 ES cells. (a) Total RNA (5mg) from ZHBTc4 ES cells at the time
of plating (T0) or ZHBTc4 ES cells grown without doxycycline (-dox) or in the presence
of 1mg/ml doxycycline (+dox) for 24, 48, 72 or 96 hours was used for miRNA northern
analysis. Expression of miR-92a, miR-25, miR-363 and the spliceosomal RNA, U6, is
shown. (b) miRNA northern membranes were exposed to a phosphoimager screen for
quantitation of expression of miR-92a and miR-25. Expression of miR-363 was too low
for quantitation by phosphoimager. Expression of each miRNA was normalised to U6
expression and is shown relative to expression of the T0 sample. N=1.
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Figure 3.10 – Expression of miR-92a and related miRNAs in various adult mouse tissues.
(a) Total RNA (5mg) from adult mouse tissues was used for miRNA northern analysis.
Expression of miR-92a, miR-25, miR-363 and the spliceosomal RNA, U6, is shown. (b)
miRNA northern membranes were exposed to a phosphoimager screen for quantitation of
expression of miR-92a and miR-25. Expression of miR-363 was too low for quantitation by
phosphoimager. Expression of each miRNA is shown normalised to U6 expression. N=1.
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3.3.8 Optimisation of systems for miRNA functional analysis
In order to investigate the role of miR-92a during the ES cell to trophoblast
transition, systems for functional analysis were optimised. The possibility of
inhibiting miRNA expression in ES cells by addition of LNA molecules comple-
mentary to the mature miRNAs was examined. LNAs are RNA nucleotides where
the O2’ and C4’ atoms are linked by a methylene group, which locks the molecule
into the ideal conformation for Watson-Crick binding. The ‘LNAs’ used in this
thesis are hybrid oligonucleotides comprised of DNA bases with LNA nucleotides
inserted at every third position. This results in an oligonucleotide that pairs with
complementary sequence more rapidly and increases the stability of the resulting
complex.
To determine the appropriate concentration of LNA required to inhibit miRNA
expression in undifferentiated ES cells, ZHBTc4 ES cells were transfected with a
range of concentrations of an LNA designed to target miR-30C. RNA was col-
lected from cultures after 24 hours of transfection and used for miRNA northern
analysis of expression of miR-30C. Figure 3.11a shows that addition of a comple-
mentary LNA inhibited miR-30C expression in a concentration-dependent man-
ner. No miR-30C expression was detected after transfection of ES cells with
>37.5nM complementary LNA. miRNA northern membranes were exposed to
a phosphoimager screen for quantitation of miR-30C expression. This analysis
showed that >85% knockdown could be achieved at 24 hours using a concentra-
tion of 9.4-150nM (62.5-250ng/ml) of LNA (Figure 3.11b). Cell numbers were
assessed after transfection of various concentrations of LNA to ensure that trans-
fection did not cause cell death. The number of cells present after transfection
with various concentrations of LNA was assessed by dissociation of the cells fol-
lowed by cell counting using a nucleocounter (Figure 3.11c). No effect on cell
numbers was observed after transfection of even the highest concentration of
LNA.
To ensure that the above findings were not specific to miR-30C, and to optimise
transfection of differentiated ZHBTc4 ES cells, the optimisation procedure was
repeated in differentiating ZHBTc4 ES cells with transfection of an LNA comple-
mentary to miR-467a*. ZHBTc4 ES cells were grown in the presence of doxycy-
cline for 72 hours to ensure robust expression of miR-467a* (see Figure 3.5a).
Cells were transfected with a range of concentrations of an LNA designed to tar-
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get miR-467a*. RNA was collected from cultures after 24 hours of transfection
and used for miRNA northern analysis of expression of miR-467a*. As observed
for miR-30C inhibition, Figure 3.12a shows that addition of a complementary
LNA inhibited miR-467a* expression in a concentration-dependent manner. No
miR-467a* expression was visible after transfection of ES cells with >37.5nM
complementary LNA. miRNA northern membranes were exposed to a phospho-
imager screen for quantitation of miR-467a* expression. This analysis showed
that >90% knockdown could be achieved at 24 hours using a concentration of
9.4-150nM (62.5-250ng/ml) of LNA (Figure 3.12b). As for miR-30C, no effect on
cell numbers was observed after transfection of even the highest concentration of
LNA complementary to miR-467a* (Figure 3.12c).
In order to determine how long the miRNA inhibition lasted, undifferentiated
ZHBTc4 ES cells were exposed to transfection reagent alone or transfected overnight
with 22.5nM or 45nM of an LNA complementary to miR-30C and subsequently
left to grow for various lengths of time. RNA was harvested from cells 24, 48 and
72 hours after transfection and used for miRNA northern analysis of miR-30C
expression. Figure 3.13a shows that the miRNA knockdown is transient and the
time taken for expression to reappear is dependent on the concentration of LNA
added. miRNA northern membranes were exposed to a phosphoimager screen for
quantitation of miR-30C expression (Figure 3.13b). These data show that a 22.5
or 45nM LNA concentration achieved approximately 80% miRNA knockdown
for 48 hours. At 72 hours post transfection 50% knockdown was observed for
a 22.5nM concentration of LNA and >60% inhibition was observed for a 45nM
concentration of LNA. It is likely that significant suppression of miRNA levels
continues beyond 72 hours after transfection.
Optimisation of LNA-mediated knockdown of miRNA expression led to the fol-
lowing conclusions: LNA oligonucleotides complementary to mature miRNA se-
quences can be used to inhibit miRNA expression in undifferentiated and differ-
entiated ZHBTc4 ES cells. Transfection of up to 150nM of LNA into undifferen-
tiated or differentiated ZHBTc4 ES cells does not result in increased cell death.
Inhibition of miRNA expression by LNAs is concentration and time dependent.
However, it must be noted that while these data provide indications about the
conditions required for miRNA inhibition by LNA, because they come from single
experiments these conclusions are not definitive. As a result of these experiments
the concentration of LNA used for future miRNA knockdown experiments was
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Figure 3.11 – Optimisation of miRNA knockdown by LNA in undifferentiated ZHBTc4 ES
cells. 50,000 ZHBTc4 ES cells were grown in serum + Lif media without doxycycline for 72
hours then grown overnight in the presence of transfection reagent (Lipofectamine 2000) or
transfected overnight with between 1.8nM and 150nM of LNA complementary to miR-30C.
RNA was extracted 24 hours after the start of transfection. (a) Total RNA (5ug) from
untransfected ZHBTc4 ES cells and from ZHBTc4 ES cells 24 hours after transfection with
different concentrations of LNA targeting miR-30C was used for miRNA northern analysis.
Expression of miR-30C and the spliceosomal RNA, U6, is shown. N=1. (b) miRNA
northern membranes were exposed to a phosphoimager screen for quantitation of expression
of miR-30C and U6. Expression of miR-30C was normalised to U6 expression and is shown
as a percentage of expression in untransfected ZHBTc4 ES cells. N=1. (c) Cells were
dissociated 24 hours after transfection and counted in duplicate by nucleocounter. Scatter
chart shows the mean number of cells per ml for untransfected ZHBTc4 ES cells (shown
on the log scale as 1nM concentration of LNA) and for ZHBTc4 ES cells transfected with
various concentrations of LNA. A linear trendline is shown. N=1.
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Figure 3.12 – Optimisation of miRNA knockdown by LNA in differentiated ZHBTc4 ES
cells. 50,000 ZHBTc4 ES cells were grown in serum + Lif media with 1mg/ ml doxycycline
for 72 hours then grown overnight in the presence of transfection reagent (Lipofectamine
2000) or transfected overnight with between 1.8nM and 150nM of LNA complementary
to miR-467a*. RNA was extracted 24 hours after the start of transfection. (a) Total
RNA (5ug) from untransfected ZHBTc4 ES cells and from ZHBTc4 ES cells 24 hours
after transfection with different concentrations of LNA targeting miR-467a* was used for
miRNA northern analysis. Expression of miR-467a* and the spliceosomal RNA, U6, is
shown. N=1. (b) miRNA northern membranes were exposed to a phosphoimager screen for
quantitation of expression of miR-467a* and U6. Expression of miR-467a* was normalised
to U6 expression and is shown as a percentage of expression in untransfected ZHBTc4 ES
cells. N=1. (c) Cells were dissociated 24 hours after transfection and counted in duplicate
by nucleocounter. Scatter chart shows the mean number of cells per ml for untransfected
ZHBTc4 ES cells (shown on the log scale as 1nM concentration of LNA) and for ZHBTc4
ES cells transfected with various concentrations of LNA. A linear trendline is shown. N=1.
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Figure 3.13 – Analysis of length of time miRNA knockdown persists for after transfection
of different concentrations of LNA. 50,000 ZHBTc4 ES cells were grown in serum + Lif
media without doxycycline for 48 hours then grown overnight in the presence of transfec-
tion reagent (Lipofectamine 2000) or transfected overnight with 22.5nM or 45nM of LNA
complementary to miR-30C. RNA was extracted 24, 48 and 72 hours after the start of
transfection. (a) Total RNA (15ug) from untransfected ZHBTc4 ES cells (0nM) and from
ZHBTc4 ES cells 24, 48 and 72 hours after transfection of 22.5nM or 45nM of LNA tar-
geting miR-30C was used for miRNA northern analysis. Expression of miR-30C and the
spliceosomal RNA, U6, is shown. N=1. (b) miRNA northern membranes were exposed to
a phosphoimager screen for quantitation of expression of miR-30C and U6. Expression of
miR-30C was normalised to U6 expression and is shown as a percentage of expression in
untransfected ZHBTc4 ES cells at each timepoint. N=1.
Chapter 3. miRNAs in trophoblast differentiation 113
between 37.5 and 150 nM.
3.3.9 The effect of miR-92a suppression on gene expression
According to our analysis, miR-92a is differentially expressed during trophoblast
differentiation and shows reduced levels as a result of the transition from ES cell
to trophoblast lineage. In order to assess if miR-92a and related miRNAs had any
direct effect on differentiation, QPCR analysis of ES cells and TE markers was
carried out on ES cells after combined inhibition of miR-92a, miR-25 and miR-
363 using 100nM of LNA oligonucleotides complementary to the three miRNAs.
Control cultures were transfected with an LNA designed to inhibit a novel chicken
miRNA (DM1) that is not found in mice (Figure 3.14a). QPCR assays for the
ES cell and TE markers detailed in Table 3.1 were used in this analysis. Figure
3.11a shows that there is no significant difference in the expression of either ES
cell or trophoblast markers following miRNA knockdown in ZHBTc4 ES cells.
Identical treatments and analysis were also carried out in two wild type ES cell
lines (E14 and CGR8 ES cells) and although there was slightly more variation
seen than with ZHBTc4 cells, there was no obvious effect of miRNA knockdown
(Figure 3.14b & c). In each case the specificity of the knockdown of miR-92a was
confirmed by miRNA northern analysis (Figure 3.11a-c). Although these data
come from a single experimental replicate, the fact that the same observation
is made in each ES cell line strengthens the preliminary conclusions made from
these results.
From this experiment it can be seen that knockdown of miR-92a and related miR-
NAs had no effect on the expression of ES cell markers or TE markers. Therefore
it is unlikely that the function of these miRNAs in this system relates to the
differentiation process per se. However, miR-92a and related miRNAs are likely
to have a role in other aspects of cell function that are associated with this devel-
opmental transition. For example, there is evidence that some miRNAs encoded
by these clusters have roles in cell proliferation (Mendell, 2008) and Figure 3.1
shows that the proliferation rate of ES cells decreases during TE differentiation.
In light of this the possibility that miR-92a and related miRNAs were involved
in regulating cell proliferation in ES cells was investigated.
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Figure 3.14 – Expression of ES cell and trophoblast marker genes after inhibition of
miRNA expression. ES cells were transfected with a combination of LNAs targeting miR-
92a, miR-25 and miR-363 or an LNA targeting DM1 (gga-miR-2954 - control transfec-
tion). RNA was extracted 96 hours after transfection. RNA was DNAse treated, converted
to cDNA and used for QPCR analysis of expression of ES cell marker genes (Oct3/4, Sox2,
Nanog and Esrrß) and trophoblast marker genes (Cdx2, Eomes, Hand1, Mash2, Id2 and
Sfmbt2 ). QPCR Ct values were normalised to b-Actin and expression is shown for the miR-
92a, miR-25 and miR-363 knockdown relative to expression in the control transfection.
Results are shown for transfection of ZHBTc4 ES cells (a), E14 ES cells (b) and CGR8 ES
cells (c). Total RNA (5ug) from control transfections and transfection of LNAs targeting
miR-92a, miR-25 and miR-363 was used for miRNA northern analysis. Expression of
miR-92a is shown. The gel image shows the presence of RNA in each lane. N=1.
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3.3.10 Optimisation of cell proliferation assays
Optimisation of MTT and Cyquant assays identified the linear range of these
assays (described in Appendix C) and as a result 1000-1500 ZHBTc4 or 3T3
cells were plated per well of 96-well plates for future MTT and Cyquant assays.
These numbers were chosen because cells would be grown for at least 48 hours
in the plates and so the final number of cells to be assayed should fall within the
linear range. Additional optimisation resulted in use of Lipofectamine LTX as the
transfection reagent for proliferation experiments, and knockdown of miR-155 as
the transfection control (Appendix C). miR-155 was chosen for use as a control
because in addition to it having little effect on cell numbers, this miRNA was not
sequenced in the miRNA profiling experiment and was not detected in mouse ES
cells by miRNA northern analysis (data not shown).
3.3.11 Effect of miR-92a suppression on cell number
In order to investigate the effect of miR-92a inhibition on ZHBTc4 ES cell pro-
liferation, ZHBTc4 ES cells were plated per well of a 96-well tissue-culture plate,
miRNA expression was inhibited by transfection of a complementary LNA and
the cultures were subjected to MTT analysis 24, 48 or 72 hours after transfec-
tion. As well as inhibition of miR-92a, the effect of inhibiting miR-25 or miR-363
expression was also investigated. Figure 3.15a shows that knock down of miR-
25 and miR-363 had no effect on cell numbers in relation to miR-155 (control)
knockdown. In contrast, knockdown of miR-92a significantly reduced cell num-
bers as early as 24 hours after treatment and this effect was maintained for up to
at least 72 hours.
To test whether there were any additive effects of knocking down miR-92a and re-
lated miRNAs, ZHBTc4 ES cells were transfected with an LNA targeting miR-92a
alone, or in combination with LNAs targeting miR-25 or miR-25 and miR-363
and cell numbers were assessed by MTT assay. Cell numbers for each combination
of miRNA knockdowns was normalised to cell numbers in control transfection of
an equivalent concentration of LNA targeting miR-155. The reduction in cell
numbers seen with miR-92a knockdown alone was similar to that observed when
knockdown was combined with knockdown of miR-25 and miR-363 suggesting
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Figure 3.15 – Effect of miRNA knockdown on cell numbers. (a) 1000 ZHBTc4 ES cells
were plated per well of 96-well plates and grown for 24 hours before being transfected
overnight (using Lipofectamine LTX) with 75nM of LNA targeting various miRNAs. Con-
trol knockdown is transfection of LNA targeting miR-155. Cells were grown for a further
24, 48 or 72 hours and subjected to MTT analysis. Bar chart shows mean absorbance
relative to control knockdown from 2 independent experiments with 8 replicate wells per
experiment. Error bars show standard error of the mean. **P<0.01. (b) 1000 ZHBTc4 ES
cells were plated per well of 96-well plates and grown for 24 hours before being transfected
overnight (using Lipofectamine LTX) with LNAs targeting various combinations of miR-
NAs (75nM per LNA). Cells were grown for a further 24, 48 or 72 hours and subjected to
MTT analysis. Bar chart shows mean absorbance relative to an equivalent concentration of
control LNA (miR-155 ) from 2 independent experiments with 8 replicate wells per experi-
ment. Error bars show standard error of the mean. (c) 1000 E14 ES cells or 3T3 cells were
plated per well of 96-well plates and grown for 24 hours before being transfected overnight
with 75nM of LNA targeting various miRNAs. Control knockdown is transfection of LNA
targeting miR-155. Cells were grown for a further 72 hours before being subjected to MTT
analysis. Bar chart shows mean absorbance relative to control knockdown from 2 indepen-
dent experiments with 8 replicate wells per experiment. Error bars show standard error of
the mean. **P<0.01.
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that the effect is highly sequence specific (Figure 3.15b). To determine whether
this effect was restricted to ZHBTc4 ES cells, the effects of 72-hour miR-92a
knockdown were also assessed in E14 ES cells and 3T3 cells. Knockdown of miR-
92a in E14 ES cells resulted in a significant decrease in cell numbers compared
to knockdown of miR-155 as measured by MTT assay. Surprisingly, knockdown
of miR-92a in 3T3 cells had no effect on cell numbers compared to knockdown
of miR-155 (Figure 3.15c). Reducing levels of miR-92a appears to affect cell
proliferation in ES cells, but not in fibroblast cells.
The MTT assay is a colorimetric assay for measuring the activity of enzymes that
reduce MTT ((3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide)) to
formazan dyes and although changes in MTT assay absorbance are considered to
reflect changes in cell number, it is possible that the changes that have been
recorded actually reflect changes to cell metabolism. Given this possibility, the
effect of miR-92a knockdown was also assessed using two alternative means of es-
timating cell numbers. The effect of miR-92a knockdown in ZHBTc4 ES cells was
assessed by both CYQUANT analysis, and by estimation of absolute cell num-
bers. The effects of miR-92a knockdown on a wt ES cell line was also assessed
by estimating absolute cell numbers. For this analysis, ZHBTc4 were plated in
6-well plates, grown for 24 hours and transfected overnight with LNAs targeting
miR-155 or miR-92a. Approximately 6 hours after transfection, cells were disso-
ciated, counted and replated in 6-well plates (for cell counting) or 96-well plates
(for Cyquant analysis). After 48 hours of growth Cyquant assays were performed
on 96-well plates and cells in 6-well plates were dissociated and counted by nucleo-
counter. RNA from cultures was extracted and used for miRNA northern analysis
of miR-92a expression. This confirmed knockdown of miR-92a in the ZHBTc4
ES cells and E14 ES cells transfected with an LNA complementary to miR-92a
(Figure 3.16a). Cyquant analysis showed a reduction of cell numbers after miR-
92a knockdown compared to miR-155 knockdown (Figure 3.17b). Quantitation
of absolute cell numbers also confirmed that ZHBTc4 cell numbers decrease upon
miR-92a knockdown (Figure 3.16c). To ensure that the effect on cell numbers
was not restricted to ZHBTC4 ES cells, a similar analysis was performed on a
second ES cell line - E14 ES cells. Knockdown of miR-92a in E14 ES cells also
caused a reduction in cell numbers confirming that this effect occurs in other ES
cells lines (Figure 3.16d).
The decrease in cell numbers induced by depletion of miR-92a by LNA anti-miR
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Figure 3.16 – Effect of miRNA knockdown on cell numbers assessed by CYQUANT assay
and cell counting.(a) Total RNA (5mg) from ZHBTc4 ES cells grown overnight in the
presence of Lipofectamine only or transfected overnight with control LNA (targeting miR-
155) or an LNA targeting miR-92a and then grown for a further 72 hours. RNA was used
for miRNA northern analysis of miR-92a expression and expression of the spliceosomal
RNA, U6. RNA was from cells used for cell count experiments (this figure c & d). (b)
200,000 ZHBTc4 ES cells were plated per well of 6-well plates and grown for 24 hours before
being transfected (using Lipofectamine LTX) overnight with 150nM of LNA targeting miR-
92a or miR-155 (control). After the transfection had been stopped the cells were left
to grow for ~6 hours before being dissociated and replated at 1000 cells per well of 96-
well plates. Cells were grown for a further 48 hours (total - 72 hours post transfection)
before being subjected to CYQUANT assay. Bar chart shows mean absorbance relative
to control knockdown from 3 experimental replicates with 8 replicate wells per experiment
(after background absorbance was deducted). Error bars show standard error of the mean.
*P<0.05. (c & d) 200,000 ZHBTc4 ES cells (c) or E14 ES cells (d) were plated per well of
6-well plates and grown for 24 hours before being transfected overnight with 150nM of LNA
targeting miR-92a or miR-155 (control). After the transfection had been stopped the cells
were left to grow for ~6 hours before being dissociated and replated at 800,000 (ZHBTc4)
or 700,000 (E14) cells per well of 6-well plates. Cells were grown for a further 48 hours
(total - 72 hours post transfection) before being dissociated and counted by nucleocounter.
Bar chart shows the mean of the total number of cells from duplicate counts of three
experimental replicates. Error bars show standard error of the mean. *P<0.05.
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mirrors the reduction in cell numbers seen during differentiation of ZHBTc4 ES
cells (Figure 3.1c). It seems likely that, having previously shown that miR-92a
is unlikely to be associated with differentiation, expression of miR-92a is related
to proliferation within this system, and the decrease in cell numbers observed
during the developmental transition may be partly due to the decrease in miR-
92a expression.
3.3.12 The effect of perturbing BMP levels on miR-92a
expression
In 2011 Wang et al. showed that the miR-17-92a cluster was regulated by BMP
signalling in P19 (mouse embryonal carcinoma) cells and 293T (human embryonic
kidney stem) cells. ES cells cultured in classic conditions are dependant on BMP
signalling to induce inhibitor-of-differentiation (ID) proteins (Ying et al., 2003).
BMP signalling is therefore thought to promote self-renewal of ES cells. It was
of interest to investigate whether BMP signalling regulated the expression of
miR-92a, which is highly expressed in ES cells, because this may suggest that
BMP signalling promotes proliferation of ES cells as well as suppressing their
differentiation.
In order to assess the effect of BMP signalling on miR-92a expression, E14 and
CGR8 ES cells were grown in a variety of culture conditions where levels of BMP
signalling were affected by serum supplementation, the addition of purified BMP4
or the addition of the BMP inhibitor, dorsomorphin (Yu et al., 2008). Figures
3.17a & b shows expression of miR-92a in wt ES cells treated to either induce
or inhibit BMP signalling. This shows that inhibition of BMP by the addition of
dorsomorphin to ES cells leads to a decrease in miR-92a expression. In contrast,
miR-92a expression was induced after addition of BMP4 to cells cultured in
N2B27 + Lif. This effect was observed only in CGR8 ES cells and not in E14 ES
cells. One possible explanation for this would arise if the ES cells themselves are
producing BMP. The BMP produced by the ES cells during the 48 hour culture
in N2B27 & Lif may be sufficient to induce miR-92a expression to maximal levels,
which would then mean that further addition of BMP4 did not induce greater
expression. This is supported by the observation that E14 ES cells grown in the
absence of BMP with addition of DMSO for 24 hours showed a similar level of
miR-92a expression to those cells cultured in the presence of BMP4.
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Figure 3.17 – Expression of miR-92a after inhibition of Bmp in ES cells. 500,000 E14 ES
cells (a) or CGR8 ES cells (b) were plated per well of 6-well plates and grown in the follow-
ing conditions: serum+Lif control - cells cultured in serum+Lif media for 24 hours then
10ml DMSO added for 48 hours; serum+Lif dorso - cells cultured in serum+Lif media for 24
hours then dorsomorphin (final concentration 5uM) added for 48 hours; N2B27+Lif+BMP
control - cells cultured in N2B27 media with 1000U Lif and 10ng/ml BMP4 for 24 hours
then 10ul DMSO added for 48 hours; N2B27+Lif+BMP dorso - cells cultured in N2B27
media with 1000 U Lif and 10ng/ml BMP4 for 24 hours then dorsomorphin (final con-
centration 5uM) added for 48 hours; N2B27+Lif BMP4 - cells cultured in N2B27 media
with 1000U Lif for 48 hours then 10ng/ml BMP4 added for 24 hours; N2B27+Lif BMP4
dorso - cells cultured in N2B27 media with 1000 U Lif for 48 hours then 10ng/ml BMP4
and dorsomorphin (final concentration 5uM) added for 24 hours; N2B27+Lif control – cells
cultured in N2B27 media with 1000U Lif for 48 hours then 10ul DMSO added for 24 hours.
RNA was extracted from each culture and total RNA (5ug) was used for miRNA north-
ern analysis of expression of miR-92a, miR-294 and the spliceosomal RNA, U6. miRNA
northern membranes were exposed to a phosphoimager screen for quantitation of expres-
sion of miR-92a and U6. Bar charts show expression of miR-92a after normalisation to
U6 expression. N=1.
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In order to confirm that the reduction in the expression of miR-92a seen with dor-
somorphin treatment was specific, and not a general effect on the entire miRNA
population, the expression of miR-294 in these samples was also analysed by
miRNA northern (Figure 3.17a & b). In contrast to expression of miR-92a, miR-
294 expression levels were not affected by the addition of dorsomorphin to the
culture media. It must be noted that conclusions from these data are preliminary
because the data arises from a single experimental replicate in each cell line.
3.4 Discussion
The primary aims of this chapter were to determine if miRNAs were differen-
tially represented in a model of trophectoderm differentiation and if differentially
represented miRNAs could be functionally associated with elements of the dif-
ferentiation process. miRNA profiling by cloning and sequencing of small RNAs
identified miRNAs that were present in undifferentiated mouse ES cells and in
cells that had been induced to differentiate into trophectoderm. This approach
identified miRNAs that were differentially expressed during the differentiation
process. Several of the miRNAs with higher representation levels in differenti-
ated cells are encoded within a placental-enriched polycomb group gene called
Sfmbt2, suggesting an important role for these miRNAs in extraembryonic devel-
opment. Inhibition of one of the miRNAs that was expressed at higher levels in
undifferentiated cells, miR-92a, was shown to have an effect on ES cell numbers.
3.4.1 The majority of miRNAs are not differentially represented
during trophectoderm differentiation
In order to explore the roles of miRNAs during early developmental transitions, an
ES cell based model of trophectoderm differentiation was used. ZHBTc4 ES cells
can be induced to differentiate down the trophectoderm lineage by conditional
repression of the ES cell regulatory gene, Oct4 (Niwa et al., 2000). Character-
isation of this model system confirmed previous observations that expression of
the TE marker genes Cdx2 and Hand1 increased and expression of pluripotency
marker genes Oct4 and Sox2 decreased upon downregulation of Oct4 expression
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(Niwa et al., 2000, Hay et al., 2004). Gene expression analysis was extended to
further show that expression of Nanog and Esrrß was downregulated and expres-
sion of Eomes, Mash2 and Id2 was upregulated following Oct4 downregulation.
Similar changes in gene expression were observed following knockdown of Oct4
expression by siRNA, which suggests that changes in expression of these genes
is due to changes in expression level of Oct4, rather than a result of doxycycline
addition to ES cells or an anomaly of the ZHBTc4 ES cell system.
miRNA profiling by cloning and sequencing of small RNAs during ZHBTc4 ES cell
differentiation identified miRNAs that were present in undifferentiated mouse ES
cells and in cells that had been induced to differentiate into trophectoderm. 461
individual sequences were identified; 160 sequences had been previously identified
as miRNAs and 31 were identified as novel miRNAs. A total of 270 sequences
were not previously identified as miRNAs or characterised as novel miRNAs in
this analysis, which corresponded to just fewer than 60% of the total sequences.
The origin of these short RNA sequences is not known. By way of comparison,
in a deep sequencing analysis of short RNA in three human cell lines, the non-
miRNA population made up between 23% and 82% of the total sequences (Vaz et
al., 2010), which is consistent with the sequencing data presented in this chapter.
The majority (90%) of the miRNAs did not change in representation during
differentiation. This finding would be expected if those miRNAs were involved
in general housekeeping of a cell or in regulating processes unique to the early
embryo in its entirety. There is much evidence for roles of miRNAs in early
developmental processes (Suh & Blelloch, 2011), but little evidence to suggest
that miRNAs regulate genes involved in cell homeostasis. In fact, it has been
reported that genes involved in basic cellular processes avoid targeting by miRNAs
due to short 3’ UTRs that are specifically depleted for miRNA binding sites (Stark
et al., 2005). Therefore, based on current evidence, it is more likely that the large
proportion of miRNAs that were not differentially represented in this analysis are
involved in regulating processes specific to the early embryo rather than regulating
processes related to cell homeostasis.
A single genomic cluster encoding the miRNAs, miR-294 and miR-295 accounted
for over 40% of the total number of RNAs sequenced in this analysis. Although
previously described as ES cell-specific and shown to be down regulated dur-
ing embryoid body and retinoic acid induced differentiation (Houbaviy et al.,
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2003), the representation levels of miR-294 and miR-295 were not significantly
affected by differentiation into trophoblast. This finding agrees with more re-
cent reports that these miRNAs are also expressed in trophoblast stem (TS) cells
(Houbaviy et al., 2005). Rather than facilitating the first perceivable develop-
mental transition in the mammalian embryo, our data points to a more general
role for miR-294 and miR-295 in early development. Supporting this is the em-
bryonic phenotype of mice deficient for the miR-290-295 miRNA cluster, which
encodes miR-294 and miR-295. Loss of the miR-290-295 cluster in mice results
in partially penetrant embryonic lethality with 50-60% of embryos exhibiting one
of two abnormal phenotypes: either partial or complete localisation of mutant
embryos outside the yolk sac or general developmental delays (Medeiros et al.,
2011). However, miR-290-295 -null blastocysts appear morphologically normal,
which suggests that normal ICM and TE compartments have been formed, and
supports the proposal that these miRNAs are not required to facilitate the first
perceivable developmental transition in the mammalian embryo.
3.4.2 Some miRNAs are differentially represented during
trophectoderm differentiation
In this analysis, 19 miRNAs were characterised as being differentially represented
during the differentiation of ES cells down the trophectoderm lineage; the levels
of 12 miRNAs increased and the levels of 7 miRNAs decreased. The differential
expression of a selection of these miRNAs was confirmed by northern analysis,
which validated the sequencing data. Interestingly, several differentially repre-
sented miRNAs contained binding sites for key ES cell transcription factors within
their promoter regions, according to data retrieved from Marson et al. (Marson
et al., 2008), which suggests that expression of these miRNAs may be directly
controlled by these factors.
As well as identifying differentially represented miRNAs, this analysis also identi-
fied protein-coding genes that were differentially expressed during trophectoderm
differentiation. It was found that, in most cases when a differentially represented
miRNA was encoded within a gene, the host gene and the encoded miRNA had
the same expression pattern. Baskerville and Bartel (2005) made the same obser-
vation in a paper that investigated the expression patterns of 175 human miRNAs.
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However, they also concluded that proximal pairs of miRNAs are generally coex-
pressed as long as the sequences are separated by less than 50kb, a finding that
disagrees with our sequencing data. It is interesting to note that when miRNAs
are encoded as a cluster, the individual members of the cluster are not always
represented at similar levels. For example, miR-106a was detected in undiffer-
entiated and differentiated cell cultures, and, according to the sequencing data,
was represented at twice the level in undifferentiated cultures compared to differ-
entiated cultures. But another miRNA that is encoded within the same miRNA
cluster, miR-363, was not detected in the profiling analysis. Differences in rep-
resentation levels between different miRNAs encoded within the same cluster
could be due to a variety of reasons including post-transcriptional regulation of
miRNAs during miRNA biogenesis or miRNA turnover (Newman & Hammond,
2010). Supporting this finding, a recent paper has shown that DROSHA cleaves
hundred of different pri-miRNA substrates with different efficiencies, including
those present within the same miRNA cluster (Feng et al., 2011).
Since commencing this study, several other groups have investigated expres-
sion of miRNAs during trophectoderm differentiation, both in vitro and in vivo
(Viswanathan et al., 2009, Spruce et al., 2010, Ohnishi et al., 2010). Comparing
the profiling data presented here with that of other groups may provide insight
into general miRNAs required for trophectoderm differentiation, and those that
are specific to the in vitro system that was used in this analysis. Viswanathan
et al. (2009) investigated expression of miRNAs in ES cells that were induced to
differentiate into trophectoderm by ectopic expression of HRas/Q61L and dur-
ing pre-implantation mouse development. As in our analysis, Viswanathan et al.
found that during TE differentiation from ES cells, expression of Sfmbt2 miR-
NAs increased and expression of the miR-290 cluster was largely unchanged. The
authors then collated their in vitro ES cell differentiation data with data gener-
ated from miRNA profiling of various stages of pre-implantation embryogenesis
to identify ‘candidate miRNAs involved in trophectoderm specification’. Of the 8
candidate miRNAs identified as being involved in trophectoderm specification in
their study, only miR-297 was also found in the analysis presented here. Addition-
ally, the single miRNA that Viswanathan et al. identified as being pluripotency
specific (miR-367a) was not differentially represented in our analysis. However,
the in vivo data from the Viswanathan study was comparing different stages of
embryo development, rather than separate ES and TE compartments. It could
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be argued that this approach would not identify miRNAs involved in TE differ-
entiation per se, but rather miRNAs involved in all aspects of transition through
embryonic development.
Ohnishi et al. (2010) examined miRNA expression in ICM and whole blastocysts
and, from this analysis, estimated miRNAs that may be expressed asymmetrically
between ICM and TE. They examined the expression of two of these miRNAs,
miR-99b and miR-210, by QPCR of material from isolated ICM and TE lineages,
and reported that both of these miRNAs had higher expression in the TE than
the ICM, which is consistent with the finding reported in this chapter that these
miRNAs increased in expression during TE differentiation in vitro. However,
other miRNAs that Ohnishi et al. estimated to be differentially expressed showed
differences as well as similarities with the results presented here. Notably, Ohnishi
et al. defined miR-467a* as ICM associated and miR-92a as TE associated, which
was directly opposite to the results presented here, as well as those reported in
the study by Viswanathan et al.
Spruce et al. (2010) profiled miRNA expression by microarray in ES cells and TS
cells. The authors reported that expression of the miR-290 cluster of miRNAs is
not different between ES cells and TS cells, which supports our finding that these
miRNAs do not change during TE differentiation. They also reported that the
majority of Sfmbt2 cluster miRNAs were associated with TS cells rather than ES
cells, which also supports our data. However, Spruce et al. also reported findings
that disagreed with the results presented here. For example, the Sfmbt2 cluster
miRNA miR-669a, which was upregulated on TE differentiation in our analysis,
was reported to be associated with both ES cells and TS cells in the Spruce et
al. analysis.
Collectively, comparison of our data with the data from other similar analyses
show the greatest similarity with other in vitro studies, although this could be
explained by the fact that the majority of the in vivo data compared ICM and
blastocyst miRNA expression profiles, rather than comparing expression profiles
from isolated ICM and TE. Overall, the results presented here and the findings
of others suggest that expression of the Sfmbt2 miRNA cluster is TE associated,
the miR-17-92a cluster appears to be ES cell associated and the miR-290 cluster
is not differentially expressed between the two cell lineages.
Chapter 3. miRNAs in trophoblast differentiation 126
3.4.3 A differentially represented miRNA cluster is encoded
within a trophectoderm-associated gene
Of the 12 miRNAs that increased in representation during trophectoderm differ-
entiation, 8 were located within a single multi-miRNA cluster located in intron
10 of the Polycomb group gene, Sfmbt2 (Scm-like with four mbt domains 2).
Expression analysis of Sfmbt2 confirmed that it increased in expression during in
vitro trophectoderm differentiation and was expressed more highly in the mouse
placenta than in the mouse embryo. This latter finding was supported by a pre-
vious analysis, which reported that, in E5.5-E8.0 embryos, Sfmbt2 was expressed
highly and continuously in the extraembryonic ectoderm, which is essential for
formation of the placenta and maintenance of trophoblast stem cells (Franken-
berg et al., 2007). In an analysis of miRNA expression, Viswanathan et al. found
that expression of Sfmbt2 miRNAs increased during trophectoderm differentia-
tion (Viswanathan et al., 2009). Interestingly, Viswanathan et al. extended this
analysis to investigate expression of miRNAs in TS cells that were induced to
differentiate by removal of FGF4. Here they found that expression of Sfmbt2
miRNAs significantly decreased. This may suggest that, during development,
the Sfmbt2 cluster of miRNAs are associated with trophoblast stem cells specifi-
cally, rather than being associated with terminally differentiated trophectoderm
(Viswanathan et al., 2009). In the adult, Sfmbt2 is expressed in many tissues in-
cluding testis, brain, lung, spleen and thymus. Interestingly, while it is expressed
from both alleles in somatic tissues after E7.5, Sfmbt2 is only expressed from
the paternal allele in the early embryo and extraembryonic tissues (Kuzmin et
al., 2008). This makes Sfmbt2 an imprinted gene in the early embryo, increasing
the likelihood of an important role for Sfmbt2, and its encoded miRNA cluster,
during early development. Intriguingly, it has been proposed that imprinting of
the Sfmbt2 gene is a direct result of the insertion of the large cluster of miRNAs
in intron 10 of this gene (Wang et al., 2011). This has been proposed because
while mouse and rat Sfmbt2 genes contain the miRNA cluster and are imprinted,
Sfmbt2 in other mammals does not encode a miRNA cluster, and expression of
Sfmbt2 in these mammals is biallelic (Wang et al., 2011).
The function of Sfmbt2 and its encoded miRNA cluster is not yet clear. How-
ever, one study suggests a possible function of this cluster in the downregulation
of pluripotency genes during differentiation. One of the differentially expressed
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miRNAs within the Sfmbt2 cluster, miR-669b, has been shown to exhibit target
enrichment for ESC-specific pluripotency genes (Tang et al., 2010) suggesting
a potential function of this cluster may be to suppress pluripotency during the
transition from ES cell to trophoblast stem cell. A further report suggests that
another Sfmbt2 cluster miRNA, miR-467a*, functionally overlaps with the miR-
290-295 miRNAs to promote growth and survival of mouse ES cells (Zheng et
al., 2011). The authors speculate that the Sfmbt2 miRNA cluster may function
to promote growth and survival of the early TE lineage, while the miR-290-295
cluster fulfils a similar function in the ICM. Interestingly in the context of differ-
ential regulation of Sfmbt2 during early development, there is a putative binding
site for the key ES cell transcription factor Oct4 in the promoter of Sfmbt2 (Loh
et al., 2006), which is consistent with the finding that Sfmbt2 expression increases
upon suppression of Oct4 expression, and suggests that there may be a direct in-
teraction between Oct4 and the Sfmbt2 promoter. However, the fact that Marson
et al. did not report Oct4 binding at the Sfmbt2 promoter in a ChIP-seq analy-
sis of promoter binding by key ES cell transcription factors, argues against this
possibility (Marson et al., 2008). Together, these findings show that expression
of Sfmbt2 and the miRNAs encoded within Sfmbt2 increase upon suppression
of Oct4 expression. It is speculated that Sfmbt2 expression is enriched in the
trophoblast stem cells of the early embryo, and possible functions include the
regulation of pluripotency factors associated with the ICM or promotion of cell
proliferation and survival in early embryonic lineages.
3.4.4 miR-92a and related miRNAs do not regulate expression
of ES cell and trophectoderm associated genes
The results presented here show that expression of miR-92a is suppressed as a re-
sult of trophoblast differentiation. However, conflicting reports on the expression
of miR-92a have suggested that levels of this miRNA both increase (Houbaviy et
al., 2003) and decrease (Viswanathan et al, 2009) as a result of ES cell differen-
tiation. The analysis that suggested that the levels of miR-92a increased during
differentiation (Houbaviy et al., 2003) was an early miRNA profiling study, with
only a few sequencing reads per miRNA. Additionally, the authors did not induce
the ES cells to differentiate down the trophectoderm lineage specifically. These
details may explain why Houbaviy et al. reached a different conclusion about the
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expression of miR-92a during differentiation than our findings indicate. miR-92a
is a member of two paralogous miRNA clusters: the miR-17-92a miRNA cluster
and the miR-106a-363 cluster and is closely related in sequence to miR-25 and
miR-363. Additionally, another paralogous miRNA cluster, miR-106b-25, also
exists. These three miRNA clusters are highly conserved across vertebrates, and
are believed to have arisen through a series of duplication and deletion events
during early vertebrate evolution (Tanzer & Stadler, 2004). As well as miR-92a,
the sequence related miR-25 was also differentially regulated during trophecto-
derm differentiation, as shown by miRNA northern analysis. However, miR-363
was not detected in the profiling data and expression was barely detectable by
miRNA northern analysis. This finding is consistent with a previous analysis
that failed to detect expression of miR-363 in ES cells by RNase protection as-
say (Ventura et al., 2008). Low expression of miR-363 in ES cells may suggest
that the entire miR-106a-363 cluster is expressed at low levels in ES cells, which
would also suggest that expression of miR-92a originates predominantly from the
miR-17-92a cluster in ES cells. However, data from the miRNA profiling analysis
suggested robust expression of another miRNA from the miR-106a-363 cluster,
miR-106a, in ES cells. For this reason it is not known if the miR-92a expression
observed in ES cells originates from a single genomic region or from both miRNA
clusters that encode this miRNA.
Despite the sequence similarity between the miR-106a-363, miR-106b-25 and the
miR-17-92a clusters, only the miR-17-92a cluster is essential for normal murine
development. Mice deficient for miR-17-92a are smaller than their wild-type
counterparts and die soon after birth (Ventura et al., 2008), whereas loss of miR-
106a-363 or miR-106b-25 has no obvious phenotypic effect. However, mice defi-
cient for both the miR-17-92a and miR-106b-25 miRNA clusters die before E15.0
with a much more severe phenotype than the miR-17-92a knockout alone sug-
gesting some functional cooperation between the two clusters during embryonic
development. miRNA northern analysis of miR-92a and miR-25 expression in
adult mouse tissues showed expression of both miRNAs in numerous tissues in-
cluding lung, heart and bone marrow. The expression of miR-92a in lung and
heart tissue is consistent with the phenotype of miR-17-92a-null mice, which ex-
hibit lung hypoplasia and ventricular septal defects (Ventura et al., 2008). Addi-
tionally, if miR-17-92a null bone marrow is used to reconstitute the bone marrow
of irradiated mice, a significant and specific reduction in circulating B-cells is
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observed (Ventura et al., 2008). The fact that miR-92a is highly expressed in the
bone marrow, and loss of the miR-17-92a cluster leads to a reduction in B-cells
that normally mature in the bone marrow, suggests that miR-92a may play a
role in the bone marrow to promote B-cell development.
miR-92 has been shown to have roles in endoderm formation and regulation
of left-right asymmetry in zebrafish embryos (Li et al., 2011), and in regula-
tion of angiogenesis in mice (Bonauer et al., 2009). Because of these functional
associations with tissue growth and differentiation, and because miR-92a was
differentially expressed during trophectoderm differentiation of ES cells, it was
hypothesised that this miRNA, and sequence-related miRNAs, may be function-
ally involved in regulating genes involved in the differentiation process. However,
depletion of miR-92a, miR-25 and miR-363 in ES cells had no effect on the ex-
pression of key ES cell genes or markers of trophectoderm differentiation. This
is in accordance with the finding that mice deficient for the miR-17-92a cluster
do not exhibit placental defects and embryos deficient for both the miR-17-92a
and miR-106b-25 clusters survive past the blastocyct stage (Ventura et al., 2008).
However, it cannot be ruled out that miR-92a, miR-25 and miR-363 are involved
in fine-tuning the expression of other genes involved in trophectoderm differenti-
ation or maintenance of the ES cell state that were not investigated in this study.
Additionally, the possibility that these miRNAs might be required for the regu-
lation of cellular events coincident with differentiation, such as modulating the
cell cycle, was considered.
3.4.5 miR-92a regulates ES cell proliferation
Investigation of the role of miR-92a, and sequence-related miRNAs, in cell prolif-
eration showed that knockdown of miR-92a, but not miR-25 or miR-363, caused a
significant reduction in ES cell numbers assayed both by cell counts and by MTT
assay. Because the miRNA ‘seed’ region is thought to be the most important
region for targeting, it is assumed that miRNAs with similar seed sequences will
target similar transcripts (Bartel, 2009). The results presented here do not fully
support this conclusion, because miR-92a, miR-25 and miR-363 have identical
seed sequences, but only knockdown of miR-92a has an affect on cell number.
These data suggest that regions outside the seed sequence may be important for
miRNA function. This finding is supported by the observation that, rather than
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just across the seed region, miRNA sequences show conservation across their en-
tire length (Brenneck et al., 2005). Additionally, two broad categories of miRNA
target sites are thought to exist: one class that requires perfect seed comple-
mentarity, and another class that has imperfect seed binding, and depends on
strong 3’ compensatory binding (Brennecke et al., 2005). It is possible that the
function of miR-92a in cell cycle regulation is mediated through regulation of
targets that are not reliant solely on perfect seed complementarity, but require
binding in other regions. This may explain the reason why inhibition of miR-25
and miR-363 has no effect on ES cell numbers.
Knockdown of miR-92a in ES cells led to a decrease in cell numbers. This suggests
that miR-92a may function to promote the proliferation of ES cells, a conclusion
supported by the demonstration that expression of the miR-17-92a cluster is reg-
ulated by the cell proliferation-related transcription factor, Myc, which is highly
expressed in ES cells (Aguda et al., 2008). Indeed, Cloonan et al. reported that
the miR-17-92a cluster is differentially expression during different phases of the
HeLa cell cycle suggesting that this locus is in itself cell cycle regulated, and
increasing the likelihood that the effect of miR-92a inhibition on cell number is
mediated through regulation of the cell cycle (Cloonan et al., 2008). Addition-
ally, when introduced into miRNA-deficient DGCR8-/- ES cells, members of the
miR-17-92a and miR-106a-363 clusters (as well as members of the related clus-
ter miR-106b-25 ) have been shown to rescue the proliferation defect observed
in these cells (Wang et al., 2008). However, it should be mentioned that the
introduction of miR-92a into DGCR8-/- ES cells was not reported to rescue the
proliferation defects of these cells. DGCR8-/- ES cells are believed to show pro-
liferation defects because of an accumulation of cells in the G1 phase of the cell
cycle, and re-introduction of certain miRNAs rescues this defect. The finding
that introduction of miR-92a into DGCR8-/- ES cells does not rescue the prolif-
eration defect is surprising because the related miRNA, hsa-miR-92b is thought
to control the G1/S checkpoint in human ES cells through direct regulation of
p57, which inhibits G1/S phase progression (Sengupta et al., 2009).
A recent analysis comparing gene expression between the inner cell mass and em-
bryonic stem cells showed that miR-92a was expressed at a significantly higher
level in embryonic stem cells relative to the inner cell mass (Tang et al., 2010).
Differential expression of miR-92a between the ICM and ES cells suggests that
this miRNA may contribute to the ES cell state through maintenance of pluripo-
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tency or the ability to self-renew indefinitely, two characteristics that are not part
of the normal developmental program. High levels of miR-92a may be maintained
in ES cells through BMP-mediated regulation. The date presented here show that
BMP inhibition lead to a reduction in expression of miR-92a in ES cells. The
finding that pre-miR-17-92a expression was reduced in the absence of BMP was
previously demonstrated by Wang et al., who showed a reduction in expression of
pre-miR-17-92a in BMP knockout embryos relative to wild-type embryos (Wang
et al., 2011). They further showed that BMP directly regulated expression of
this cluster through binding of SMAD1/5 proteins to a region within miR-17-
92a. Our finding that miR-92a expression decreases upon BMP inhibition shows
that BMP regulation of miR-17-92a expression also occurs in mouse ES cells.
However, it must be noted that while dorsomorphin is an inhibitor of BMP sig-
nalling, it has also been shown to have off-target effects, for example inhibition of
AMP kinase (Zhou et al., 2001). Therefore while the results seen here are likely
to be a result of BMP inhibition, the possibility exists that changes in miR-92a
expression are due to modulation of factors other than BMP signalling. BMP
already has a known role in ES cells – it promotes self-renewal by inhibiting neu-
ral differentiation through induction of Id proteins (Ying et al., 2003). The data
presented here suggest that BMP may have a secondary role to promote ES cell
proliferation or survival by regulating expression of miR-92a.
In keeping with a role in proliferation of certain cell types, both the miR-17-92a
and the miR-106a-363 clusters have been associated with oncogenesis (Petrocca
et al., 2008, Landais et al., 2007). Both ES cells and cancer cells proliferate
rapidly, and may share some common features that are thought to be predomi-
nantly mediated through high expression of myc in both cell types (Kim et al.,
2010a). The miR-17-92a cluster is regulated by myc, which suggests a potential
overlapping function for miR-92a in promoting the rapid proliferation of both
cancer cells and ES cells. Of note is the finding that inhibition of miR-92a ex-
pression did not affect the cell numbers of the mouse fibroblast cell line, 3T3.
This suggests that the effect of miR-92a on cell numbers may be specific to fea-
tures of the ES cell cycle, which lacks the G1 phase and is not dependent on
Cdk4/6-CyclinD-mediated phosphorylation of Rb protein (Savatier et al. 1994).
Speculatively, perhaps similarities between the cell cycle of ES cells and cancer
cells result in miR-92a-mediated regulation of ES and cancer cell proliferation,
but not regulation of cell proliferation in other cell types. During ES cell differ-
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entiation, the cell cycle regains the G1 phase and regulation by Cdk4/6-CyclinD,
and cell proliferation slows (Savatier et al., 2002). The reduction in ES cell num-
bers observed upon miR-92a inhibition is similar to that seen when mouse ES
cells are induced to differentiate into trophectoderm. Perhaps these data suggest
that miR-92a functions as a regulator of the ES cell cycle, but not the cell cycle
of differentiated cell types. It is possible that miR-92a is downregulated during
TE differentiation from ES cells in order to facilitate the changes in cell cycle
regulation that occur with ES cell differentiation.
While it is believed, for reasons described above, that the decrease in cell number
observed upon knockdown of miR-92a is a result of a reduction in cell prolifera-
tion, it cannot be ruled out that miR-92a may have a cell survival function and
therefore its reduction may result in an increase in apoptosis and a subsequent
decrease in cell numbers. Indeed, enforced expression of the miR-17-92a cluster
in a mouse model of B-lymphoma has been reported to lead to a reduction in
apoptosis in c-myc induced lymphomas, suggesting that expression of this miRNA
cluster may be anti-apoptotic (He et al., 2005), and it has recently been shown
that miR-92a directly targets the pro-apoptotic protein, Bim (Tsuchida et al.,
2011). Although an obvious increase in cell death was not observed following in-
hibition of miR-92a in the experiments presented in this chapter, further analysis
would be required to rule out the possibility that increased cell death is the cause
of a reduction in cell numbers following miR-92a inhibition in ES cells.
3.4.6 Summary and Future Work
miRNAs have been shown to be essential for correct embryonic development, and
it was hypothesised that they are involved in regulating individual developmen-
tal transitions. The data presented here show that miRNAs are differentially
represented during a cell-based model of a developmental transition, and that
differentially regulated miRNAs can be functionally associated with the differ-
entiation process. This analysis identified miRNAs that are differentially repre-
sented during ES cell differentiation into trophoblast, being either induced during
differentiation, or principally associated with the pluripotent state. Several of the
miRNAs that were represented at higher levels in differentiated cells are encoded
within a gene called Sfmbt2 that has been shown in this analysis, and in pre-
vious analyses, to be associated with the trophectoderm lineage. Intriguingly,
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the large miRNA cluster that is encoded within Sfmbt2 is thought to be specific
to only some rodent species. Further examination of Sfmbt2 and its encoded
miRNA cluster may provide insight into possible functional reasons behind rapid
evolution of this cluster in rodents, but not other mammals.
This analysis also identified miRNAs that were represented more highly in undif-
ferentiated cells than differentiated cells, and therefore may be associated with
maintenance of the ES cell state. ES cell-associated miRNAs may be downregu-
lated during the transition from ES cell to trophoblast in order to facilitate the
many cellular changes required for differentiation to occur. For example, down-
regulation of miR-92a may facilitate the reduction in proliferation from the ES
cell state to that of a differentiated cell. Further analysis in this area would de-
termine the exact nature of the effect of miR-92a inhibition on ES cell number.
Additionally, expression analysis during embryogenesis may indicate if miR-92a
regulation of proliferation or survival is likely to occur in pluripotent cells of the
early mouse embryo.
Chapter 4
Methods to identify miRNA target
gene transcripts in ES cells
4.1 Introduction
4.1.1 Sequence-based methods for identifying miRNA targets
miRNAs function through post-transcriptional regulation of target genes, and
therefore identification of miRNA targets is a key goal in any miRNA-focused
work. Because of the imperfect binding between a miRNA and its target mRNA
molecule, the identification of miRNA targets has proved challenging. Nucleotides
2-8 from the 5’ end of the miRNA, which make up the seed region, generally pair
perfectly with the target mRNA, but a 7 nucleotide sequence is too short to allow
specific identification of targets in the mus musculus genome, and the involve-
ment of the 3’ end of the miRNA in targeting is still under debate. In addition,
secondary and tertiary RNA structures must be taken into consideration, and
obviously the miRNA and mRNA must be expressed at the same time in the
same tissue for an interaction to be biologically significant. In this part of the
project, various means of identifying mRNA targets of miRNAs were assessed.
Some key requirements for miRNA function have been identified, and these have
been utilised in computational methods to predict miRNA targets. The most
general feature of miRNA regulation is the perfect complementarity between the
134
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seed region of the miRNA and regions within the mRNA target. Together with
other criteria, such as conservation of the target site and site accessibility, this
makes up the basis of the majority of target prediction programs. Examples of
commonly used algorithms are miRanda (John et al., 2004), TargetScan (Lewis
et al., 2003) and PicTar (Krek et al., 2005).
A major limitation of computation approaches for miRNA target prediction is
that they cannot highlight novel aspects of mRNA target recognition because
the programs predict miRNA targets based on only a few established rules. The
weakness of target prediction software is highlighted by the interaction between
let-7 and the oncogene Ras : Ras has been validated as a target of let-7 in sev-
eral systems (Johnson et al., 2005, Kumar et al., 2007), but at least three major
prediction programs (TargetScan, miRanda and Diana-microT v3.0) fail to iden-
tify this interaction because the interaction includes GU pairings (Johnson et al.,
2005). Another limitation of target prediction algorithms is the number of false-
positives. Many predicted targets do not show miRNA regulation in validation
experiments. For example, Jiang et al. (2009) used luciferase reporter assays to
test miRNAs predicted to target CyclinD1. Of the 45 miRNAs tested, only 7
recapitulated regulation in the validation experiments. Another analysis showed
a similar result for miRNAs predicted to target p21 (Wu et al., 2010), with only
28 out of 266 miRNA predictions standing up to experimental validation. The list
of 266 miRNAs was compiled from four of the most widely used target prediction
algorithms (TargetScan, miRanda, PicTar and RNA22). The authors observed
that overall the programs produced very different sets of miRNA predictions but
those that considered conservation of target sites performed the best (although
clearly these programs would not be effective for species-specific miRNAs). Al-
though the large numbers of false positive results generated by target prediction
programs could in theory be determined by experimental analysis, what is diffi-
cult to estimate is the number of real miRNA targets that these programs miss.
The targeting of Ras by let-7, mentioned above, is an example of a miRNA target
that was not predicted by target prediction software.
Combining data from experimental approaches for identifying miRNA targets
may help to overcome the limitations of computer based target prediction. Nu-
merous attempts have been made to try and identify miRNA targets experimen-
tally both directly and indirectly. Direct methods would include biochemical
approaches involving pulldown of RISC complex proteins, while indirect meth-
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ods include transcriptome-based methods (such as microarrays) and proteome
analysis methods (including SILAC).
4.1.2 Direct experimental methods to identify miRNA targets
Biochemical approaches involve pull-down of endogenous or tagged AGO proteins
(Beitzinger et al., 2007, Easow et al., 2007) or tagged miRNA molecules (Orom &
Lund., 2007) followed by analysis of associated mRNAs. A study by Easow et al.
(2007) in Drosophila identified 89 mRNAs that were reproducibly enriched in an
HA tagged AGO1 immunoprecipitated sample compared with control samples.
Although they showed that the mRNAs were enriched for miRNA seed matches,
the authors did not confirm if they were direct miRNA targets. Beitzinger et al.
(2007) performed direct immunoprecipitation of AGO1 and AGO2 using mon-
oclonal antibodies in HEK293 human cells. They identified 95 RNAs that co-
purified with AGO1 and 49 RNAs that co-purified with AGO2, and validated
that 5 out of 6 of the AGO1-bound miRNAs tested were direct miRNA targets.
It is notable that only 60% of AGO1-bound mRNAs and 50% of AGO2-bound
mRNAs were predicted as miRNA targets by computation prediction programs.
While it is possible that a substantial proportion of the AGO-associated mRNAs
identified in this study are not direct miRNA targets suggesting a high level of
background noise in the system, it seems more likely that the prediction programs
are lacking. The immunoprecipitation methods mentioned above yield lower num-
bers of potential targets than trancriptome-based methods and have the benefit
of identifying transcripts more likely to be directly involved in miRNA-mediated
regulation because the transcripts identified have a direct association with RNA
silencing machinery.
Crosslinking of RNA-protein complexes has recently been shown to increase the
number of potential target transcripts being identified in immunoprecipitation-
based methods (Chi et al., 2009). Hafner et al. (2010a&b) developed the PAR-
CLIP method, which involves UV crosslinking of photoactivatable nucleoside
analogs (following incorporation into cellular RNAs) to their associated proteins
followed by immunoprecipitation of the desired protein and recovery of associ-
ated RNAs. Using this method the group identified approximately 4000 clusters
of sequence reads that overlapped between AGO proteins 1-4 in HEK293 cells.
Because the different AGO proteins bound similar sets of transcripts, the authors
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amalgamated the data sets yielding 17,319 clusters corresponding to 4647 differ-
ent transcripts of which 557 were miRNAs. Enrichment for 7-mer sequences was
investigated in the combined data set of sequences relative to random sequences.
The authors found that the most significantly enriched 7-mers corresponded to
the reverse complement of the seed region of the most abundant HEK293 miR-
NAs. These data show that the PAR-CLIP method yields large numbers of
AGO-associated mRNAs, which are likely to represent miRNA targets. For these
reasons the PAR-CLIP protocol was investigated as a possible method for iden-
tifying direct miRNA targets in ES cells.
4.1.3 Indirect experimental methods to identify miRNA
targets
Alternative to the immunoprecipitation-based direct methods of identifying miR-
NAs targets, are indirect methods of target identification. These methods yield
data on changes in expression of mRNA or proteins. The relationship between
these changes and changes in miRNA expression are then correlated and used
to identify potential miRNA targets. These methods identify both direct and
indirect miRNA targets and so may provide insight into the broader effects on
the transcriptome and/or proteome resulting from changes in miRNA expression.
When it was realised that as well as translational repression, animal miRNAs may
also down-regulate the level of their target transcripts (Bagga et al., 2005, Lim
et al., 2005), transcriptome-based methods began to be used to identify miRNA
targets. As a result several studies have attempted to identify miRNA targets
through overexpression or inhibition of a miRNA, followed by transcriptome anal-
ysis by microarray (Lim et al., 2005). More recently, studies have combined the
transcriptome analyses from both overexpression and inhibition of a miRNA in
order to gain a more accurate indication of direct targets (Nicolas et al., 2008).
Transcriptome-based methods are successful at producing putative lists of direct
and indirect miRNA targets, but are limited to identifying those mRNAs that
are degraded by detectable levels by their targeting miRNA.
Proteome analysis has also been used to identify miRNA targets through stable
isotope labelling by amino acids in cell culture (SILAC) (Vinther et al., 2006,
Yang et al., 2010). The SILAC method involves analysing the protein content
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of two differently labelled cell culture extracts using mass-spectrometry. One
advantage of this method lies in the fact that the two samples are combined prior
to cell lysis and sample preparation. This is a complex, multi-step procedure and
combining samples prior to protein extraction avoids the introduction of artificial
differences frequently observed with this type of proteomic analysis. Samples can
be combined in this way because the proteins in one sample have incorporated
heavy isotopes of particular amino acids, allowing them to be distinguished from
proteins from the other sample during mass-spectrometry analysis.
Proteome-based methods have an advantage over transcriptome-based methods
in the context of identifying miRNA targets. This is because the SILAC method
will detect changes in putative target levels as a result of both methods of miRNA
regulation: mRNA destabilisation and translational inhibition. The SILAC tech-
nique was investigated as a method to identify miRNA targets in ES cells by
correlating differential expression of proteins during trophoblast differentiation
with differential expression of miRNAs identified in Chapter 3 of this thesis.
4.2 Aims of Chapter 4
The aim of this chapter was to compare different methods of miRNA target
identification. Current predictive software approaches and direct and indirect
biochemical approaches were evaluated.
4.3 Results
4.3.1 Investigation of sequence-based methods of identifying
miRNA target transcripts
4.3.1.1 Sequence-based prediction of miR-92a targets
There are numerous programs currently available for computational prediction
of miRNA targets but these methods have varying degrees of reliability (Baek et
al., 2008, Selbach et al.,2008) as a result of using different parameters for target
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prediction. In order to increase the power of computer-based target predictions
there are now online utilities that amalgamate the target prediction results from
multiple prediction programs. One such resource is miRecords (Xiao et al., 2009,
http://mirecords.biolead.org/). miRecords shows prediction miRNA targets from
up to 11 different target predictions programs. A summary of the target predic-
tion programs represented, and their criteria for target identification, is shown in
Table 4.1.
Assuming that the criteria adopted by different prediction algorithms have merit,
it was reasoned that miRNAs targets predicted by a number of programs would
be more likely to represent genuine targets than those predicted by a single al-
gorithm. For this reason miRecords was used for all target prediction in this
chapter. Firstly, miRecords was used to predict targets for miR-92a. This analy-
sis generated 6331 predicted interactions for at least one of the 8 target prediction
programs that yielded predictions for miR-92a. Table 4.2 shows the 69 targets
for miR-92a that were predicted by at least 5 of the 8 target prediction programs.
According to the database of ‘Validated Targets’ available through miRecords,
only one gene listed in Table 4.2 has been validated as a direct miR-92a target.
This target is Mylip (Myosin regulatory light chain interacting protein), which is
also the only target to be predicted by 6 of the 8 algorithms. Mylip interacts with
myosin regulatory light chain B and affects cytoskeleton interaction regulating cell
motility, such as neurite growth (Olsson et al., 1999). The only other validated
target listed for miR-92a is LOC100048439, which is predicted as an miR-92a
target by 3 of the 8 target prediction programs in miRecords. Both of these
targets were validated in a paper by Landais et al. (2007) who showed that the
protein levels of MYLIP and LOC100048439 (similar to HIPK3) decreased upon
miR-92a expression. In addition, the 3’ UTRs of Mylip and LOC100048439 were
cloned downstream of firefly luciferase and luciferase reporter activity was shown
to decrease as a result of miR-92a expression.
In order to determine if Mylip may be a functional target of miR-92a during tro-
phectoderm differentiation of ZHBTc4 ES cells, expression of Mylip was investi-
gated during ZHBTc4 ES cell differentiation and in ES cells following knockdown
of miR-92a expression. A QPCR assay was designed and optimised for Mylip
(Figure 4.1a). Primer optimisation was carried out on pooled cDNA derived
from undifferentiated and differentiated ES cell cultures. Optimisation QPCR
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Table 4.1 – Target prediction programs. Table showing prediction criteria for the miRNA
target prediction programs used by miRecords.
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Table 4.2 – Predicted targets of miR-92a. Table showing Refseq identifiers and gene
symbols for mus musculus targets of miR-92a as predicted by at least 5 different target
prediction programs. ‘Total’ column indicates the number of programs that predict each
target.
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Figure 4.1 – Expression analysis of Mylip following Oct4 knockdown and miR-92a knock-
down. (a) Optimisation details for QPCR primers used in Chapter 4. (b) ZHBTc4 ES cells
were grown without doxycycline or in the presence of 1mg/ml doxycyline for 24, 48 or 72
hours. RNA was extracted from untreated and doxycycline-treated cell cultures, DNAse
treated and used to generate cDNA for QPCR analysis of Mylip expression. QPCR Ct
values were normalised to b-Actin expression. Untreated cultures are represented by a
value of 1.0 and results show gene expression in doxycycline treated cultures relative to
non-treated cultures at each timepoint. N=1. (c) ZHBTc4, E14 and CGR8 ES cells were
transfected with a combination of LNAs targeting miR-92a, miR-25 and miR-363 or an
LNA targeting DM1 (gga-miR-2954 - control transfection). RNA was extracted 96 hours
after transfection. RNA was DNAse treated, converted to cDNA and used for QPCR anal-
ysis of expression of Mylip. QPCR Ct values were normalised to b-Actin and expression
is shown for the miR-92a, miR-25 and miR-363 knockdown relative to expression in the
control transfection. N=1.
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was performed on a series of cDNA dilutions over a range of 1x106 fold. Primers
were considered suitable for use if they amplified a single product over >100-fold
range with 95-105% efficiency and a ‘goodness of fit’ of >0.95. Primer sequences
can be found in Materials and Methods, Figure 4.1a shows the amplification effi-
ciencies, ’goodness of fit’ and amplification range for primer pairs used in Chapter
4 of this thesis. ZHBTc4 ES cells were grown without doxycycline, or in the pres-
ence of 1mg/ml doxycycline, and RNA was harvested after 24, 48 and 72 hours
of growth and used to generate cDNA for QPCR analysis of Mylip expression
(Figure 4.1b). After 24 and 48 hours of growth an increase in Mylip expression
was observed in doxycycline-treated cultures relative to untreated cultures. This
expression pattern is consistent with a decrease in miR-92a expression at these
timepoints. However, no difference in Mylip expression was observed 72 hours
after addition of doxycycline. In order to assess if miR-92a and related miRNAs
had any direct effect on Mylip expression in ES cells, QPCR analysis was carried
out on ES cells after combined inhibition of miR-92a, miR-25 and miR-363 using
100nM of LNA oligonucleotides complementary to the three miRNAs. Control
cultures were transfected with an LNA designed to inhibit a novel chicken miRNA
(DM3) that is not found in mice. Figure 4.1c shows that there is no difference in
the expression of Mylip following miRNA knockdown in ZHBTc4 ES cells. These
data suggest that Mylip is not a functionally significant target of miR-92a in ES
cells. However, it must be noted that this analysis investigates mRNA expression
and significant differences in Mylip expression at the protein level as a result of
ZHBTc4 differentiation or miRNA knockdown cannot be ruled out. Additionally,
because this data is from a single experiment, conclusions about Mylip expression
are not definitive
Of the 69 potential miR-92a targets predicted by 5 prediction programs, none
have been validated as direct targets. However, one of the predicted targets,
Cdkn1c, has been validated as a target of the closely related miRNA hsa-miR-
92b, (Sengupta et al., 2009) a miRNA with a single nucleotide difference to miR-
92a. Cdkn1c, also known as P57, would be an interesting potential target of
miR-92a, as Cdkn1c is a tumour suppressor, and has a role in cell proliferation
in mouse embryos (Zhang et al., 1997). Reduction in the expression of Cdkn1c
is associated with Beckwith-Wiedemann syndrome in humans. This syndrome
results in overgrowth, a predisposition to tumours and congenital malformations
(Higashiomoto et al., 2006). The function of miR-92a in promoting an increase
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in cell numbers could partly be explained by its suppression of the inhibitor of
cell proliferation, Cdkn1c.
4.3.1.2 Gene ontology analysis of miR-92a predicted targets
In order to assess whether the predicted targets of miR-92a show enrichment for
functional associations, the list of targets predicted by at least 3 target prediction
programs was subjected to analysis for enrichment of GO terms (Figure 4.2a)
and KEGG pathways (Figure 4.2b) using DAVID Bioinformatics Resources 6.7
(http://david.abcc.ncifcrf.gov/home.jsp). Initially, the list of targets predicted by
5 prediction programs (shown in Table 4.2 ) was used for analysis but this did not
yield significant enrichment for any GO terms or KEGG pathways, presumably
because the number of targets was relatively low. 1238 targets are predicted for
miR-92a by at least 3 target prediction programs, and it was this list of targets
that was used for GO term and KEGG pathway analysis.
Enrichment values were calculated as –log2(P-Value) and a cut-off P-Value of
<0.00003 (corresponding to an enrichment score of >15) was assigned. The list
of predicted targets showed enrichment in multiple GO terms (Figure 4.2a) and
KEGG pathways (Figure 4.2b). The enriched GO terms contain multiple terms
involving positive regulation of metabolic processes, biosynthetic processes and
gene expression. The enriched KEGG pathways contain a large proportion of
cancer-associated pathways. Both of these findings are of interest in the context
of miR-92a functioning as a regulator of cell proliferation. However, a similar
analysis of targets of the unrelated miR-155 also showed enrichment of targets in
GO terms associated with gene expression and regulation of metabolic processes,
but not biosynthetic processes (data not shown).
4.3.1.3 Sequence-based prediction of Sfmbt2 miRNA cluster targets
The Sfmbt2 miRNA cluster was identified as being upregulated during trophec-
toderm differentiation of ES cells and contains multiple highly related miRNAs
within intron 10 of Sfmbt2 (see Figure 3.7 ). Target predictions for the Sfmbt2
miRNA cluster were investigated to see if they would give insight into the function
of this miRNA cluster. miRecords was used to compile a list of targets predicted
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Figure 4.2 – Analysis of functional associations of predicted miR-92a targets with GO
Terms and KEGG pathways. Enrichment of GO Terms (a) and KEGG pathways (b)
in list of targets for miR-92a predicted by at least 3 different target prediction pro-
grams. Names of GO Terms and KEGG pathways are shown that had an enrich-
ment score of >15, which corresponds to a P-Value of <0.00003. Enrichment for GO
Terms and KEGG pathways was assessed using DAVID Bioinformatics Resources 6.7
(http://david.abcc.ncifcrf.gov/home.jsp).
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by at least 3 target prediction programs for each of the 7 differentially represented
Sfmbt2 -cluster miRNAs identified in the profiling analysis. Targets predicted for
miR-669d however are from a maximum of 2 target prediction programs due to
predictions being unavailable from the other prediction programs. Sequences of
the 7 Sfmbt2 miRNAs used in this analysis are shown in Figure 4.3a.
The 7 lists of predicted targets were then compiled using the free-ware BioLayout
Express 3D (Theocharidis et al., 2009) program for network visualisation and
analysis. This analysis resulted in a list of potential targets of all 7 of the differ-
entially represented miRNAs from the Sfmbt2 cluster. The list was then filtered
to show targets shared by multiple different miRNAs. Figure 4.3b shows a list
of targets predicted for at least 5 of the 7 differentially represented Sfmbt2 clus-
ter miRNAs. According to the database of ‘Validated Targets’ available through
miRecords, none of these predicted targets have yet been validated as real tar-
gets of any of the miRNAs in this analysis. Interestingly, there were 6 genes that
were predicted as targets of all 7 of the Sfmbt2 -cluster miRNAs in this analysis
(Figure 4.3c). A level of similarity between target lists is unsurprising because
some of the 7 Sfmbt2 cluster miRNAs belong to the same family and have very
similar or identical seed sequences (Figure 4.3a). These miRNAs would therefore
be expected to be predicted to target the same transcripts by the programmes.
However, the seed sequences of other miRNAs within the cluster are different.
The dissimilar miRNAs cannot be targeting the same sites within their shared
targets, meaning there must be several predicted target sites for Sfmbt2 miRNAs
within these shared targets. This increases the likelihood of the 6 genes being
real targets of the Sfmbt2 -cluster miRNAs and suggests that their repression is
important during trophoblast differentiation.
The 6 targets predicted for all 7 of the differentially represented Sfmbt2 -cluster
miRNAs are Rabgap1l, Ogfod1, Trim33, Btbd14a (also known as NACC2), Bcl11b
and Dnmt3a. Little is known about the function of NACC2 (NACC family
member 2, BEN and BTB (POZ) domain containing) although interestingly
the related NACC1 interacts with NANOG in mouse ES cells to regulate pro-
liferation via the Eras/PI3K/Akt pathway (Ma et al., 2009). Bcl11b (B-cell
CLL/lymphoma 11B (zinc finger protein)) is a transcriptional repressor that is
essential for developmental processes of the immune and central nervous systems
as well as skin and tooth development (Golonzhka et al., 2009). Germline dele-
tion of Bcl11b leads to perinatal lethality (Wakabayashi et al., 2003). Ogfod1
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(2-oxoglutarate and iron-dependent oxygenase domain containing 1) is a protein
found in stress granules that functions to link recovery from stress with trans-
lation regulation. Overexpression of Ogfod1 leads to an increase in apoptosis in
stressed cells and those recovering from stress. The pro-apoptotic roles of Ogfod1
are mediated through its regulation of phosphorylation of eukaryotic translation
initiation factor 2alpha (eIF2a) (Wehner et al., 2010). The function of Rabgap1l
(RAB GTPase activating protein 1-like) is not yet known although it is related to
Rabgap1, which may have roles in mitosis by participating in a RAB6A-mediated
pathway involved in the metaphase-anaphase transition (Miserey-Lenkei et al.,
2006). Numerous studies have been published regarding Trim33 (tripartite motif
containing 33) function. Trim33 is thought act as a transcriptional co-repressor
and is essential for embryonic development (Kim & Kaartinen, 2008). It also
acts as a SMAD4 monoubiquitin ligase (Dupont et al.,2009) enabling cells to
set their Nodal responsiveness. In this way Trim33 is involved in negatively
controlling Nodal activity to allow a balance between stem cell self-renewal and
differentiation of trophoblast cells in the early embryo (Morsut et al., 2010). In
the presence of too much Nodal signalling trophoblast stem cells are not main-
tained. The Sfmbt2 miRNA cluster may be required to regulate Trim33 expres-
sion levels during trophoblast differentiation. This would ensure that Trim33
ubiquitination of SMAD4 stayed within certain boundaries allowing a balance
between trophoblast stem cell maintenance and terminal trophectoderm differen-
tiation. Dnmt3a (DNA (cytosine-5-)-methytransferase 3 alpha) is a de novo DNA
methyltransferase that is essential for mouse development (Okano et al., 1999),
and genomic imprinting (Hata et al., 2002). Dnmt3a interacts with polycomb pro-
teins, suggesting that these proteins may direct de novo DNA methylation (Rush
et al., 2009). These findings are interesting in the context of Dnmt3a regulation
by Sfmbt2 -cluster miRNAs because Sfmbt2 is both a predicted polycomb-group
gene and is imprinted in early embryos (Kuzmin et al., 2008).
In order to determine if Trim33 and Dnmt3a may be a functional targets of
Sfmbt2 miRNAs during trophectoderm differentiation of ZHBTc4 ES cells, ex-
pression of these genes was investigated during ZHBTc4 ES cell differentiation
and in ES cells following knockdown of miR-467a* and miR-669b expression.
QPCR assays were designed and optimised for Trim33 and Dnmt3a (Figure 4.1a).
ZHBTc4 ES cells were grown without doxycycline, or in the presence of 1mg/ml
doxycycline, and RNA was harvested after 24, 48 and 72 hours of growth and used
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Figure 4.3 – Predicted targets of the Sfmbt2 miRNA cluster. (a) Sequences of 7 differ-
entially represented miRNAs in Sfmbt2 miRNA cluster. Seed sequences are highlighted
in colour. (b) List of targets predicted by at least 3 target prediction programs using
miRecords for at least 5 of the differentially represented Sfmbt2 cluster miRNAs. (c) Bi-
olayout Express 3D (http://www.biolayout.org/) schematic diagram showing targets that
are predicted for all 7 of the differentially represented Sfmbt2 cluster miRNAs.
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Figure 4.4 – Expression analysis of Trim33 and Dnmt3a following Oct4 knockdown and
miRNA knockdown. (a & b) ZHBTc4 ES cells were grown without doxycycline or in the
presence of 1mg/ml doxycyline for 24, 48 or 72 hours. RNA was extracted from untreated
and doxycycline-treated cell cultures, DNAse treated and used to generate cDNA for QPCR
analysis of Trim33 (a) and Dnmt3a (b) expression. QPCR Ct values were normalised
to b-Actin expression. Untreated cultures are represented by a value of 1.0 and results
show gene expression in doxycycline treated cultures relative to non-treated cultures at
each timepoint. N=1. (c & d) ZHBTc4 ES cells were grown without doxycycline or in
the presence of 1mg/ml doxycycline for 24 hours then transfected with a combination of
LNAs targeting miR-467a and miR-669b or an LNA targeting a chicken miRNA (control
transfection). RNA was extracted 24 hours after transfection. RNA was DNAse treated,
converted to cDNA and used for QPCR analysis of expression of Trim33 (c) and Dnmt3a
(b). QPCR Ct values were normalised to b-Actin and expression is shown for the miR-467a,
miR-669b knockdown relative to expression in the control transfection. N=1.
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to generate cDNA for QPCR analysis of gene expression. After 24 and 48 hours
of growth an increase in Trim33 expression was observed in doxycycline-treated
cultures relative to untreated cultures (Figure 4.4a). This expression pattern is
not consistent with regulation of Trim33 by Sfmbt2 miRNAs, which also increase
in expression in doxycycline-treated cultures. Expression of Dnmt3a was similar
in cultures grown without doxycycline and those grown in the presence of doxy-
cycline for 24 and 48 hours (Figure 4.4b). However, at 72 hours expression of
Dnmt3a was reduced in doxycycline-treated cultures relative to untreated cul-
tures. This result is consistent with regulation of Dnmt3a by Sfmbt2 miRNAs,
which increase in expression in doxycycline-treated cultures.
In order to assess if Sfmbt2 miRNAs had any direct effect on Trim33 or Dnmt3a
expression in undifferentiated and differentiated ZHBTc4 ES cells ES cells, QPCR
analysis was carried out on cDNA from cells after combined inhibition of miR-
467a* and miR-669b. Control cultures were transfected with an LNA designed
to inhibit a novel chicken miRNA. Figures 4.4c & d show that there is a slight
increase in Trim33 and Dnmt3a expression following miR-467a* and miR-669b
inhibition in undifferentiated ZHBTc4 ES cells relative to control knockdown, but
no difference in differentiated cultures. The increase in expression of Trim33 and
Dnmt3a observed following knockdown of miR-467a* and miR-669b in undiffer-
entiated ES cells is consistent with the prediction that these mRNAs are targets
of Sfmbt2 miRNAs. However, the lack of an increase in expression following miR-
467a* and miR-669b knockdown in differentiated cells, where these miRNAs are
expressed at higher levels and therefore may be exerting more repression on tar-
get transcripts, means that interactions between Sfmbt2 miRNAs and Trim33 or
Dnmt3a cannot be confirmed in this system. It must be noted that this analy-
sis investigates mRNA expression and therefore significant differences in Trim33
and Dnmt3a expression at the protein level as a result of ZHBTc4 differentia-
tion or miRNA knockdown cannot be ruled out. Additionally, these results arise
from single experiments and replicate experiments would be required to make
conclusions from expression data definitive.
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Figure 4.5 – Analysis of functional associations of predicted Sfmbt2 cluster miRNA targets
with GO Terms and KEGG pathways. Enrichment of GO Terms (a) and KEGG pathways
(b) in list of targets predicted for at least 3 different Sfmbt2 cluster miRNAs by at least 3
target prediction programs (2 for miR-669d). Names of GO Terms and KEGG pathways are
shown that had an enrichment score of >15, which corresponds to a P-Value of <0.00003.
Enrichment for GO Terms and KEGG pathways was assessed using DAVID Bioinformatics
Resources 6.7 (http://david.abcc.ncifcrf.gov/home.jsp).
Chapter 4. Methods to identify miRNA target gene transcripts in ES cells 152
4.3.1.4 Gene ontology analysis of predicted targets for Sfmbt2 cluster
miRNAs
In order to assess whether the predicted targets of the Sfmbt2 miRNA cluster
show enrichment for functional associations, the list of targets predicted for at
least 3 of the 7 miRNAs was subjected to analysis for enrichment of GO terms
(Figure 4.5a) and KEGG pathways (Figure 4.5b) using DAVID Bioinformat-
ics Resources 6.7 (Huang et al., 2009, http://david.abcc.ncifcrf.gov/home.jsp).
Enrichment values were calculated as –log2(P-Value) and cut-off P-Values were
assigned as <0.00003 for GO term analysis and KEGG pathway analysis (corre-
sponding to enrichment scores of >15, respectively).
Similar to results for miR-92a targets, GO terms showed enrichment for terms
associated with positive regulation of metabolic processes and gene expression
(Figure 4.5a). Similarly, the enriched KEGG pathways contained a large propor-
tion of cancer-associated pathways (Figure 4.5b). miR-92a is a part of a known
onco-miR cluster that has been associated with numerous cancers (Olive et al.,
2010), but no such association has yet been made for the Sfmbt2 cluster. However,
part of the function of this cluster may be to promote survival and proliferation
of trophoblast cells in the placenta.
4.3.1.5 Investigating the limitations of sequence-based target prediction
As briefly discussed above, computer-based target prediction programs have mul-
tiple limitations. One major limitation is that each program will predict a largely
different list of potential targets from the other programs. This is exemplified in
Figure 4.6, which shows the number of targets predicted by miRecords by 1 or
more target prediction programs. There are 6331 predictions made by 1 prediction
program, but only 2049 potential targets shared by at least 2 target prediction
programs. This means that a large proportion of targets within miRecords are
predicted by a single algorithm.
Although the algorithms differ in the criteria they use for target analysis, the
basic rules they employ are similar. Therefore, it is surprising that there is so
little overlap between predicted lists of targets. Additionally, if we assume that
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Figure 4.6 – Comparison of the results from combinations of different target prediction
programs. Graph showing the number of predicted targets for miR-92a against the number
of programs that predict them.
prediction of a miRNA target is more reliable if it occurs from more than one pre-
diction program, then it follows that the majority of miRNA targets yielded by
a single program are unreliable. The disagreement between target lists from dif-
ferent prediction programs makes it difficult for a user to determine which target
prediction program to use or what proportion of the predictions are real. Because
of the limitations of computational methods of target predictions, experimental
methods were tested.
4.3.2 Investigation of PAR-CLIP as a method for identifying
miRNA target transcripts
The PAR-CLIP (Photoactivatable-Ribonucleoside-Enhanced Crosslinking and Im-
munoprecipitation) protocol (Hafner et al., 2010) was used as part of a novel pro-
tocol to attempt to identify direct targets of a single miRNA in ES cells. The idea
was to express a single miRNA in ES cells that were devoid of all other miRNAs.
The PAR-CLIP protocol would then be used to isolate the miRNA targets from
the RISC complex. In theory, any mRNAs identified should be targets of the
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miRNA that was introduced to the cells. The full experimental protocol can be
found in materials and methods (Section 1.3.2). Following optimisation of the
PAR-CLIP method, PAR-CLIP analysis was performed on DGCR8-/- ES cells
overexpressing miR-467a*, as well as on DGCR8-/- ES cells (negative control)
and on wt ES cells (positive control).
The resulting sequencing data was analysed for the presence of sequences origi-
nating from the PAR-CLIP method. 5 sequences >8nt were obtained from the
DGCR8-/- untransfected library, 1 sequence from the DGCR8-/- miR-467a trans-
fected library and 2 sequences from the E14 library. In contrast, the original
PAR-CLIP paper showed thousands of different sequences from a single library,
although this was as a result of deep sequencing of libraries rather than cloning
and sequencing. Most sequences were from the untransfected DGCR8-/- library,
which was the negative control in the experiment. This suggests the possibility
of background noise in this system. However, a greater problem with this tech-
nique was the fact that only 2 sequences were recovered from the positive control
libraries suggesting that aspects of the procedure were not successful. Further,
only one sequence resulted in a 100% match to a mouse mRNA. PAR-CLIP is
a complex, laborious, time-consuming set of procedures, mastery of which would
obviously require a number of repetitions. While this analysis suggested that the
majority of technical difficulties had been overcome, time limitation meant that
final optimisation was not possible.
4.3.3 Investigating SILAC analysis as a method of identifying
miRNA target transcripts
4.3.3.1 SILAC analysis of undifferentiated and differentiated ZHBTc4
cells
An indirect method for identifying potential miRNA targets was also investigated.
The ‘Stable isotope labelling of amino acids in cell culture’ (SILAC) method (Ong
et al., 2002) was used to attempt to identify potential miRNA targets in ES cells.
This method depends on metabolic incorporation of ‘heavy’ or ‘light’ isotopes of
amino acids into newly synthesised proteins in cell culture. Two cell populations
are grown in culture media that is identical except that one of them contains
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Figure 4.7 – Overview of SILAC experiment. Schematic diagram of the SILAC experi-
mental procedure. ZHBTc4 ES cells were grown in the presence of ‘light’ media (R0K0,
Lys-0, Arg-0) or ‘heavy’ media (R6K6, Lys-6, Arg-6) for 96 hours. The ‘light’ culture was
subsequently grown without doxycycline and the ‘heavy’ culture was grown in the presence
of 1mg/ml doxycycline for 48 hours. Bright field photographs were taken of undifferentiated
(a) and differentiated (b) cell populations prior to SILAC analysis (x100 magnification).
Protein was harvested from ZHBTc4 ES cells grown without doxycycline or in the presence
of 1mg/ml doxycycline and used for western analysis of Oct4 expression (c). Western mem-
brane was re-probed for b-actin expression to estimate protein-loading levels in individual
lanes (loading control). Equal numbers of ZHBTc4 ES cells grown without doxycycline
or in the presence of 1mg/ml doxycycline were combined and used for downstream SILAC
analysis.
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light forms of a particular amino acid and the other contains heavy forms. A
key feature of the protocol is that the two cell populations are then mixed and
used to prepare a single sample for mass spectrometry analysis. Because light
and heavy labelled peptides have different m/z ratios, quantitative differences in
protein expression between the two original cell populations can be determined.
A visual overview of the SILAC experiment is shown in Figure 4.13 and the full
SILAC protocol can be found in Materials and Methods (Chapter 2).
Cells from a single ZHBTc4 ES cell culture were harvested and then cultured in ei-
ther ‘light’ or ‘heavy’ medium for 96 hours in order to uniformly label all expressed
proteins. The ‘light’ cell population was grown for a further 48 hours in ‘light’
media and remained morphologically undifferentiated (Figure 4.13a), whereas
the ‘heavy’ cell population was induced to differentiate by the addition of 1mg/ml
doxycycline and cultured for a further 48 hours in ‘heavy’ media. Doxycycline
induces ZHBTc4 ES cells to switch off Oct4 expression, which results in their
rapid differentiation down the trophoblast lineage. Visual inspection of the cells
showed that trophoblast differentiation was occurring in the doxycycline-treated
population (Figure 4.13b). Western analysis of OCT4 expression confirmed that
the ‘heavy’ cells had down-regulated the pluripotency marker OCT4 following
doxycycline treatment (Figure 4.13c).
The cells from the undifferentiated and differentiated populations were counted
and 5x106 cells from each population were mixed and lysed by addition of T-Per
buffer to the cell pellet. In addition, protein was extracted and quantitated from
1x106 cells from the two uncombined populations to confirm that protein levels
were approximately similar between the two populations (data not shown). Pro-
tein samples were taken from equal numbers of undifferentiated and differentiated
ES cells grown in normal media and in ‘light’ or ‘heavy’ labelled media. These
samples were separated on an SDS-PAGE gel, which was then silver-stained.
Protein quantity appeared approximately equal between the ‘light’ and ‘heavy’
populations, confirming the protein quantitation data (data not shown).
4.3.3.2 Analysis of protein expression during the ES cell to trophoblast
transition
Two of the ten gel pieces were selected for processing and analysis. The gel slices
chosen were those that contained proteins of between 30kDa and 40kDa, and
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between 40 kDa and 50kDa in size (estimated by position of gel slices relative to
protein weight markers). 75% of peptides identified by mass spectrometry repre-
sented proteins of approximately the expected size (between 30kDa and 50kDa).
Sequencing analysis was carried out by Dundee Cell Products and yielded almost
2000 unique peptide sequences corresponding to 444 different proteins. Raw data
from SILAC analysis can be found in Appendix D. Proteins were classed as be-
ing differentially expressed if they had a heavy (R6K6)/light (R0K0) or a light
(R0K0)/ heavy (R6K6) ratio of greater than or equal to 2. By this criterion,
12 proteins were predicted to be expressed at higher levels in the differentiated
sample and 16 proteins were predicted to have higher expression in the undiffer-
entiated sample (Table 4.3 ).
In order to validate the SILAC analysis, a protein identified as being up-regulated
on differentiation, and a protein identified as being down-regulated on differenti-
ation were chosen for further analysis. Rather than simply relying on predicted
‘fold change’, the differentially expressed proteins with the most significant PEP
scores were selected. Accordingly, using protein samples previously prepared by
T. Burdon, western analysis was used to establish the expression of Creatine Ki-
nase B-type (CKB) and C-terminal binding protein 2 (CTBP2) in ZHBTc4 ES
cells that had been cultured in the presence of doxycycline for various lengths
of time compared to protein levels in ZHBTc4 ES cells that had been grown
without doxycycline for the corresponding lengths of time (Figure 4.14 ). It is
important to note that the SILAC analysis was carried out 48 hours after addi-
tion of doxycycline. At this timepoint the mass spectrometry analysis found that
CKB was 3.46-fold higher in differentiated cells and CTBP2 was 2.97-fold higher
in undifferentiated cells. Western blot analysis confirmed these results with both
CKB and CTBP2 showing differential expression between undifferentiated and
differentiated samples. Quantitation of western images showed expression differ-
ences of 3.5-fold for CKB and 13.3-fold for CTBP2. These values are preliminary
however because data is from a single experimental replicate. CKB (Creatine
kinase, brain) reversibly catalyses the transfer of phosphate between ATP and
cellular phosphogens such as creatine phosphate (Morrison & O’Sullivan, 1965).
The Ctbp2 (C-terminal binding protein 2) gene produces two alternative tran-
scripts, which produce distinct proteins. One protein is a transcriptional repressor
(CTBP2) (Turner & Crossley, 1998), while the other is a component of specialised
synapses called synaptic ribbons (RIBEYE) (Schmitz et al., 2000). Interestingly,
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Table 4.3 – Results from SILAC analysis. Table showing proteins with an R6K6/R0K0
ratio of >2.0 or <0.5. The R6K6/R0K0 ratios are the average ratio for all peptides se-
quenced for each protein. Also shown is the number of peptides sequenced, the percentage
sequence coverage that these peptides represent, the molecular weight of the protein (kDa),
the sequence length in amino acids and the PEP (posterior error probability) score, which
is the probability of a false hit in protein identification.
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Figure 4.8 – Western analysis of CKB and CTBP2 expression in undifferentiated and
differentiated ZHBTc4 ES cells. Western analysis of CKB (a) and CTBP2 (b) expression
in ZHBTc4 ES cells at time of plating (Time 0) and ZHBTc4 ES cells grown without
doxycycline (- dox) or in the presence of 1mg/ml doxycycline (+dox) for 12, 24, 48, 72 or 96
hours. Western membrane was re-probed for b-actin expression to estimate protein-loading
levels in individual lanes (loading control). Lanes showing protein expression at 48 hours
are expanded and the ratios of protein expression from SILAC analysis and quantitation
of the autorad image are shown. N=1.
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Table 4.4 – miRNA target predictions for differentially expressed proteins from SILAC
analysis. Table showing if proteins expressed at higher levels in differentiated cultures
(a) or undifferentiated cultures (b) are predicted targets of miRNAs represented at higher
levels in undifferentiated cultures or differentiated cultures, respectively. Values correspond
to the number of prediction programs that predict an interaction between miRNAs and
potential targets.
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CTBP2 is mainly expressed during embryogenesis (Furusawa et al., 1999) and
CTBP2-null mice die during embryogenesis due to aberrant extraembryonic de-
velopment (Hildebrand and Soriana, 2002). From these data the SILAC profiling
appears reliable and has correctly identified proteins that are differentially ex-
pressed between ES cells and trophoblast-like cells.
4.3.3.3 Investigating interactions between proteins and miRNAs identified
as being differentially expressed during ZHBTc4 ES cell differentiation
The purpose of the SILAC analysis was to identify potential miRNA targets dur-
ing ES cell differentiation. As such the list of differentially expressed proteins
was tested for sequence-based predictions of miRNA binding sites for the differ-
entially represented miRNAs shown in Table 3.3. The online utility, miRecords
(http://mirecords.biolead.org/), was used to determine the number of programs
that predicted interactions between differentially expressed proteins and differen-
tially represented miRNAs (Table 4.4 ). 19 out of the 28 differentially expressed
proteins are predicted to be targets of at least one differentially represented
miRNA by at least three different target prediction programs and 11 interac-
tions are predicted by at least four target prediction programs.
4.4 Discussion
The primary aim of this chapter was to compare methods for the identification of
miRNA targets. A sequence-based method was compared with two experimental
methods: the direct experimental method, PAR-CLIP, and the indirect experi-
mental method, SILAC. Lists of targets for miR-92a and Sfmbt2 miRNAs were
generated by sequence-based prediction, but the reliability of these target lists
was questioned because none of the predicted targets could be experimentally
validated. Direct miRNA targets were not successfully identified as a result of
the PAR-CLIP method, probably due to lack of experience with the methodology.
Use of the SILAC method identified proteins that were differentially expressed
during the ES cell to trophoblast transition, some of which were predicted targets
of miRNAs that were differentially represented during this transition.
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4.4.1 Sequence-based methods predict targets of miR-92a
and the Sfmbt2 miRNA cluster
The miRNA target database miRecords was used to predict targets of the Sfmbt2
miRNA cluster and miR-92a. miRecords amalgamates target predictions from
multiple prediction programs and results can be filtered to include only those
targets predicted by a minimum number of programs (Xiao et al., 2009). For
example, there were 69 miR-92a targets predicted by five or more different target
prediction programs. This list of predicted targets contained only one target that
had been previously experimentally verified according to the miRecords validated
targets database – Mylip. Mylip interacts with myosin regulatory light chain B,
which in turn regulates the activity of the actomyosin complex important for
many motile processes in eukaryotes (Olsson et al., 1999). Mylip was identified as
a direct target of miR-92a in 3T3 cells (Landais et al., 2007). However, expression
analysis presented here suggests that Mylip is not a target of miR-92a in ES cells.
This disagreement could result from two possibilities: Mylip may be a target of
miR-92a in 3T3 cells, but not in ES cells; or regulation by miR-92a may involve
translational repression, rather than mRNA degradation. Indeed, Landais et al.
reported that miR-92a affected Mylip expression at the protein level, but did not
investigate Mylip mRNA expression.
The miRecords database was also used to predict targets of the seven differen-
tially represented Sfmbt2 cluster miRNAs, and results for all seven miRNAs were
amalgamated using BioLayout Express. 126 targets were predicted for at least
five of the Sfmbt2 cluster miRNAs by at least three different target prediction
programs. According to the database of ‘Validated Targets’ available through
miRecords, none of these predicted targets have yet been validated as real tar-
gets of any of the miRNAs in this analysis. Significantly, six potential targets
were predicted for all seven of the Sfmbt2 cluster miRNAs: Rabgap1l, Ogfod1,
Trim33, Btbd14a, Bcl11b and Dnmt3a. The fact that some of the seven miRNAs
have different sequences, including different seed sequences, means that they must
be predicted to target different sites within these genes. The presence of more
than one predicted target site for Sfmbt2 miRNAs increases the likelihood that
these genes are targets of Sfmbt2 miRNAs. Two of the potential targets, Trim33
and Dnmt3a, were investigated further. Both Trim33 and Dnmt3a increased in
expression upon knockdown of miR-467a* and miR-669b in undifferentiated ES
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cells, but no increase in expression was observed upon miRNA knockdown in dif-
ferentiated cells. miR-467a* and miR-669b expression is higher in differentiated
cells relative to undifferentiated cells, so it is surprising that an effect on gene
expression was observed in the undifferentiated cultures, but not the differenti-
ated cultures. While it is possible that Trim33 and Dnmt3a are direct targets
of miR-467a* and/or miR-669b in ES cells but not in differentiated cells, this
disagreement in results makes it difficult to infer a direct association between
Sfmbt2 miRNAs and Trim33 or Dnmt3a. Analysis of expression of Trim33 and
Dnmt3a protein following miRNA suppression would confirm whether regulation
by Sfmbt2 miRNAs is evident at the protein level.
In order to assess if the predicted targets of the Sfmbt2 cluster and miR-92a were
associated with any particular biological functions, the enrichment of these targets
in specific GO terms and KEGG pathways was investigated. Results showed an
enrichment of miR-92a targets in GO terms associated with positive regulation
of metabolic processes, biosynthetic processes and gene expression, and KEGG
pathways associated with cancer. The targets of the Sfmbt2 cluster miRNAs were
also enriched in similar pathways. miR-92a and the Sfmbt2 cluster miRNAs have
different sequences including completely different seed sequences, and are shown
to generate different target lists from the data presented here. The fact that miR-
92a targets and targets of Sfmbt2 miRNAs are associated with similar biological
processes and pathways may be explained if these miRNAs have similar functions,
perhaps in different systems. However, targets of the unrelated miRNA, miR-
155, also show enrichment in GO terms and KEGG pathways that overlap with
those of miR-92a targets and targets of the Sfmbt2 cluster. While there is a
possibility that miR-155 has similar functional roles to miR-92a and Sfmbt2
miRNAs, there is little experimental evidence to support this. The function of
miR-155 is normally associated with the immune system: loss of miR-155 in
mice results in immunodeficiency and miR-155 is important for the function of
B-cells, T-lymphocytes and dendritic cells (Rodriguez et al., 2007). Therefore, it
is believed more likely that these data reflect a limitation of the use of GO term
and KEGG pathway enrichment for this type of analysis.
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4.4.2 Estimating the reliability of target prediction programs
Investigation of a sequence-based method of target identification for miR-92a
and Sfmbt2 cluster miRNAs resulted in lists of predicted target genes. One out
of the 69 predicted targets of miR-92a have been experimentally validated but
none of the Sfmbt2 cluster targets have any experimental verification. Because
experimental verification of miRNA targets is a labour intensive process, very
few predicted miRNA-mRNA interactions have been confirmed. Verification of
targets should improve our understanding of the factors important for miRNA
targeting and lead to improved sequence-based methods.
The lists of predicted targets of miR-92a and Sfmbt2 miRNAs are likely to contain
a significant proportion of false-positive predictions, which is a consequence of
the challenges presented by predicting miRNA targets that show only partial
complementarity with their regulatory miRNAs. The reason for a mechanism of
regulation requiring partial, rather than full, complementarity between miRNA
and mRNA target is not fully understood, but a number of possibilities have
been proposed: that a central loop region improves miRNA-mediated regulation
(Ye et al., 2008); or that extensive complementarity between miRNA and mRNA
target site triggers miRNA destabilisation (Ameres et al., 2010). Large miRNA
target lists are not unexpected however, because rather than existing as switches
for a few targets, each miRNA is thought to regulate in the region of 200 target
transcripts (Baek et al., 2008, Farh et al., 2005), and multiple miRNAs may
act combinatorially to regulate expression of a single target (Stark et al., 2005).
Another limitation of several target prediction programs is that they are based
on matching short complementary sequences without taking into consideration
whether the target sequence is available in the cell. Many target prediction
programs do not take into account the fact that a target site may be inaccessible
due to RNA-folding or the presence of RNA-binding proteins.
Two proteome-based approaches of measuring the impact of miRNAs on protein
levels examined the reliability of different target prediction programs based on
their findings. Selbach et al. (2008) used a pulse-labelling SILAC approach to
compare levels of newly synthesised proteins in cells with normal miRNA levels,
and protein from cells where miRNA levels were perturbed, leading to a list of
proteins that may be regulated by specific miRNAs. Comparison of this list of
predicted miRNAs targets with targets predicted by sequence-based prediction
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programs showed that all sequence-based prediction programs tested, apart from
RNA22, achieved an accuracy that was greater than random chance. Prediction
programs that took evolutionary conservation of seed sites into account achieved
a further step up in accuracy (TargetScan, PicTar and Diana microT 3.0). Even
the best prediction program however, only achieved an accuracy of approximately
66%. This means that even with the most reliable target prediction program, one
third of all predicted targets are false positives. A similar analysis (Baek et al.,
2008) came to the same conclusion. They found that only taking into account
the top 29 predictions improved the reliability of most of the programs by a small
amount. However, while taking into account evolutionary conservation of seed
sites clearly improves overall target prediction, it will bias against those miRNA
targets that have arisen as a result of recent evolution.
Studies into the reliability of target prediction programs suggest that there is
not one program that stands out as being the most reliable. Therefore it has
been commonplace for researchers to consult several target prediction databases
when searching for miRNA targets (Xiao et al., 2009). It is presumed that by
amalgamating results from multiple target prediction programs, the reliability of
the predicted targets will be increased. This led to the development of a web-
based utility called miRecords that combines the results from multiple target
prediction programs (Xiao et al., 2009). However, while it assumed, there is yet
no experimental evidence that amalgamating target lists from different programs
actually improves target prediction. An analysis of miR-92a targets, presented
here, that were predicted by multiple target programs generated 6331 targets that
were predicted by at least one target prediction program. This figure corresponds
to almost one third of the entire transcriptome. Each miRNA is thought to
regulate in the region of a few hundred target transcripts (Farh et al., 2005), so it is
highly unlikely that expression of the 6331 predicted targets is actually regulated
by miR-92a. This means that the vast majority of predictions made by target
prediction programs are not real targets, and it could therefore be argued that
combining prediction from multiple packages may not actually improve prediction
accuracy.
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4.4.3 SILAC – a method to identify direct and indirect
miRNA targets
The proteome-based method SILAC was investigated as a method of identifying
miRNA targets. While the proteins identified in SILAC cannot be classed as
direct miRNA targets without further experimental analysis, this method can
identify proteins directly and indirectly regulated by miRNAs. A SILAC anal-
ysis, therefore, has greater power in determining the global proteome effects of
perturbing miRNA expression than a direct method such as PAR-CLIP. The
original purpose of the SILAC analysis presented in this thesis was to evaluate
the method on the basic trophectoderm differentiation system used in Chapter
3 of this thesis. Following this, a further goal was to use the SILAC method to
evaluate proteomic changes following missexpression of specific miRNAs. Due
to time constraints the miRNA missexpression analysis was not carried out. In-
stead, proteins identified as being differentially expressed in the SILAC analysis
of undifferentiated and differentiated cells were analysed as potential targets of
miRNAs also identified as being differentially represented.
SILAC analysis was carried out on undifferentiated and differentiated populations
of ZHBTc4 ES cells. From the SILAC analysis, mass spectrometry identified
peptides corresponding to 444 different proteins. Considering that only one fifth
of the total gel was processed for mass spectrometry analysis, it is possible that a
full analysis could identify in the region of 1500 proteins. It is difficult to estimate
the coverage of this analysis because the size of the mouse ES cell proteome is not
known. For comparison, previous SILAC analyses in HeLa or mouse ES cells have
resulted in quantitation of between 504 and 5111 individual proteins (Vinther et
al., 2006, Graumann et al., 2008).
One potential limitation of the SILAC analysis is a lack of sensitivity, which would
result in failure to identify proteins present in low cellular quantities. Generally,
it is thought that proteins involved in cell signalling, including transcription fac-
tors, are present at lower quantities than housekeeping and structural proteins.
The size range of proteins identified by this SILAC analysis should include the
transcription factors OCT4 and CDX2, which are key for trophectoderm differ-
entiation, and would be expected to show strong differential expression in the
ZHBTc4 differentiation system. According to data presented in Chapter 3 of this
thesis, OCT4 proteins levels should be drastically reduced upon trophectoderm
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differentiation and CDX2 expression should increase, but these proteins were not
identified in the SILAC analysis. This may suggest that SILAC analysis is limited
because it is biased towards detecting changes in abundant cell proteins. How-
ever, the reason that differential expression of OCT4 and CDX2 may not have
been reported may be if peptides from these proteins were not identified in one
of the samples. Because automated SILAC analysis will only report the quanti-
tative difference in protein expression, if a protein is expressed at low levels in
one sample, and is therefore undetected by SILAC, then a ratio cannot be cal-
culated and that protein will not be reported in the results. A previous SILAC
analysis of mouse ES cells successfully identified the key ES cell transcription
factors OCT4, SOX2 and NANOG suggesting that these proteins exist at a level
detectable by SILAC analysis in ES cells (Graumann et al., 2008). Further, Sel-
bach et al. reported that, although mass spectrometry is biased to detect more
highly expressed genes, this bias was mild in their SILAC analysis and did not
affect the detection range (Selbach et al., 2008).
4.4.4 SILAC analysis identified differentially expressed proteins
Proteins with differential expression levels between undifferentiated and differ-
entiated ES cells were identified by SILAC analysis and the expression profiles
of two of these proteins, CTBP2 and CKB, were confirmed by western analysis.
This proved the reliability of the data and identified two proteins that are differ-
entially expressed during trophectoderm differentiation. The list of differentially
expressed proteins was then analysed for potential regulation by differentially rep-
resented miRNAs. The miRecords database was used to identify if differentially
expressed proteins were predicted targets of differentially represented miRNAs,
and how many target prediction programs predicted this interaction. For interac-
tions predicted by at least 4 different target prediction programs: results showed
that 8 out of 12 proteins that were expressed at higher levels in differentiated
cells were predicted to be targets of miRNAs represented at higher levels in un-
differentiated cells, and 3 out of 16 proteins that were expressed at higher levels
in undifferentiated cells were predicted to be targets of miRNAs represented at
higher levels in differentiated cells. This suggests the possibility that the expres-
sion patterns of these proteins could arise from direct regulation by differentially
represented miRNAs. Experimental validation of predicted interactions between
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differentially represented miRNAs and proteins would confirm whether the SILAC
method can be used in combination with sequence-based prediction methods to
identify direct miRNA targets.
Previous SILAC analyses have been used to identify potential targets of specific
miRNAs in a variety of systems (Vinther et al., 2006, Selbach et al., 2008, Baek
et al., 2008, Yang et al., 2010). In each of these analyses, miRNA expression was
perturbed by miRNA expression or inhibition, and subsequent SILAC analysis
was used to identify differentially expressed proteins. The SILAC analyses iden-
tified between 12 and 130 potential miRNA targets. Variation in the number of
targets identified appeared to correlate with variation in the number of proteins
identified from the analysis. Vinther et al. identified 12 proteins that were dif-
ferentially regulated upon miR-1 transfection in HeLa cells, and reported that
7 of these proteins were predicted as miR-1 targets by several target prediction
programs (Vinther et al., 2006). This suggests two possibilities: that target pre-
diction programs fail to identify a significant proportion of real miRNA targets,
or that SILAC analysis identifies both direct and indirect miRNA targets. Both
of these possibilities are likely to contribute to the discrepancy between predicted
miR-1 targets and targets identified by SILAC analysis. Further, sequence-based
predictions identified 36 potential targets of miR-1, which were not found to be
targets by SILAC analysis, suggesting that sequence-based programs predict a
large number of false positives (Vinther et al., 2006). Of the 12 proteins identi-
fied as potential miR-1 targets, Vinther et al. validated 6 as direct miR-1 targets
by luciferase assay. In a similar analysis, Yang et al. identified 93 proteins as
being downregulated by more than 2-fold upon expression of miR-143. Valida-
tion analysis of 34 of the potential targets by luciferase assay showed that 10 of
them were likely to be direct targets of miR-143 (Yang et al., 2010). Together,
these data suggest that SILAC analysis can be used to identify proteins that are
directly or indirectly regulated by miRNAs.
4.4.5 Summary and Future Work
Three different methods for identifying miRNA targets were investigated: A
sequence-based method led to predicted lists of targets for the Sfmbt2 miRNA
cluster and miR-92a; conclusions from the PAR-CLIP experimental method were
limited by the technically challenging nature of this analysis; and the SILAC
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method identified proteins that were differentially expressed during a develop-
mental transition, many of which were predicted targets of miRNAs also differ-
entially represented in the transition. Sequenced-based methods of target predic-
tion are convenient, but normally generate very large lists of predicted targets.
It is estimated that each miRNA probably targets several hundred different mR-
NAs (Farh et al., 2005) so a large number of predicted targets are expected, but
it is also known that a significant proportion of sequence-based predictions are
false-positives (Selbach et al., 2008, Baek et al., 2008). Researchers that use
sequence-based target predictions to select candidates for experimental investi-
gation generally select targets that they believe will be functionally important
in the system they are investigating, which introduces a degree of subjectivity
into miRNA target analysis. This approach may miss miRNA targets that have
not been previously associated with a function in the system, and/or lead to
experimental investigation of targets that are not biologically relevant. Further
investigation of the effect of missexpressing miRNAs on the protein levels of tar-
gets predicted by single or multiple prediction programs would provide insight
into whether amalgamating prediction results actually improves the reliability
of target prediction. Experimental methods can be used to narrow down the
list of targets to those more likely to have biological relevance. The use of the
PAR-CLIP method for the identification of direct miRNAs was not successful in
this analysis, and the technically challenging nature of this protocol may render
it unsuitable for routine use in the laboratory. Proteome-based methods such
as SILAC are relatively straightforward, and have been previously used to iden-
tify direct and indirect miRNA targets. Further, SILAC analysis can be used to
identify differential expression of proteins in cell-based models of developmental
transitions. Lists of predicted miRNA targets can then be compared with analy-
sis of differentially expressed proteins and allow focused investigation of potential
miRNA targets that are likely to be biologically relevant. SILAC analysis could
be further extended in this system by missexpression of differentially regulated
miRNAs in undifferentiated or differentiated ZHBTc4 ES cells, and use of the
SILAC method to identify biologically relevant targets of these miRNAs.
Chapter 5
The general role of miRNAs in ES
cell differentiation
5.1 Introduction
The aim of this chapter was to investigate the overall role of the total miRNA
population in developmental transitions. To study the role of miRNAs in general
on cell differentiation, ES cells deficient in mature miRNAs were obtained and
their differentiation potential was compared with the differentiation of wt ES cells.
Differentiation is defined in The Chambers Dictionary as ‘a change by which what
was generalised or homogeneous became specialised or heterogeneous’. Although
the signals and factors involved will differ depending on the differentiation method
and lineage outcome, certain key aspects of ES cell differentiation are likely to
remain the same, e.g. expression of pluripotency genes, including Oct4, Sox2 and
Nanog, will be downregulated. Concomitantly, up regulation of early markers
of differentiation such as the epiblast marker Fgf5 occurs. Cells will become
increasingly specialised in terms of gene expression, growth requirements and
functional capability.
In order to harness the potential of embryonic stem cells, differentiation protocols
for the generation of specific cell types need to be developed. Many previous ad-
vances have resulted from in vivo and in vitro observation of the factors involved
in differentiation. For this reason it is important to understand the factors that
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drive differentiation into particular lineages, including the role of genetic regula-
tors such as miRNAs.
5.1.1 miRNA deficient ES cells
miRNAs are essential for full mammalian development (Bernstein et al., 2003,
Wang et al., 2007) and have been shown to be involved in a number of aspects of
differentiation (reviewed in Ivey & Srivastava, 2010). In order to study the role of
miRNAs in differentiation, a number of groups have generated miRNA-deficient
ES cells. This was achieved by ablation of essential components of the miRNA
biogenesis pathway such as Dicer (Murchison et al., 2005, Kanellopoulou et al.,
2005) and DGCR8 (Wang et al., 2007). Dicer functions during the biogenesis of
miRNAs and siRNAs by cleaving short hairpin RNA molecules to double stranded
RNA molecules in the cytoplasm. DGCR8 functions in the miRNA pathway with
its partner Drosha, ensuring correct processing of pri-miRNAs to pre-miRNAs
in the nucleus. Dicer is involved in processing of miRNAs and siRNAs while
DGCR8 activity is thought to be restricted to miRNA processing. For this reason
DGCR8-/- ES cells were used in this project to investigate the role of miRNAs
in differentiation. However, it must be noted that examples of miRNAs that are
not processed by the canonical pathway have now been documented (Babiarz et
al., 2008). These non-canonical miRNAs are rare but mean that the DGCR8-/-
ES cells still contain a small number of miRNAs.
The DGCR8-/- ES cells were previously generated in the laboratory of Robert
Blelloch at the University of California (Wang et al., 2007). These cells were
created by excision of exon 3 from DGCR8 by sequential targeting of mouse
ES cells. Loss of exon 3 results in a frame shift in the open reading frame of the
DGCR8 transcript and generates several stop codons in downstream exons. Wang
et al. showed that the pre-miRNAs and the mature versions of selected miRNAs
were not present in RNA extracted from DGCR8-/- ES cells. An accumulation of
pri-miR-293 was observed in the DGCR8-/- ES cells (not seen in wt ES cells or
DGCR8+/- ES cells). This is in keeping with the reported function of DGCR8;
processing of miRNAs from pri-miRNA to pre-miRNA.
Wang et al. reported that DGCR8-/- ES cells showed an extended population dou-
bling time relative to wt ES cells although they reported that the cells appeared
Chapter 5. The general role of miRNAs in ES cell differentiation 172
morphologically normal and expressed ES cell marker genes. Additionally, they
reported that the cells showed defects in differentiation following two non-directed
differentiation protocols – EB differentiation and retinoic acid-induced differentia-
tion. The differentiation defect was associated with a failure to fully downregulate
pluripotency markers (Wang et al., 2007). In these experiments, the cells were
grown on a MEF feeder layer and removed from feeders one passage prior to ex-
perimental analysis. We asked the question of whether miRNA-deficient ES cells
could be cultured long-term in the absence of feeder cells and maintain normal
morphology and expression of ES cells markers. In addition, further investigation
was carried out into the differentiation capabilities of miRNA-deficient ES cells,
including their ability to differentiate when subjected to directed differentiation
protocols compared to non-directed methods such as EB differentiation.
5.1.2 Systems for embryonic stem cell differentiation
In order to compare the differentiation capacity of DGCR8-/- ES cells and wt ES
cells non-directed and directed differentiation methods were used. The differenti-
ation methods mentioned below are some of the best-characterised protocols for
ES cell differentiation. For this reason these protocols were used to investigate
the differentiation capacity of miRNA-deficient ES cells.
Arguably the differentiation procedure that most closely replicates early embry-
onic development is 3D suspension culture of ES cells. Embryoid body (EB)
differentiation was first documented by Doetschman et al. (1985), and involves
the culture of ES cells in the absence of both feeders and Lif in suspension where
cells preferentially adhere to one another rather than to the substrate. The ES
cells aggregate to form spheres of cells, which may mimic aspects of early em-
bryonic development including the formation of a visceral endoderm layer, which
precedes formation of cavities called cysts - structures thought to be analogous
to the visceral yolk sac (Doetschman et al., 1985). EBs may also mimic elements
of gastrulation because they show localised Wnt signalling, reminiscent of forma-
tion of a primitive streak-like structure (ten Berge et al., 2008). After a fixed
period of culture in suspension, EBs can be transferred to conditions allowing
their adherence to a fixed surface. This allows observation of further differenti-
ation events such as the differentiation of beating cardiomyocytes and neurons.
During EB differentiation, cell types from all three germ layers are generated. As
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a result this method is often used as an initial test to determine the differentiation
potential of ES cells and iPS cells. Despite being non-directed, multiple studies
of EB differentiation have concluded that it represents a relevant model of early
embryonic development (Doetschman et al., 1985, ten Berge et al., 2008). As a
result there are now numerous directed differentiation methods that utilise EB
differentiation as part of the protocol (reviewed in Desbaillets et al., 2000).
Over recent years protocols have been derived for the directed differentiation of
ES cells into a broad range of cell types including cardiomyocytes, hematopoietic
cells and dopaminergic neurons (reviewed in Murry and Keller, 2008). One of
the best-characterised systems to date is that of neural differentiation. Bmp
normally acts through induction of ID proteins to inhibit neural differentiation
and neural differentiation can be induced in ES cells simply by removal of BMP
signalling (Ying et al., 2003). A standard method for neural differentiation is to
transfer ES cells from growth in serum + Lif conditions to low-density growth in
the serum free media, N2B27 (Lowell et al., 2006). However, even in this well-
characterised system, a significant proportion of ES cells still resist differentiation,
which may be due to inherent heterogeneity of embryonic stem cell populations
(Canham et al., 2010). The question of why some cells resist commitment in
stringent differentiation conditions needs to be answered for the generation of
safe populations of cells for therapeutic use.
One differentiation system that does generate a relatively homogeneous popula-
tion of differentiated cells is the ZHBTc4 ES cell model system. The ZHBTc4 ES
cell system was the first system for the differentiation of trophectoderm from ES
cell cultures and has been discussed in Chapter 3 (Niwa et al., 2000). It relies
on genetic modification of ES cells to allow rapid downregulation of Oct4, which
results in upregulation of Cdx2 and other trophectoderm marker genes. Down-
regulation of Oct4 can also be achieved by transfection of Oct4 specific short
interfering RNA in ES cells (Hay et al., 2004). This method has been shown to
result in upregulation of the trophectoderm-associated gene Cdx2 in mouse ES
cells, providing a second means of inducing trophectoderm differentiation.
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5.2 Aims of Chapter 5
In order to examine the role of the general miRNA population in ES cell dif-
ferentiation the primary aim of this chapter was to compare the differentiation
capabilities of DGCR8-/- ES cells with those of wt ES cells using non-directed
and directed differentiation methods.
5.3 Results
5.3.1 Validation of the DGCR8-/- ES cell line
5.3.1.1 Transfer of DGCR8-/- ES cells to feeder-free culture conditions
DGCR8-/- ES cell were generated by Robert Blelloch’s laboratory at the Univer-
sity of California and obtained from Novus Biologicals. Cells were grown on a
mitotically inactivated layer of mouse embryonic fibroblasts, which were derived
from E12.5 or E13.5 mouse embryos. Initially the cells grew very slowly and were
passaged every 3 or 4 days. On the second passage a vial of cells was frozen in
10% DMSO, 50% FCS in ES cell media. Cells were further expanded for transfer
to growth on gelatin and freezing of multiple stock vials of cells.
Initially, DGCR8-/- ES cells were grown on feeders, as suggested by the labora-
tory in which they originated (Wang et al., 2007). However, growth of ES cells
on feeder cells is undesirable for several reasons: potential contamination of ex-
perimental samples with fibroblast cells, undefined conditions and more labour
intensive cell culture. For these reasons, DGCR8-/- ES cells were transferred to
culture on gelatin-coated tissue culture plastic. A culture of DGCR8-/- ES cells
growing on a feeder layer was dissociated and plated in a gelatin-coated tissue
culture treated T25 flask. Initially, cells grew slowly and were passaged every 4
days. DGCR8-/- ES cells were expanded on gelatin for 3 passages before feeder-
free stocks of cells were frozen for long-term storage. After removal from growth
on a feeder layer, wt ES cells are frequently observed to go through a ‘crisis’ with
increased cell death and high levels of differentiation. Although DGCR8-/- ES
cells appeared to grow at a slightly slower rate immediately after transfer, cells
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did not differentiate and no increase in cell death was observed suggesting that
no ‘crisis’ occurred in these cells after transfer to growth on gelatin. The growth
rate of DGCR8-/- appeared to be affected by the plating density. When plated
at a similar density to wt ES cells the DGCR8-/- ES cells showed slowed growth
compared to growth following plating at a higher density. Therefore, in general,
DGCR8-/- cultures were passaged every 2 days at a 1:3 split ratio, in comparison
to wt ES cells, which were passaged every 2 days at a 1:6 split ratio. DGCR8-/-
ES cells could be continuously passaged in the absence of a feeder layer for at
least 20 passages.
5.3.1.2 Generation of DGCR8-/- ES cell clones
It was necessary to subclone the DGCR8-/- ES cells because of recurring problems
of wt contamination within the DGCR8-/- cultures. This problem occurred in two
different batches of cells received from Novus Biologicals, but the source of the
contamination is not known. Because wild type cells grow at a much-increased
rate compared to DGCR8-/- ES cells (see Figure 5.5 ) they rapidly dominated
the miRNA-deficient cultures. Early passage DGCR8-/- ES cells were plated at
clonal density and left to grow. After >30 days 16 of 500 plated cells (3.2%) had
grown into colonies of ES cells. This was a much lower proportion than the 116
clones that grew from 250 plated CGR8 ES cells (46.4%). Twelve DGCR8-/- ES
cells clones were picked and expanded and when enough material was available,
RNA was extracted from the cells and used to generate cDNA. QPCR analysis of
synthesised cDNA from DGCR8-/- ES cell clones and wt ES cells showed that wt
ES cells expressed DGCR8 but all 12 DGCR8-/- clones were deficient for DGCR8
expression (Figure 5.1 ). Further QPCR analysis for expression of ES cell marker
genes showed that the clones had variable levels of expression of Oct4 and Nanog
relative to levels in wt ES cells (Figure 5.1 ). Four clones (DGCR8-/- clone 3,
DGCR8-/- clone 4, DGCR8-/- clone 6 or DGCR8-/- clone 9) were selected for use
in future experiments that represented the variation in expression of Nanog and
Oct4. Further experimental repeats would be required to determine whether the
variation in Oct4 and Nanog expression between clones is stable or a result of
slight differences in culture conditions of the different clones. To ensure that
DGCR8-/- ES cell cultures were not contaminated with significant proportions
of wt ES cells, all experiments within this chapter were carried out using either
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Figure 5.1 – Gene expression in DGCR8-/- ES cell clones. QPCR analysis of expression
of Dgcr8 (blue), Oct4 (red) and Nanog (green) in E14 ES cells and 12 different DGCR8-/-
ES cell clones (subclones). Gene expression was normalised to b-Actin expression and is
shown relative to expression in E14 ES cells. N=1.
early passages of the original DGCR8-/- ES cell line (original stock) or the newly
derived DGCR8-/- ES cells (subclones). For each experiment the figure legend
indicates whether DGCR8-/- ES cells were from the original stock or newly derived
subclones.
5.3.1.3 Analysis of DGCR8 and miRNAs expression in DGCR8-/- ES
cells
Although the cell line was generated by disruption of exon 3 of DGCR8, Wang
et al. (2007) did not confirm loss of DGCR8 protein directly, but indirectly
through the loss of miRNAs in the DGCR8-/- cells. Therefore, the expression of
DGCR8 protein was examined in wt and DGCR8-/- ES cell cultures. ES cells
were cultured in conditions that would maintain the undifferentiated state and
conditions that would induce differentiation (as embryoid bodies). Protein was
extracted and used for Western analysis of DGCR8 expression. Western analysis
confirmed that DGCR8 protein was present in undifferentiated wt ES cells and in
wt ES cells that had been induced to differentiate. In contrast, no DGCR8 protein
expression was detected in undifferentiated or differentiated DGCR8-/- ES cells
although it must be noted that these data arise from a single experiment (Figure
5.2a). To ensure that DGCR8-/- cultures were free from contamination with wt
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cells, DGCR8-/- cultures were routinely screened to ensure absence of DGCR8.
In order to develop a simple and reliable method of screening cells for DGCR8
deficiency, a QPCR assay was developed with primers designed to amplify exon
3 of DGCR8. Primer optimisation was carried out on pooled cDNA derived from
wt ES cell cultures. Optimisation QPCR was performed on a series of cDNA
dilutions over a range of 1x106 fold. The primer pair was considered suitable for
use because it amplified a single product over a 10,000-fold range with 104.8%
efficiency and a ‘goodness of fit’ (RSq) of 0.978. Primer sequences can be found
in Materials and Methods. Table 5.1 contains a list of optimisation details for all
primer pairs used in Chapter 5. Following primer optimisation, RNA was isolated
from cultures of wt ES cells and DGCR8-/- ES cells and used to generate cDNA.
QPCR amplification of cDNA from wt ES cells using the primers specific to exon
3 of DGCR8 showed product amplification (Figure 5.2b). In DGCR8-/- ES cells
exon 3 of DGCR8 has been removed so no PCR amplification should occur. As
expected, no product amplification was observed in DGCR8-/- ES cells (Figure
5.2b). In order to confirm that absence of amplification was not due to absence
of cDNA within the DGCR8-/- ES cell sample, QPCR was also performed using
primers specific to b-Actin. b-Actin was amplified from both wt and DGCR8-/-
cDNA samples confirming that cDNA was present within the DGCR8-/- sample
(data not shown).
DGCR8-/- ES cells should not express canonical miRNAs. In order to confirm
loss of expression of miRNAs in DGCR8-/- ES cells, RNA was extracted from
cultures of two wt ES cell lines (E14 and CGR8), DGCR8-/- ES cells, primary
mouse embryonic fibroblasts (MEFs) and a fibroblast cell line called 3T3, and
used for Northern analysis of miRNA expression. MiR-294 is highly expressed
in ES cells, but is not expressed in most differentiated cell types (Medeiros et al.,
2011). As expected, although miR-294 was expressed in both wt ES cell lines,
no miRNA expression was detected in DGCR8-/- ES cells, or in fibroblast cells
(Figure 5.2c). It was possible that lack of expression of miR-294 in DGCR8-/-
ES cells was due to differences between wt ES cells and DGCR8-/- ES cells rather
than a specific deficiency of miRNA processing in DGCR8-/- ES cells. Therefore,
the expression of other miRNAs was also investigated. Figure 5.2c shows that
miR-199a is expressed in fibroblast cells, but not in wt ES cells or in DGCR8-/- ES
cells. This showed that DGCR8-/- ES cells do not express miRNAs associated with
fibroblast cells and that there was no miRNA contamination from MEFs in the
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Figure 5.2 – Expression of DGCR8 and miRNAs in DGCR8-/- ES cells. (a) Western
analysis for expression of DGCR8 and b-ACTIN in E14 and CGR8 ES cells and four
DGCR8-/- ES cell clones (subclones), and in day 16 EBs generated from these cell lines.
N=1. (b) QPCR amplification plots (MxPro) for expression of DGCR8 in E14 ES cells and
DGCR8-/- ES cells (original stock). Triplicate reactions are shown. (c) miRNA northern
analysis for expression of miR-294, miR-199a, miR-467a* and U6 using 5ug of total RNA
from E14 ES cells, CGR8 ES cells, DGCR8-/- ES cells (original stock), primary mouse
embryonic fibroblasts (MEFs) and 3T3 cells. N=1.
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Table 5.1 – Optimisation details for QPCR primers used in Chapter 5
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feeder-free DGCR8-/- ES cell cultures. Additionally, miR-467a* was expressed
in both wt ES cells and fibroblasts, but no expression was detected in RNA from
DGCR8-/- ES cells. While these data strongly suggest that DGCR8-/- ES cells do
not express mature miRNAs it must be noted that these data are from a single
experiment and conclusions are therefore preliminary. All together, these data
suggest that DGCR8-/- ES cells do not express Dgcr8 RNA, DGCR8 protein or
mature miRNAs.
5.3.1.4 Can transient expression of DGCR8 rescue miRNA expression
in DGCR8-/- ES cells?
The DGCR8-/- ES cells were obtained and cultured with the ultimate aim of
investigating the role of the general miRNA population in ES cell differentiation.
However, there is a possibility that differences may arise between different ES
cell lines during their derivation from single cells (Wang et al., 2007), which may
introduce clonal variation. To evaluate whether differences between wt ES cells
and DGCR8-/- ES cells were due to the absence of miRNAs alone, rescue of
DGCR8 expression in DGCR8-/- ES cells was attempted.
Figure 5.3a shows a schematic map of a DGCR8 expression vector containing the
cDNA for human DGCR8, which was obtained from Addgene (Addgene plasmid
10921, Landthaler et al., 2004). Because this vector produced human DGCR8,
it was necessary to first confirm that expression of human DGCR8 could rescue
miRNA expression in DGCR8-/- mouse ES cells. The protein sequences of human
and mouse DGCR8 were compared using ClustalW2 (Larkin et al., 2007), which
showed that the proteins were 95.6 % identical in amino acid sequence (Alignment
is shown in Appendix E). In order to test whether this level of similarity was
sufficient to allow human DGCR8 to compensate for a lack of mouse DGCR8,
DGCR8-/- ES cell cultures were transiently transfected overnight with either the
DGCR8 expression vector or an empty vector control. RNA was harvested from
DGCR8-/- ES cells at the time of transfection (T0) and 24, 48, 72 and 96 hours
after transfection as well as from wt ES cells (+ve), and was used for northern
analysis of expression of miR-294, which is normally expressed in mouse ES cells
(Figure 5.3b). Wt ES cells expressed miR-294, but DGCR8-/- ES cells at T0
showed no expression of miR-294. No expression of miR-294 was observed at
any timepoint following transfection of empty vector into DGCR8-/- ES cells. In
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Figure 5.3 – Expression analysis of miR-294 in DGCR8-/- ES cells transfected with a
DGCR8 expression vector. (a) Vector diagram of Addgene human DGCR8 expression
vector 10921 (b) miRNA northern analysis for expression of miR-294 and U6 in 5ug
of total RNA from E14 ES cells (+ve control) and DGCR8-/- ES cells (original stock)
transfected with 2ug/ml empty vector (E) or DGCR8 expression vector (D) and harvested
after increasing lengths of time. N=1.
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contrast, transfection of the vector expressing human DGCR8 resulted in rescue
of expression of miR-294 in DGCR8-/- ES cells at all timepoints investigated
(Figure 5.3b). This shows that transient expression of human DGCR8 is sufficient
to rescue loss of miRNA expression in DGCR8-/- ES cells.
In order to attempt to generate a line of DGCR8-/- ES cells that stably expressed
human DGCR8, DGCR8-/- ES cells were transfected with either linearised or
circular DGCR8 expression vectors or with empty vector or a vector expressing
EGFP. After 48 hours cells were replated at clonal density and 48 hours later
puromycin was added to cultures in order to select for clones that had taken up
the vector. After 15-17 days clones expressing the empty vector (>100 clones
from 5x105 transfected cells = >0.02% efficiency) or the EGFP expression vector
(>200 clones from 5x105 transfected cells = >0.04% efficiency) were large enough
to transfer to 96-well plates. These clones were expanded and vials of cells were
frozen for storage. No stable clones expressing the DGCR8 expression vector
were recovered. The experiment was repeated but again no clones expressing the
DGCR8 expression vector were recovered. The reason for the failure to generate
a rescue clone is not clear; possible explanations include toxicity of high levels of
expression of DGCR8 or a cloning efficiency that was too low to yield a clone from
the number of cells initially transfected. Because a DGCR8-/- ES cell rescue clone
was not generated, in this thesis chapter experimental results from DGCR8-/- ES
cells were compared with results from two wt ES cell lines, with the caveat that
some differences may be attributable to clonal variation of the DGCR8-/- ES cell
line rather than absence of the general miRNA population.
5.3.2 Characterisation of DGCR8-/- ES cells
5.3.2.1 Morphological analysis of DGCR8-/- ES cells
It was noted that the morphology of the DGCR8-/- ES cells on gelatin was differ-
ent to that of wt ES cells (compare Figures 5.4a & Figure 5.4c with Figure 5.4d)
although when grown on a feeder layer DGCR8-/- ES cell cultures were morpho-
logically similar to what is seen for wt ES cells (Figure 5.4b). DGCR8-/- ES cells
had a flatter morphology and appeared to have a larger cytoplasmic to nuclear
ratio than wt cells. Additionally, the DGCR8-/- cultures often had space between
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Figure 5.4 – The morphology of DGCR8 k/o ES cells. (a-d)Bright-field images of wt
and DGCR8-/- ES cells (original stock) at x100 magnification. (a) E14 ES cells growing on
gelatin-coated tissue culture treated plastic. (b) DGCR8-/- ES cells (original stock) growing
on a mitotically inactivated layer of MEFs. (c) CGR8 ES cells growing on gelatin-coated
tissue culture treated plastic. (d) DGCR8-/- ES cells (original stock) growing on gelatin-
coated tissue culture treated plastic. (e-h) Images of IHC staining for E-CADHERIN
(red) and DAPI (blue) on wt (e & g) and DGCR8-/- ES cells (subclones) (f & h) at x400
magnification. N=1.
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cells, rather than existing as the tightly packed domed colonies characteristic of
wt ES cells.
E-CADHERIN is expressed highly in undifferentiated mouse ES cells and is crit-
ical for their cell-cell adhesion (Larue et al., 1996). E-CADHERIN null ES cells
are defective in cell aggregation, reminiscent of the morphology of DGCR8-/- ES
cells. To see if the morphological differences between wt and DGCR8-/- cells were
reflected in changes in E-CADHERIN expression, DGCR8-/- ES cells and wt ES
cells were grown in standard ES cell conditions and fixed in 4% PFA for immuno-
histochemical analysis of E-CADHERIN expression (Figure 5.4e-h). Although
the distribution of E-CADHERIN seemed normal in DGCR8-/- ES cells, in that
expression was cytoplasmic with enrichment at the boundaries between cells sim-
ilar to what was seen in wt ES cells, the overall expression level appeared higher.
While results were consistent across both wt cell lines and both DGCR8-/- ES cell
lines it must be noted that conclusions from this data are preliminary because
they arise from a single experiment.
5.3.2.2 Establishing the proliferation rate of DGCR8-/- ES cells
In addition to morphological differences, it has been reported that miRNA-
deficient ES cells grow at a slower rate than wt cells (Wang et al., 2007). To
establish whether or not this difference was maintained under feeder-free condi-
tions, cultures of wt ES cells and DGCR8-/- ES cells were grown in standard ES
cell conditions in 96-well plates and were subjected to MTT analysis of cell pro-
liferation 24, 48, 72 and 96 hours after plating. Cell numbers increased over time
in wt and DGCR8-/- ES cell cultures, but the increase was much greater in the
wt ES cell cultures than the DGCR8-/- ES cell cultures with wt ES cell doubling
rates approximately twice that of DGCR8-/- ES cell doubling rates (Figure 5.5 ).
Wild type doubling rates were consistent with that observed by Wang et al. (~16
hours) but Wang et al. reported doubling rates of DGCR8-/- ES cells to be ~21-23
hours whereas these data suggest a doubling time of >24 hours. The observed
differences in doubling rates is difficult to rationalise because cell densities and
sampling times were approximately similar between the two analyses. However,
the cell proliferation analysis in the Wang et al. paper was carried out on cells
that had been directly removed from a feeder layer whereas the cells in our anal-
ysis were grown permanently in the absence of feeder cells. Perhaps differences
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Figure 5.5 – CYQUANT analysis of wt and DGCR8-/- ES cell proliferation. Bar chart
showing relative absorbance at 485nm of E14, CGR8 and DGCR8-/- ES cells (original stock)
from CYQUANT analysis. Readings are an average of 12 replicates, were normalized to
blank wells and are shown relative to absorbance at 24 hours. Error bars show standard
deviation.
in proliferation rates are reflective of differences between cells that have recently
been removed from a feeder layer, and those that have adapted to feeder-free
growth.
5.3.2.3 Expression analysis of ES cell marker gene and signalling pathway
components in DGCR8-/- ES cells
Wild type ES cells express characteristic markers of pluripotency. DGCR8-/- ES
cells had previously been shown to express a limited set of ES cell markers. To
determine how similar DGCR8-/- cells were to wt ES cells, this characterisation
was extended at the RNA and protein levels. Cells were cultured in standard ES
cell media and harvested for RNA or protein. RNA was used to generate cDNA
for QPCR analysis of Oct4, Sox2, Nanog, Stella and Rex1 expression. Oct4, Sox2,
Rex1 and Stella were expressed at similar levels in DGCR8-/- ES cells relative to
levels in wt ES cells (Figure 5.6a). However, Nanog was expressed at almost twice
the level in DGCR8-/- ES cells seen in wt ES cells. This finding was reproducible
and statistically significant as assessed by Student T-Test (p<0.01).
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Protein samples were also harvested from cell cultures and used for Western anal-
ysis of OCT4 expression and expression of key signalling pathway components.
Western analysis confirmed that protein levels of the key ES cell pluripotency
gene, OCT4, were equivalent between both wt ES cell lines and all 4 different
DGCR8-/- ES cell clones (Figure 5.6b). The expression of the key signalling
pathway components GSK3B, STAT3, AKT and ERK and their phosphorylated
forms was compared by Western analysis of protein from wt and DGCR8-/- ES
cells (Figure 5.6b). Western analysis was performed on protein from four dif-
ferent DGCR8-/- ES cell clones and from wt ES cell lines. The expression of
phosphorylated forms of GSK3B, STAT3, AKT and ERK1/2 were compared
with expression levels of the total protein. Analysis of ß-ACTIN expression was
used to ensure that similar levels of total protein were being compared. Ex-
pression levels of phosphorylated forms of GSK3B, STAT3, AKT and ERK were
similar in DGCR8-/- ES cells and wt ES cells. This was also the case for ex-
pression levels of the total protein. However, it must be noted that the antibody
for phosphorylated STAT3 detected phosphorylation at serine residue 727 but
phosphorylation of STAT3 normally associated with maintaining pluripotency is
at tyrosine residue 705 (Niwa et al., 1998). Therefore, differences in activation of
the STAT3 pathway due to Lif signalling would not have been picked up by this
analysis.
These results demonstrated that, in terms of marker gene expression and sig-
nalling pathway activation, DGCR8-/- ES cells are similar to wt mouse ES cells.
This suggests that miRNAs are not required for the normal expression of key
pluripotency markers or activation of signalling pathways associated with the
pluripotent state. However, IHC analysis of E-CADHERIN expression suggested
that expression of this protein may be higher in DGCR8-/- ES cells than wt ES
cells, and Nanog RNA was expressed at higher levels in DGCR8-/- ES cells than
in wt ES cells. Therefore, DGCR8-/- ES cells show differences in expression of
some ES cell-related genes compared to wt ES cells.
Nanog was expressed at a consistently higher level in DGCR8-/- ES cells com-
pared to wild type ES cells. This observation was explored further at the cellular
level. While OCT4 is expressed uniformly in undifferentiated ES cells, NANOG
expression is normally heterogeneous in ES cell cultures (Chambers et al., 2003,
Singh et al., 2007). The possibility that the increased expression of Nanog mRNA
in the DGCR8-/- ES cells may be due to a reduction in heterogeneity of expression
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Figure 5.6 – Expression of ES cell genes and signaling pathway components in DGCR8-/-
ES cells and wt ES cells. (a) QPCR analysis for ES cell genes in E14 ES cells, CGR8 ES
cells and DGCR8-/- ES cells (subclones). QPCR readings were normalized to expression
of the housekeeping gene, b-Actin and corrected values are shown relative to expression in
E14 ES cells. Error bars are SEM. **=p<0.01. Data shows mean of at least 2 E14 and
CGR8 replicates and at least 3 DGCR8-/- replicates. (b) Western analysis for expression
of OCT4, signaling pathway components and b-ACTIN on protein from 1x106 CGR8 ES
cells, E14 ES cells and 4 different DGCR8-/- clones (subclones).
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Figure 5.7 – IHC analysis of OCT4 and NANOG expression in wt and DGCR8-/- ES
cells. Photographs of DAPI staining of nuclei (blue) and IHC for OCT4 (green) and
NANOG (red) expression in E14 ES cells, CGR8 ES cells and 2 different clones of DGCR8-/-
ES cells (subclones). Photographs are representative of two independent experiments.
Magnification is x100.
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in these cells was considered. In order to test this idea, immunohistochemistry
to visualise NANOG expression was performed in DGCR8-/- ES cells and wt ES
cells. Cultures were co-stained for OCT4 to identify undifferentiated cells. Het-
erogeneous NANOG expression could therefore be visualised by comparing the
proportions of NANOG +ve/OCT4 +ve cells (yellow) with NANOG –ve/OCT4
+ve cells (green). Figure 5.7 shows that there is greater heterogeneity in NANOG
expression in wt cultures than in DGCR8-/- cultures indicated by a greater pro-
portion of green OCT4 stained nuclei than yellow co-stained nuclei. Figure 5.7
shows images representative of two experimental repeats of OCT4/NANOG im-
munohistochemistry staining of 2 wt ES cell lines and multiple DGCR8-/- ES cell
clones. These data suggest that miRNAs may be required for maintaining the
cyclic expression of NANOG that is normally seen in ES cell cultures.
5.3.3 Differentiation of DGCR8-/- ES cells
5.3.3.1 Analysis of gene expression following siRNA knockdown of
Oct4 expression
Chapter 3 of this thesis described the results of investigating the role of miR-
NAs during trophectoderm differentiation of ES cells. In the initial analysis,
trophectoderm differentiation was induced in the ZHBTc4 ES cell line through
rapid downregulation of Oct4 (Niwa et al., 2000) but can also be induced in
wt ES cells by transfection of siRNAs targeting Oct4 (Hay et al., 2004). This
method was used to test whether DGCR8-/- ES cells were capable of differenti-
ating into trophectoderm, as assessed by upregulation of a panel of trophoblast
marker genes.
siRNAs designed to inhibit expression of Oct4 or EGFP (as control) were trans-
fected into wt E14 ES cells, ZHBTc4 ES cells and DGCR8-/- ES cells. ZHBTc4
ES cells grown in the presence of doxycycline differentiate rapidly into trophec-
toderm and were used as positive controls. In ZHBTc4 cultures morphological
changes were observed after as little as 24 hours of growth: areas of the cultures
became flat and the boundaries between cells were less obvious. 72 hours after the
initial transfection similar morphological changes were observed in the cultures
transfected with Oct4 siRNA but not in those transfected with a siRNA designed
to inhibit EGFP expression (Figure 5.8 ).
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Figure 5.8 – The morphology of wt and DGCR8-/- ES cells following siRNA knockdown of
Oct4 expression. Bright field photographs of E14 ES cells, ZHBTc4 ES cells and DGCR8-/-
ES cells (original stock) 72 hours after transfection of 100ng/ml siRNA targeting Oct4 or
EGFP (control). Positive control for differentiation is ZHBTc4 ES cells grown in the pres-
ence of 1mM doxycycline. Photographs are representative of three replicates. Magnification
is x100.
Chapter 5. The general role of miRNAs in ES cell differentiation 191
Figure 5.9 – Expression of ES and TE genes following siRNA knockdown of Oct4 ex-
pression in ES cells. QPCR analysis for markers of pluripotency (top) and trophectoderm
differentiation (bottom) after EGFP knockdown (light grey), in ZHBTc4 ES cells grown
in the presence of 1 mM doxycycline (dark grey), and in ZHBTc4 ES cells (blue), E14 ES
cells (green) and DGCR8-/- ES cells (original stock - red) after transfection with 100ng/ml
siRNA targeting Oct4. QPCR readings were normalized to expression of the housekeeping
gene, b-Actin and corrected values are shown relative to expression after EGFP knockdown
(light grey). Error bars are SEM, n=3.
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RNA was extracted from the cultures 72 hours after transfection of siRNA oligonu-
cleotides and used to make cDNA for QPCR analysis of expression of ES cell and
TE marker genes (Figure 5.9 ). ZHBTc4 ES cells grown in the presence of doxy-
cycline showed marked downregulation of ES cell genes compared to ZHBTc4 ES
cell cultures transfected with siRNA targeting EGFP, which were grown in the
absence of doxycycline. They also showed upregulation of the TE marker genes
Cdx2, Hand1, Mash2 and Id2. Following siRNA knockdown of Oct4 expres-
sion, the ES cell markers Oct4 and Sox2 were downregulated in ZHBTc4, E14
and DGCR8-/- cultures, and Nanog and Esrrb were downregulated in ZHBTc4
and DGCR8-/- cultures relative to cultures transfected with EGFP siRNA. Con-
versely, expression of multiple trophoblast markers (Cdx2, Eomes, Hand1, Mash2
and Id2 ) was up regulated after transfection of Oct4 siRNA relative to EGFP
siRNA in wt and DGCR8-/- cultures. These data show that DGCR8-/- ES cells
are capable of downregulating expression of ES cell marker genes and up regu-
lating expression of trophoblast marker genes to the same extent as wt ES cells
after Oct4 knockdown and suggests that miRNAs are not required for initiation
of TE differentiation. A recent paper from Robert Blelloch’s laboratory, which
showed that miRNAs are not required for pre-implantation blastocyst formation
(and therefore initiation of TE formation), supported this finding (Suh et al.,
2010).
5.3.3.2 Examination of the morphology and gene expression in DGCR8-/-
ES cells subjected to a neural differentiation protocol
The capacity for miRNA-deficient ES cells to undergo neural differentiation was
investigated using a neural differentiation method that was developed in our
laboratory. Two wt ES cell lines and 4 DGCR8-/- ES cell clones were grown
on laminin in N2B27 media supplemented with 0.25uM PD0325901 and 1.5uM
CHIR99021 for 7 days. After 7 days cultures were fixed in 4% PFA and expression
of the early neural marker NESTIN, and the mature neural marker TUJ1 were
visualised by immunohistochemistry (Figure 5.10 ). Tuj is a marker of mature
neurons only when the cell expressing TUJ1 also displays a neural morphology,
with long thin processes protruding from it. As can be seen from Figure 5.10,
both wt and miRNA-deficient ES cells were capable of producing cells with a
neural morphology that were positive for TUJ1. QPCR analysis of cDNA from
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Figure 5.10 – IHC analysis of NESTIN and TUJ1 expression in wt ES cells and
DGCR8-/- ES cells subjected to a neural differentiation protocol. (a-e) Photographs of
IHC staining for DAPI (blue), NESTIN (green) and TUJ1 (red) expression in cultures
grown in N2B27 with 0.25uM PD0325901 and 1.5uM CHIR99021 for 7 days. Photographs
are from a single experiment and show cultures from 2 wild type ES cell lines - E14 (a) and
CGR8 (b) and 3 different clones of DGCR8-/- ES cells (subclones) (c-e). Magnification is
x400. (f) Quantitation of IHC photographs by cell counting. Bar graphs show percentage
of NESTIN positive or TUJ1 positive cells relative to DAPI stained cells. 3 photographs
were counted per well. DGCR8-/- result is average of clone 3, clone 6 and clone 9 counts.
Error bars show standard deviation.
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parallel cultures confirmed the DGCR8-deficient status of the DGCR8-/- cultures
(data not shown).
It appeared that the DGCR8-/- cultures produced a smaller proportion of NESTIN-
positive neural precursors than wt cultures. In order to quantitate this the num-
ber of Dapi stained cells, NESTIN positive cells and TUJ1 positive neural cells
were counted. Three randomly selected areas were counted per well of differ-
entiated cells. It should be noted that counts were only performed on areas of
culture that contained TUJ1 positive neurons so will overestimate the proportion
of NESTIN positive and TUJ1 positive cells in the total culture. Figure 5.10f
shows the average percentages of cells that stained positive for either NESTIN
or TUJ1. The two wild type cultures differed in their capacity to make mature
neurons, E14 ES cells produced a greater proportion of NESTIN-positive neural
precursors, but a lower proportion of TUJ1 positive neurons than CGR8 ES cells.
The DGCR8-/- ES cell clones produced similar proportions of TUJ1 positive neu-
rons but a much lower proportion of NESTIN-positive neural precursors than wild
type cultures. These data suggest that some form of neurogenesis can occur in
the absence of miRNAs, but that miRNAs may be involved in regulating aspects
of normal neurogenesis including maintenance of neural progenitor populations.
These conclusions are preliminary because data is from a single experimental
analysis.
5.3.3.3 Comparison of the differentiation of embryoid bodies from wt
and DGCR8-/- ES cells
DGCR8-/- ES cells appear to be able to undergo some level of differentiation down
the trophectoderm and neuroectoderm lineages as a result of directed differentia-
tion. Therefore the question of whether miRNAs were required for differentiation
into other lineages using an undirected differentiation method was asked. Embry-
oid body (EB) differentiation is a general differentiation method, which is capable
of generating cells belonging to the three germ lineages. EBs were made from
wt ES cells and from miRNA deficient ES cells and grown in suspension for 8
days, followed by growth in adherent culture for a further 8 days. Cultures were
harvested and RNA prepared from cells from the starting population of ES cells
(T0) and from cells collected at days 4, 8, 12 and 16 of EB differentiation. Differ-
ences in morphology were observed between wild type and miRNA-deficient EBs
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(Figure 5.11 ). DGCR8-/- EBs were generally smaller than wt EBs, and never
formed cysts during suspension culture. It is thought that primitive endoderm
forms on the surface of embryoid bodies and this allows an inner layer of columnar
epithelium to form that surrounds a fluid filled cavity thought to be functionally
analogous to the visceral yolk sac (Weitzer, 2006). The total absence of such
‘cysts’ in DGCR8-/- embryoid bodies suggests a problem with formation of this
structure, which may be due to an inability to properly specify primitive endo-
derm. When transferred to adherent culture, cells from the EBs did not spread
across the plate to the same extent as cells from wt EBs; the plated DGCR8-/-
EBs remained small with a tight area of cell outgrowth containing cells that re-
sembled those of an ES-like morphology or a much more flattened morphology
akin to that of trophoblast-like cells. In contrast the wt EB outgrowths were very
heterogeneous in appearance.
RNA was extracted from samples collected at various timepoints during EB differ-
entiation. Following cDNA synthesis, QPCR was performed to determine levels
of transcripts of markers of different lineages. In wt ES cells Fgf5 levels peak in
expression on day 4 and then decline throughout the remainder of the differentia-
tion timecourse (Figure 5.12 ). This could be expected as Fgf5 expression is seen
to increase upon Lif withdrawal (Martinez-Ceballos et al., 2005). In contrast, in
DGCR8-/- ES cells the peak in Fgf5 expression occurs at day 8 and levels remain
high during differentiation. Maintenance of Fgf5 expression may indicate that
miRNA-deficient ES cells are initiating early differentiation but failing to progress
to more advanced stages.
Previous experiments indicated that miRNA-deficient ES cells could initiate tro-
phectoderm differentiation upon siRNA knockdown of Oct4 expression displaying
a 10-fold increase in the expression of the TE marker gene, Cdx2. During embry-
oid body differentiation of wt ES cells, Cdx2 expression increased up to a peak
at day 8 of differentiation and then declined through the remainder of the differ-
entiation timecourse (Figure 5.12 ). In DGCR8-/- EBs Cdx2 expression increased
throughout differentiation, peaking at day 12 and remaining high at day 16. This
suggests that DGCR8-/- EBs are capable of trophectoderm differentiation, but
that differentiation may occur at a slower rate than in wt EBs.
Proper early embryonic development is characterised by the specification of the
three germ lineages: ectoderm, endoderm and mesoderm. In order to assess the
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Figure 5.11 – The morphology of wt and DGCR8 /- embryoid bodies. Bright field pho-
tographs of embryoid bodies generated from E14 ES cells and DGCR8 /- ES cells (sub-
clones). Photographs show embryoid bodies in suspension at day 4 and day 8 of differen-
tiation, and in adherent culture at day 12 and day 16 of differentiation. Photographs are
representative of 4 experimental replicates for E14 ES cells and 5 experimental replicates
for DGCR8 /- ES cells. Magnification is x40.
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Figure 5.12 – Expression of lineage marker genes during EB differentiation of wt ES
cells and DGCR8 -/- ES cells. QPCR analysis for expression of the epiblast marker Fgf5,
the trophectoderm marker Cdx2 and the neuroectoderm marker Nestin during embryoid
body differentiation of E14 ES cells (blue) CGR8 ES cells (green) and DGCR8-/- ES cells
(subclones - red). QPCR readings were normalized to expression of the housekeeping gene,
b-Actin and corrected values are shown relative to expression in E14 ES cells at T0. Error
bars are SEM, E14 n=4, CGR8 n=3, DGCR8-/- n=5.
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overall differentiation capacity of DGCR8-/- ES cells, expression of markers of
each of these lineages was assessed during EB differentiation, and compared to
levels in wt ES cells. The expression of Nestin, a marker of neuroectodermal
differentiation, was variable during differentiation of EBs from wt ES cells and
induction of expression varied between approximately 2-fold and 8-fold. In con-
trast, Nestin expression remained relatively constant in EBs from DGCR8-/- ES
cells and expression was not induced by greater than 3-fold during the differen-
tiation timecourse (Figure 5.12 ). This was consistent with the finding in Figure
5.10, which showed that the proportion of NESTIN positive cells was lower in
cultures of DGCR8-/- ES cells induced to differentiate down the neural lineage
compared to the proportion of cells from wt cultures. However, cells with neural
morphology were observed in later cultures of wt and DGCR8-/- EBs suggesting
that some form of neural differentiation does occur in miRNA-deficient cultures
following non-directed EB differentiation.
Gata4 and Gata6 are genetic markers of the endoderm lineage. Gata4 expres-
sion was rapidly induced and maintained at 50-80-fold above T0 levels in wt
ES cells, but in DGCR8-/- ES cells Gata4 levels were induced and maintained
throughout the differentiation timecourse at only 20-fold above the level in E14
T0 cultures (Figure 5.13 ). More strikingly, while expression of Gata6 was also
rapidly induced in wt EBs and was maintained at levels 150-fold higher than in
E14 T0 samples, expression in DGCR8-/- EBs did not reach E14 T0 levels un-
til day 12 of differentiation, and then increased to an expression level that was
only 30-fold greater than in the E14 T0 sample (Figure 5.13 ). These findings
suggest a deficiency in proper endoderm specification in miRNA-deficient EBs.
The observation that DGCR8-/- EBs never formed cysts supports this conclusion,
because differentiation of primitive endoderm is thought to be essential for cyst
formation.
The mesoderm marker Brachyury was dramatically induced early in wt EB dif-
ferentiation, with a peak in expression at day 4 of differentiation. In contrast,
Brachyury expression was never detected in DGCR8-/- ES cells and remained
undetectable at day 4 of embryoid body differentiation (Figure 5.14a). Very low
levels of Brachyury expression were present in 2 of the 5 DGCR8-/- EB differenti-
ation replicate timecourses at day 8 of differentiation and in 4 of the 5 timecourses
at days 12 and 16 of differentiation. The expression of Snail, a regulator of epithe-
lial to mesenchymal transition, was induced and maintained in DGCR8-/- EBs
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Figure 5.13 – Expression of endoderm marker genes during EB differentiation of wt ES
cells and DGCR8 /- ES cells. QPCR analysis for expression of the endoderm markers
Gata4 and Gata6 during embryoid body differentiation of E14 ES cells (blue) CGR8 ES
cells (green) and DGCR8-/- ES cells (subclones - red). QPCR readings were normalized
to expression of the housekeeping gene, b-Actin and corrected values are shown relative to
expression in E14 ES cells at T0. Error bars are SEM, E14 n=4, CGR8 n=3, DGCR8-/-
n=5.
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similar to what was observed for wt EBs although the induction was of a smaller
magnitude. In wt EBs, Snail expression peaked at 6-8-fold higher than the level
in the E14 T0 sample, but in DGCR8-/- ES cells the induction peaked at only
3-fold (Figure 5.14b). Expression of the mesoderm marker, Goosecoid, was in-
duced to a similar extent in EBs from E14 and DGCR8-/- ES cells although a
greater induction in expression was observed in CGR8 EBs at day 4 of differenti-
ation (Figure 5.14b). Overall, these data suggest that DGCR8-/- EBs may have
a particular deficiency in aspects of mesoderm differentiation. This conclusion
was supported by the observation that although between 40% and 50% of plated
wt EBs contained beating cardiomyocytes, beating cardiomyocytes were never
observed in DGCR8-/- EBs (Figure 5.14b).
In order to investigate the expression of signalling pathway components in wt and
DGCR8-/- cultures induced to differentiate, EBs were made from wt ES cells and
from DGCR8-/- ES cells and grown in suspension for 8 days, followed by adherent
culture for a further 8 days. At day 16 of differentiation, protein was harvested
from cultures and used for western analysis of expression of signalling pathway
components (Figure 5.15 ). Expression of signalling molecules was similar be-
tween EBs from CGR8 ES cells and E14 ES cells. Additionally, the expression
of pGSK3B and GSK3B was similar in EBs from wt ES cells and four clones of
DGCR8-/- ES cells. In contrast, pSTAT3 (ser727) and STAT3 were expressed at
lower levels in miRNA-deficient EBs than wt EBs. In ES cells, phosphorylated
STAT3 is associated with the maintenance of pluripotency, but it is also associ-
ated with differentiation during embryonic development (Calo et al., 2003). The
fact there is less phosphorylated STAT3 in miRNA deficient EBs substantiates
the finding that expression of differentiation markers is generally lower than in
wt EBs. The reduced level of phosphorylated STAT3 is likely to be a result of re-
duced differentiation in DGCR8-/- EBs, but there is also evidence to suggest that
it could represent the cause of the differentiation deficiency (Foshay et al., 2005).
The levels of AKT and ERK were similar between wt and DGCR8-/- EBs, but the
active versions of these molecules, pAKT and pERK, were generally expressed
at lower levels in DGCR8-/- EBs than in wt EBs. Signalling through the ERK
pathway is known to have a pro-differentiative effect in ES cells (Burdon et al.,
1999), interesting in the context of reduced expression in DGCR8-/- EBs because
of their reduced differentiation capacity. The function of AKT is normally asso-
ciated with cell survival and proliferation (Brazil et al., 2004). Perhaps reduced
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Figure 5.14 – Expression of mesoderm marker genes during EB differentiation of wt ES
cells and DGCR8 -/- ES cells. (a) QPCR analysis for expression of the mesoderm mark-
ers Brachyury, Snail and Goosecoid during embryoid body differentiation of E14 ES cells
(blue) CGR8 ES cells (green) and DGCR8-/- ES cells (subclones - red). QPCR readings
were normalized to expression of the housekeeping gene, b-Actin and corrected values are
shown relative to expression in E14 ES cells at T0. Error bars are SEM, E14 n=4, CGR8
n=3, DGCR8-/- n=5. (b) Bar graph showing percentage of embryoid bodies containing
beating cardiomyocytes at day 12 of differentiation for E14 ES cells, CGR8 ES cells and
4 different clones of DGCR8-/- ES cells (subclones). Result is mean percentage from 6
different cultures containing >10 EBs per culture. Error bars show standard deviation.
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Figure 5.15 – Expression of signaling pathway components in wt and DGCR8-/- EBs.
Western analysis for expression of signaling pathway components and b-ACTIN on protein
from day 16 EBs generated from CGR8 ES cells, E14 ES cells and 4 different DGCR8-/-
clones (subclones). Numbers show expression signal in each band relative to signal in E14
EBs after normalization to b-ACTIN expression.
Chapter 5. The general role of miRNAs in ES cell differentiation 203
activation of the AKT pathway partly explains the observation that DGCR8-/-
EBs are smaller than wt EBs.
5.3.3.4 Analysis of expression of ES cell marker genes during embryoid
body differentiation of wt and DGCR8-/- ES cells
In order to investigate the expression of pluripotency genes in differentiating wt
and DGCR8-/- ES cells, EBs were made from wt ES cells and from DGCR8-/-
ES cells and grown in suspension for 8 days, followed by adherent culture for
a further 8 days. Cultures were harvested and RNA prepared from cells from
the starting population of ES cells (T0) and from cells collected at days 4, 8,
12 and 16 of EB differentiation. RNA was used to generate cDNA for QPCR
analysis of ES cell genes. Figure 5.16a shows that expression of Oct4, Sox2
and Nanog is downregulated during EB differentiation of E14 ES and CGR8 ES
cells. However, expression of Oct4, Sox2 and Nanog is maintained during the
differentiation timecourse in EBs from DGCR8-/- ES cells. Indeed, Sox2 and
Nanog expression increased relative to E14 T0 levels during EB differentiation
of DGCR8-/- cultures. Protein was harvested from parallel cultures of day 16
EBs from CGR8, E14 and DGCR8-/- ES cells and used for western analysis of
OCT4 expression. OCT4 protein was not detectable in day 16 EBs from either
wt cell line but was readily detectable in day 16 EBs from 4 different DGCR8-/-
ES cell clones (Figure 5.16b). This finding confirmed that OCT4 expression is
not downregulated during DGCR8-/- EB differentiation.
This result suggested two possibilities: either differentiating DGCR8-/- ES cells
co-express markers of differentiation and pluripotency, or the cells remain in an
ES cell-like state and simply fail to differentiate. In order to distinguish between
these possibilities IHC analysis was performed on cells from wt and DGCR8-/-
EBs. EBs were formed from CGR8 ES cells, E14 ES cells and DGCR8-/- ES
cells. At T0 and at day 2, 4, 6 and 8 of EB differentiation, cells were dissociated
to a single-cell suspension, plated as a monolayer and fixed for IHC analysis
of expression of the pluripotency marker, OCT4 and the differentiation marker,
NESTIN. IHC analysis showed that a large proportion of DGCR8-/- cells were
still expressing OCT4 protein after 8 days of EB differentiation, whereas most wt
cells did not express OCT4 but did express the differentiation marker NESTIN
(Figure 5.17a).
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Figure 5.16 – Expression of pluripotency marker genes during EB differentiation of wt and
DGCR8-/- ES cells. QPCR analysis for the pluripotency markers Oct4, Sox2 and Nanog
during embryoid body differentiation of E14 ES cells, CGR8 ES cells and DGCR8-/- ES
cells (subclones). QPCR readings were normalized to expression of the housekeeping gene,
b-Actin and corrected values are shown relative to expression in E14 ES cells at T0. Error
bars are SEM, E14 n=4, CGR8 n=3, DGCR8-/-n=5.
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Figure 5.17 – IHC analysis of OCT4 and NESTIN expression in differentiating EBs from
wt and DGCR8-/- ES cells. (a) Photographs of IHC for OCT4 (green) and NESTIN (red)
in E14 ES cells and DGCR8-/- ES cells (subclones), and after 8 days of EB differentiation
of each ES cell line. Magnification is x100. (b) Quantitiation of IHC analysis of OCT4
and NESTIN expression during embryoid body differentiation of E14 ES cells, CGR8 ES
cells and DGCR8-/- ES cells (subclones). The number of OCT4 positive (green), NESTIN
positive (red), co-stained (yellow) and unstained (grey) cells were counted at T0 and at 2,
4, 6 and 8 days of differentiation. Each pie chart segment represents the mean percentage
of cells that stained for each marker. 3 photographs were counted per well of cells. N=2
experimental replicates.
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IHC analysis of OCT4 and NESTIN expression was carried out on CGR8, E14 and
DGCR8-/- cells at T0 and at day 2, 4, 6 and 8 of EB differentiation. Photographs
of cells were taken and the numbers of DAPI positive, OCT4 positive, NESTIN
positive, double positive and total cells were counted. Figure 5.17b shows pie
charts of the proportion of the cell populations staining for different proteins
through differentiation. In wt cultures, the proportion of OCT4 positive cells
decreased during differentiation, and the proportion of NESTIN positive cells
increased and then decreased (CGR8) or stabilised (E14). Additionally, CGR8
ES cells showed greater expression of NESTIN than E14 ES cells at earlier time
points through differentiation. This may suggest that CGR8 ES cells cultures are
pre-disposed to differentiate down the neural lineage because of a bias towards
this lineage in the starting population of ES cells. In contrast to the findings
from the wt EBs, a large proportion of cells from DGCR8-/- EBs remained OCT4
positive throughout the differentiation timecourse. Some DGCR8-/- cells became
NESTIN positive showing that these cells are capable of differentiation although
the proportion was lower than that of wt cultures. Cells co-stained for OCT4 and
NESTIN expression were observed in wt and DGCR8-/- cultures. Importantly, the
proportion of cells co-stained for OCT4 and NESTIN was not higher in DGCR8-/-
cultures than wt cultures. In fact, the proportion of co-stained cells at day 6 and
day 8 of DGCR8-/- differentiation was similar to that seen at day 2 and day 4 of wt
differentiation. Together, these results show that maintenance of ES cell marker
expression is not due to large proportions of DGCR8-/- ES cells co-expressing
pluripotency and differentiation markers and that DGCR8-/- ES cells are capable
of downregulating pluripotency markers and upregulating differentiation markers
at the single cell level. However, even in differentiation inducing conditions a
large proportion of DGCR8-/- ES cells remain undifferentiated, characterised by
continued expression of pluripotency markers.
5.3.3.5 Expression of ES cell and differentiation marker genes in wt
and DGCR8-/- ES cells cultured in different conditions
In order to investigate the reason behind impaired differentiation of the DGCR8-/-
ES cells the ES cells themselves were assessed for expression of pluripotency and
differentiation markers by QPCR after growth in different conditions for 24 hours.
Following growth in standard ES cell media, wt and DGCR8-/- ES cell cultures
Chapter 5. The general role of miRNAs in ES cell differentiation 207
Figure 5.18 – Expression of ES cell and lineage marker genes in wt and DGCR8-/- ES
cells grown in different culture conditions. QPCR analysis for the pluripotency markers
Oct4 and Nanog, the epiblast marker Fgf5, the endoderm marker Gata4, the mesoderm
marker Brachyury (T) and the neuroectoderm marker Nestin in E14 ES cells (dark blue),
CGR8 ES cells (light blue) and DGCR8-/- ES cells (subclones - red). Cells were cultured
in normal ES cell media, washed twice with PBS and then grown for 24 hours in either
normal ES cell media (serum + Lif), ES cell media without Lif (serum – Lif), N2B27 media
supplemented with 1.0uM PD0325901 and 3.0uM CHIR99021 (2i) or N2B27 media alone
(N2B27). QPCR readings were normalized to expression of the housekeeping gene, b-Actin
and corrected values are shown relative to expression in E14 ES cells in serum + Lif. Error
bars are SEM. In +lif: CGR8 n=3, E14 n=3, DGCR8-/- n=6, in 2i: CGR8 n=3, E14 n=3,
DGCR8-/- n=5, in –lif and N2B27: CGR8 n=2, E14 n=2, DGCR8-/- n=3.
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were washed twice in PBS and then one of four different medias was added to
cultures. The cultures were either grown in standard ES cell media (serum +
Lif) or in media with serum but without the Lif cytokine. Removal of Lif from
the culture media normally induces differentiation of ES cells after several days.
Cells were grown without Lif for 24 hours to see if early changes in marker gene
expression could explain the defects in differentiation observed in DGCR8-/- ES
cells. Cells were also grown in 2i media, which is supposed to maintain ES cells in
a ‘ground state’, and in N2B27, which is the base media for 2i, and is reported to
induce neural differentiation of ES cells. After 24 hours of growth in the different
medias RNA was harvested from the cultures and used to generate cDNA for
QPCR analysis of marker gene expression (Figure 5.18 ).
Oct4 expression was similar in CGR8 ES cells, E14 ES cells and DGCR8-/- ES
cells in all four medias. This shows that even in conditions inducing differentia-
tion (serum – Lif and N2B27) Oct4 expression does not change after 24 hours.
However, expression of Nanog decreased after 24 hours of growth in differentiation
inducing conditions (serum – Lif and N2B27) compared to growth in conditions
that maintained pluripotency (serum + Lif and 2i). The level of Nanog expres-
sion was consistently higher in DGCR8-/- ES cell cultures. Nevertheless, the
decrease in Nanog expression upon transfer to differentiation inducing conditions
was observed in CGR8, E14 and DGCR8-/- ES cell cultures. Fgf5 is a marker
of epiblast and expression increases on Lif withdrawal from ES cell cultures. As
expected, Fgf5 expression increased in wt ES cell cultures grown in serum – Lif
and N2B27 media for 24 hours. Additionally, Fgf5 expression decreased when
cultures were transferred to growth in 2i media, consistent with the cells being in
a ‘ground state’ and not expressing even early markers of differentiation. Inter-
estingly, Fgf5 expression was much lower in DGCR8 /- ES cells than in wt ES
cells and expression did not increase significantly upon transfer to differentiation
inducing conditions. In all conditions, the early mesoderm and epiblast marker
Brachyury was undetectable in DGCR8-/- ES cells whereas it was expressed in wt
ES cells. Expression of the endoderm marker Gata4 remained constant in CGR8
and E14 ES cell cultures. Strikingly, expression of Gata4 was significantly higher
in DGCR8-/- ES cell cultures than both wt cultures in all conditions. This may
suggest that Gata4 expression is normally under miRNA control in ES cells or
that DGCR8-/- ES cells contain some cells with an endodermal-like identity. Ex-
pression of the neural differentiation marker Nestin was similar between E14 ES
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cells and DGCR8-/- ES cells in all four conditions. CGR8 ES cells showed consis-
tently higher Nestin expression in all conditions, which may suggest that CGR8
ES cells cultures are biased towards differentiating down the neural lineage.
5.4 Discussion
The primary aim of this chapter was to examine the role of the general miRNA
population in ES cell differentiation through comparison of DGCR8-/- ES cells
and wt ES cells. When comparing DGCR8-/- ES cell cultures with wt ES cell cul-
tures two differences were immediately apparent: a difference in morphology and
a slower proliferation rate in the DGCR8-/- ES cells. In addition, it was shown
that DGCR8-/- ES cell cultures express NANOG homogenously compared to het-
erogenous expression in wt ES cells, show deficiencies in silencing self-renewal
when exposed to differentiation stimuli, and that markers of differentiation were
expressed differently in DGCR8-/- ES cell and wt ES cells in standard culture
conditions and during differentiation.
5.4.1 miRNA-deficient ES cells are morphologically different
from wt ES cells
DGCR8-/- ES cells were transferred from growth on feeder cells (MEFs) to feeder-
free conditions and it was observed that when grown in the absence of feeders
DGCR8-/- ES colonies appeared much flatter than those of their wt counter-
parts and contained cells that were loosely packed together. It was surprising
to find that both DGCR8-/- ES cells and Dicer-/- ES cells have been previously
described as morphologically normal (Wang et al., 2007, Kanellopoulou et al.,
2005). However, in these reports the cells were grown on a feeder layer rather
than on gelatin-coated tissue culture plastic, which may account for the differ-
ences in morphology of the cells. Indeed, in this chapter it is observed that, when
grown on a feeder layer, DGCR8-/- ES cells appeared similar in morphology to
wt ES cells with tightly packed, domed colonies. It is probable that the phys-
ical constraints of feeder-associated culture, where ES cell colonies must grow
between feeder cells, provides the simple explanation for this. In these conditions
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DGCR8-/- ES cells may be forced to grow in close proximity to one another giving
the appearance of tightly packed domed colonies. An alternative explanation is
that the feeder layer is producing a factor required for proper cell-cell adhesion
of ES cells in the absence of miRNAs.
It was hypothesised that the morphological difference observed between DGCR8-/-
and wt ES cells, grown in the absence of feeders, may be due to aberrant expres-
sion of E-CADHERIN because E-CADHERIN null ES cells lose cell-cell contacts
and grow more dispersed that wt ES cells, similar to the phenotype of DGCR8-/-
ES cells (Larue et al., 1996). Although E-CADHERIN had a normal expression
pattern in the DGCR8-/- ES cells its expression level appeared higher in DGCR8-/-
ES cell cultures than in wt ES cell cultures. This finding was difficult to ratio-
nalise in the context of a reduction of cell-cell contact in DGCR8-/- ES cells and
could be explained by two possibilities: Differences in morphology between wt
ES cells and DGCR8-/- ES cells may be explained by elevated expression of E-
CADHERIN by an as yet unknown mechanism; or the morphological differences
are due to defects in another, uncharacterised mechanism of cell adhesion in ES
cells.
As well as differences in morphology, there was a clear difference in proliferation
rate between DGCR8-/- ES cells and wt ES cells, with DGCR8-/- ES cells growing
at a slower rate. This has been previously observed in both DGCR8-/- ES cells
(Wang et al., 2007) and Dicer-/- ES cells (Kanellopoulou et al., 2007, Murchison et
al., 2005) showing a clear role for miRNAs in maintaining the rapid proliferation
of ES cells. The reduction in proliferation rate in DGCR8-/- ES cells is associated
with an accumulation of the cells in the G1 phase of the cell cycle (Wang et
al., 2007). Introduction of miRNAs belonging to the miR-290 family was shown
to rescue the slow proliferation rate of DGCR8-/- ES cells by suppressing key
regulators of the G1/S transition (Wang et al., 2008). In contrast to the finding
that miR-92a is a regulator of ES cell proliferation (Chapter 3, this thesis), Wang
et al. did not observe rescue of the proliferation defect upon introduction of this
miRNA into DGCR8-/- ES. However, this experiment was carried out as part of
a large scale screening strategy of 266 different miRNAs so perhaps subtle affects
on cell proliferation of individual miRNAs may have been missed.
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5.4.2 miRNAs are not required for maintenance of ES cell
pluripotency
QPCR analysis of expression of the ES cell marker genes Oct4, Sox2, Rex1 and
Stella showed similar expression levels in DGCR8-/- ES cell and wt ES cell cultures
suggesting that miRNAs are not required for maintenance of pluripotency gene
expression. These data are supported by previous findings: Oct4 has previously
been reported to be expressed at similar levels in Dicer-/- ES cells compared to
wt ES cells (Kanellopoulou et al., 2005) and in DGCR8-/- ES cells compared to
wt ES cells (Wang et al., 2007). Additionally, the expression of Sox2, Rex1 and
Nanog has been demonstrated in DGCR8-/- ES cells although the analysis was
non-quantitative (Wang et al., 2007). The finding that the pluripotency gene
Oct4 shows normal expression in the absence of miRNAs also agrees with in
vivo findings. Analysis of Oct4 expression in DGCR8-/- blastocyst stage embryos
showed normal expression in cells of the ICM (Suh et al., 2010).
Interestingly, while the expression levels of the majority of key pluripotency genes
were similar in DGCR8-/- ES cells and wt ES cells, Nanog was expressed at ap-
proximately twice the level in the DGCR8-/- ES cell cultures as in wt ES cell
cultures. Immunohistochemistry for OCT4 and NANOG showed robust expres-
sion of both proteins in individual DGCR8-/- ES cells and wt ES cells. NANOG
is normally expressed heterogeneously in ES cells but IHC analysis revealed that
NANOG expression is homogeneous in DGCR8-/- ES cells than wt ES cells. These
findings may be due to the absence of specific miRNAs, as several miRNAs are
known to target Nanog : miR-134 (Tay et al., 2008b), miR-296 and miR-470 (Tay
et al., 2008a) in DGCR8-/- ES cells. Perhaps direct regulation by these miRNAs
normally regulates the cyclical expression of NANOG that is observed in wt cells.
On the other hand, homogeneous NANOG expression may be an indirect result
of cellular change imposed by the loss of the miRNA population. This result has
not been reported in any other analyses of miRNA-deficient ES cells although the
presence of Nanog expression has been previously demonstrated in DGCR8-/- ES
cells (Wang et al., 2007).
In addition to expression of key ES cell pluripotency markers DGCR8-/- ES cells
were found to activate similar signalling pathways as wt ES cells. These data
support the proposition that DGCR8-/- ES cells retain key features of ES cells.
Furthermore, DGCR8-/- ES cell colonies can be grown from a single cell (albeit at
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much reduced frequency), which is a property of ES cells. These cells obviously
provide a good model system for the analysis of the role of miRNAs in ES cell
differentiation and developmental transitions.
These results suggest that, at least superficially, miRNAs are not required to
maintain ES cell pluripotency per se. This conclusion comes from several ob-
servations: (i) the expression levels of key ES cell genes are similar between
DGCR8-/- and wt ES cells; (ii) DGCR8-/- ES cells robustly express OCT4 and
NANOG protein; (iii) DGCR8-/- ES cells activate similar signalling pathways to
wt ES cells; and (iv) DGCR8-/- ES cells can be propagated clonally.
The likelihood that miRNAs are not required for the pluripotent state is inter-
esting in the context of the ‘ground state’ hypothesis. Austin Smith’s laboratory
propose that ES cells exist in a ground state and can maintain a pluripotent state
indefinitely if shielded from the appropriate pro-differentiative stimuli (Ying et al.,
2008). In the ground state hypothesis, ES cells are intrinsically self-maintaining.
DGCR8-/- ES cells have lost expression of almost all mature miRNAs and yet they
continue to proliferate and maintain expression of key pluripotency genes. The
fact that ES cells devoid of miRNA regulation still behave largely like their wt
counterparts suggests that complex genetic regulation is not required for the ES
cell state and may support the hypothesis that ES cells represent an intrinsically
self-maintaining state.
5.4.3 miRNAs are required for silencing self-renewal
The original description of DGCR8-/- ES cells pointed to an inability of these
cells to downregulate pluripotency markers during EB differentiation. QPCR
analysis of expression of pluripotency genes during embryoid body differentia-
tion confirmed that, in miRNA-deficient ES cells, expression does not decrease
during differentiation. This finding is supported by previous reports of an inabil-
ity to downregulate pluripotency markers during EB differentiation of DGCR8-/-
ES cells, DICER-/- ES cells and AGO2-/- ES cells (Wang et al., 2007, Kanel-
lopoulou et al., 2005, Chandra Shekar et al., 2011). A surprising finding was that
the expression of the pluripotency markers Sox2 and Nanog increased during
EB differentiation of DGCR8-/- ES cells. If the process of exiting self-renewal is
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blocked, as it appears to be in DGCR8-/- ES cells, perhaps the EB microenviro-
ment is permissive or even preferable for the maintenance of pluripotency marker
gene expression.
IHC analysis of individual cells from EBs showed that a failure to downregulate
pluripotency gene expression during differentiation is not due to co-expression of
differentiation and pluripotency markers in individual cells, but is due to failure
of individual cells to escape pluripotency. This implies that the cells are not
silencing self-renewal factors and remain in a pluripotent state for longer even in
the absence of self-renewal stimuli. The conclusion that miRNAs are required for
silencing self-renewal is supported by data from Wang et al., which shows that,
when plated at clonal density, DGCR8-/- ES cells form more alkaline positive
colonies that wt ES cells both in the presence and absence of Lif (Wang et al.,
2007). Wang et al. reported that in the absence of Lif, almost 100% of DGCR8-/-
colonies were alkaline positive compared to <20% of wt colonies suggesting, as
for the data presented in this chapter, that individual DGCR8-/- cells were failing
to silence self-renewal. The inability to silence self-renewal genes observed in
DGCR8-/- ES cells also occurs in Dicer-/- ES cells (Kanellopolou et al., 2005) and
is thought to be at least partly due to an inability of the cells to methylate the
Oct4 promoter on differentiation due to upregulation of Rbl2, a repressor of de
novo DNA methyltransferases (Dnmts) (Sinkkonen et al., 2008).
However, other data presented in this chapter shows that it is functionally possi-
ble for DGCR8-/- ES cells to downregulate ES cell markers. Firstly, IHC analysis
showed that not all miRNA-deficient ES cells were OCT4 positive after 8 days
of embryoid body differentiation, suggesting that OCT4 expression had been si-
lenced in these cells. Secondly, siRNA knockdown of Oct4 in DGCR8-/- ES cells
led to downregulation of not only Oct4, but also Sox2 and Nanog by approxi-
mately 50%. In the event of forced downregulation of a key ES cell pluripotency
gene it appears that expression of other key pluripotency genes can also be desta-
bilised, even in the absence of miRNAs. This is perhaps unsurprising, given that
the key ES cell genes are known to function as part of a regulatory network with
feed-forward and autoregulatory loops (Loh et al., 2006). However, it may also
suggest that one function of miRNAs during differentiation is to destabilise the
network of key ES cell regulatory genes, and so initiate their collective downreg-
ulation. While it has been previously published that miRNA-deficient ES cells
fail to downregulate pluripotency markers during EB differentiation (Wang et al.,
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2007, Kanellopoulou et al., 2005, Chandra Shekar et al., 2011), and retinoic acid
induced differentiation (Wang et al., 2007), the ability of miRNA-deficient ES
cells to downregulate pluripotency genes upon knockdown of key pluripotency
genes has not been reported. Because of this, and because of the report that
miRNA-deficient ES cells cannot methylate the Oct4 promoter (Sinkkonen et al.,
2008), it would be interesting to investigate whether the repression of pluripo-
tency genes is stable following siRNA knockdown of Oct4.
Overall, it can be concluded that, compared to wt ES cells, pluripotency genes
are not downregulated upon undirected differentiation of miRNA-deficient ES
cells, and that this is due to an inability of individual cells to silence self-renewal.
However, it is functionally possible for individual cells to downregulate expression
of pluripotency markers and general downregulation of pluripotency marker gene
expression occurs upon destabilisation of the pluripotency network. Although
further work is needed to confirm that downregulation of pluripotency genes
is stable in miRNA-deficient ES cells, these data suggest the conclusion that
miRNA-deficient ES cells are incapable of silencing self-renewal is premature.
5.4.4 miRNAs are required for proper ES cell differentiation
The differentiation capacity of DGCR8-/- ES cell was examined in comparison
to wt ES cells by three differentiation methods: trophectoderm differentiation
induced by siRNA k/d of Oct4 ; neural differentiation induced by a serum-free
culture method; and embryoid body differentiation. In both the trophectoderm
and neural differentiation experiments, DGCR8-/- ES cells differentiated into the
expected lineage as defined by analysis of morphology and marker gene expression.
This may suggest that miRNAs are not required for the initiation of trophecto-
derm or neuroectoderm differentiation and/or that miRNA-deficient ES cells are
capable of differentiating down particular lineages if directed differentiation meth-
ods are used. siRNA knockdown of Oct4 and serum-free neural differentiation
‘force’ undifferentiated cells into a particular cell type so it is perhaps unsurpris-
ing that trophectoderm and neurons can be generated from miRNA-deficient ES
cells. It has previously been shown that DGCR8-/- embryos can initiate trophec-
toderm differentiation in vivo, forming blastocysts with normal distributions of
Cdx2 positive TE and OCT4 positive ICM cells (Suh et al., 2010). Later in de-
velopment, however, Ago2-null mice have hypertrophic placentas with a marked
Chapter 5. The general role of miRNAs in ES cell differentiation 215
reduction in the thickness of the labyrinthine layer (Cheloufi et al., 2010). Addi-
tionally, Dicer ablation in the mouse neocortex leads to defects in neural survival
and differentiation (De Pietri Tonelli et al., 2008). This shows that although it
may be possible for some level of trophectoderm and neural differentiation to
occur from DGCR8-/- ES cells, it is doubtful that these cells are functionally
equivalent to cells generated from ES cells with miRNAs. Substantiating this,
Spruce et al. found that Dicer null embryos could not maintain the TS cell com-
partment although differentiated trophoblast cell types were observed (Spruce et
al., 2010).
Embryoid body differentiation is largely undirected and should result in the dif-
ferentiation of cells into the three germ lineages. It was found that DGCR8-/-
ES cells expressed normal levels of the trophectoderm gene Cdx2, but induction
of neuroectoderm, endoderm and mesoderm marker gene expression was either
absent, delayed or markedly reduced in the DGCR8-/- embryoid bodies. Analysis
of EB differentiation in miRNA-deficient ES cell has been reported previously
and supports the data presented here: Dicer-/- EBs are reported to show no ex-
pression of the endoderm marker Hnf4 or the mesodermal markers Brachyury,
Bmp4 and Gata1 during differentiation (Kanellopoulou et al., 2005); and Wang
et al. reported that EBs from DGCR8-/- ES cells exhibited reduced or delayed
expression of the endoderm marker Hnf4, the mesoderm marker Brachyury and
the neuroectoderm marker Sox1 (Wang et al., 2007). Although some evidence of
neural differentiation was observed in DGCR8-/- embryoid bodies, they did not
form cysts, possibly suggesting a potential defect in primitive endoderm forma-
tion, and never formed beating bodies, illustrating an obvious defect in cardiomy-
ocyte differentiation. These data showed that embryoid bodies do not undergo
proper germ layer differentiation in the absence of miRNAs. This conclusion is
supported by the findings of Spruce et al. who examined gene expression dur-
ing early development of Dicer-/- embryos. They found that, in the absence of
miRNAs, initiation of gastrulation and mesoderm formation did occur, but was
delayed with respect to wt embryos and that there was a failure to elongate the
primitive streak (Spruce et al., 2010). Therefore, although some aspects of nor-
mal development are observed in Dicer-/- embryos, progression of patterning was
abnormal.
Induction of expression of the early differentiation marker, Fgf5, was delayed in
EBs from DGCR8-/- ES cells and expression was maintained throughout differen-
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tiation, rather than being downregulated as it was in EBs from wt ES cells. This
suggested that the observed defects in DGCR8-/- EB differentiation might be
due to defects in early differentiation. In order to investigate the reason behind
impaired differentiation of DGCR8-/- ES cells, the expression of pluripotency and
differentiation markers was assessed in these cells after 24 hours of growth in
conditions supporting pluripotency or inducing differentiation. Fgf5 expression
did not increase in DGCR8-/- ES cells immediately after Lif withdrawal as it did
in wt ES cells. These data suggest that the differentiation deficiencies seen in
DGCR8-/- ES cells may originate from a defective Fgf5 response to the removal
of self-renewal stimuli.
Interestingly, Fgf5 expression was markedly lower in DGCR8-/- ES cells relative
to wt ES cells. This supports the Nanog data in suggesting that miRNA-deficient
ES cells may be in a more naïve state that wt ES cells. Fgf5 is an early marker
of primitive ectoderm differentiation, and its expression increases in wt ES cells
as a result of Lif withdrawal (Martinez-Ceballos et al., 2005). A low level of Fgf5
expression may indicate that DGCR8-/- ES cells contain a smaller proportion
of cells that are primed to differentiate. Furthermore, while Fgf5 expression
markedly decreased in wt ES cells upon transfer to 2i media, it did not decrease
in DGCR8-/- ES cells. It is thought that ES cells grown in 2i media are in a more
naïve state than those grown in serum + Lif conditions and the finding that wt
expression of Fgf5 decreases upon transfer from serum + Lif to 2i conditions
supports this. The finding that Fgf5 expression did not decrease upon transfer
of DGCR8-/- ES cells from growth in serum + Lif to 2i conditions supports the
proposition that these cells already exist in a more naïve state than wt ES cells.
Another gene expressed in the epiblast, called Brachyury, which also marks meso-
derm, is easily detected in wt ES cells by QPCR, but is undetectable in DGCR8-/-
ES cells. This may support the hypothesis that DGCR8-/- ES cells are in a more
primitive state that wt ES cells, or it may point simply to a potential deficiency
in mesoderm differentiation in these cells. However, while the neuroectoderm
marker Nestin is expressed at similar levels in DGCR8-/- ES cells and wt ES
cells, the endoderm marker Gata4 is found at between 5 and 8 fold higher levels
in DGCR8-/- ES cells. This may point to the DGCR8-/- ES cells being in a state
that is predisposed to differentiate into endoderm, or it may suggest that nor-
mally Gata4 is regulated by expression of a miRNA or miRNAs in ES cells. Our
data point to the latter option because another marker of endoderm, Gata6, does
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not show increased expression in DGCR8-/- ES cell relative to wt ES cells (from
EB differentiation data). Additionally, the expression of Gata4 in ES cells is not
indicative of a state that is observed in vivo: GATA4 is not normally expressed
in the embryo until the mid-blastocyst stage and then rarely co-stains with cells
positive for the pluripotency marker, NANOG (Plusa et al., 2008).
Together, these data suggest that the differentiation deficiencies observed in
DGCR8-/- ES cells could be due to two possibilities: either the DGCR8-/- ES
cell culture is in a naïve state that cannot respond appropriately to differentia-
tion stimuli; or the culture exists in a state ‘primed’ for endoderm differentiation,
which compromises its differentiation capability. For the following reasons it is
believed that the former of these two options is more likely to be true: (i) expres-
sion of NANOG is elevated and homogeneous in DGCR8-/- cultures compared
to wt cultures, reminiscent of ‘naïve’ wt ES cell cultures; (ii) expression of the
primitive ectoderm marker Fgf5 is markedly reduced in DGCR8-/- cultures com-
pared to wt cultures and does not increase upon removal of Lif from the culture
media; (iii) DGCR8-/- cultures show increased expression of only one differentia-
tion marker gene, and another marker gene of the same lineage is not elevated in
expression in DGCR8-/- cultures; and (iv) differentiation of DGCR8-/- cultures is
not biased to one particular lineage.
5.4.5 Summary and Future Research
The data in this chapter suggest that miRNAs are not required for the main-
tenance of the ES cell state, but that they are required for efficient exit from
self-renewal. This may be due to an inability of miRNA-deficient ES cell to
destabilise the pluripotency network by silencing key pluripotency genes, partic-
ularly Nanog, during EB differentiation. Further investigation into the reason
for homogeneous expression of NANOG in miRNA-deficient ES cells, and exper-
iments forcing its downregulation prior to differentiation protocols, would help
to determine whether elevated Nanog expression is the cause or an effect of the
inability of miRNA-deficient ES cells to silence self-renewal.
These data also show that miRNAs are required for proper differentiation of lin-
eages derived from all three germ layers during embryoid body differentiation,
but that ES cells deficient for miRNAs can be induced to initiate trophectoderm
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and neuroectoderm differentiation by stringent differentiation protocols. With
the finding that differentiation into mesoderm and endoderm lineages was par-
ticularly compromised during embryoid body differentiation, it would be inter-
esting to investigate if these lineages could be generated from miRNA-deficient
ES cells by directed differentiation methods. The data presented here suggest
that miRNA-deficient ES cells exist in a naïve state that is unable to respond
to early differentiation stimuli. Further investigation into this possibility may




The process of embryonic development, whereby an organism develops from a
single cell to a complex form consisting of highly specialised structures, tissues
and cell types, is truly remarkable and far from being understood. In order for
correct development to proceed, tight temporal and spatial regulation of gene
expression is essential. Investigation of the factors that control developmental
transitions, including the regulation of gene expression, will not only provide
insight into the processes of normal and abnormal embryonic developmental, but
may also lead to the establishment of an unlimited source of specialised cell types
and organs for therapeutic benefit.
Because the process of embryonic development is so complex, it is likely that gene
expression is controlled at multiple levels to ensure that it remains tightly con-
trolled throughout development, even if errors arise at one level of genetic regula-
tion. Some means of regulating gene expression, such as control of transcription,
translation and protein modification, have long been established. Recently, an en-
tirely novel level of regulation has been described – post-transcriptional regulation
of gene expression by microRNAs (miRNAs). miRNAs were initially discovered
as regulators of development in nematode worms, and have since been shown to
be essential for embryonic developmental of numerous organisms. Therefore, the
primary aim of this thesis was to investigate the roles of miRNAs in regulating
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mammalian developmental transitions. This final discussion will detail how the
findings presented here, along with the findings of others, support a model where
miRNAs primarily function to ensure canalisation during development.
6.2 Two possible roles for miRNAs in development
As post-transcriptional regulators of gene expression, miRNAs are likely to play
roles in most, if not all, developmental transitions. Two of the possible ways
in which miRNAs may function during development are as master regulators of
developmental transitions, and to ensure canalisation during development. The
term ‘canalisation’ was first coined by C. H. Waddington to describe a process “as
to bring about one definite end-result regardless of minor variations in conditions
during the course of the reaction” (Waddington, 1942). In other words, the
process of canalisation ensures robust outcomes from developmental transitions
in the face of perturbations arising from environmental changes and/or differences
in gene expression.
While some miRNAs act as master regulators of developmental transitions, for
example, lin-4 regulation of progression from C. elegans larval stage 1 to larval
stage 2 (Lee et al. 1993), it is believed that most miRNAs function during mam-
malian development to fine-tune developmental transitions. The general miRNA
population is clearly essential for proper embryonic development in numerous
species, including mice (Wienholds et al., 2003, Reinhart et al., 2000, Bernstein
et al., 2003, Brennecke et al., 2003). However, mice deficient for single miRNAs
or families of miRNAs often do not show early embryonic lethality, and several
are viable into adulthood (Medeiros et al., 2011, Ventura et al., 2008, van Rooij
et al., 2007, Zhao et al., 2007, Rodriguez et al., 2007, Thai et al., 2007, Boldin et
al., 2011). Although deletion of individual miRNAs or miRNA families in mice
can lead to specific developmental abnormalities, the mice are often viable and
show relatively normal phenotypes. This suggests that these individual miRNAs
do not function as master regulators of development, but function to fine-tune
and therefore ensure canalisation during developmental transitions.
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6.3 miRNAs can be functionally associated with
individual developmental transitions
Results from the third chapter of this thesis show that miRNAs are differentially
expressed in a cell-based model of a developmental transition. Some of the differ-
entially expressed miRNAs were expressed at higher levels in undifferentiated ES
cells, and others were expressed at higher levels in cells that had been induced
to differentiate down the trophectoderm lineage. It is possible that differentially
expressed miRNAs could be functioning as master regulators of the ES cell: tro-
phectoderm transition, or to ensure canalisation during this process. Analysis
of predicted targets for miR-92a and Sfmbt2 miRNAs did not show interactions
between these differentially expressed miRNAs and key regulators of the ES cell:
trophoblast transition such as Oct4 and Cdx2. Based on target predictions, this
suggests that these differentially expressed miRNAs may have roles in ‘finessing’
the ES: trophoblast transition, rather than directly regulating it. Furthermore,
evidence from in vivo studies does not support miRNAs as master regulators ini-
tiating trophectoderm specification. It has been reported that mice deficient for
the miRNA processing enzymes DICER or DGCR8 arrest around E7.5 (Bernstein
et al., 2003, Wang et al., 2007), and although Dicer -/- embryos appear abnormal
at this stage, embryonic and abembryonic regions are recognisable, suggesting
that some level of trophectoderm differentiation has occurred (Bernstein et al.,
2003). Further, an analysis of Dgcr8 -/- blastocyst stage embryos reported that
they were morphologically normal, with similar numbers of cells and similar dis-
tributions of OCT4-positive ICM cells and CDX2-positive trophectoderm cells
(Suh et al., 2010). In contrast to some other analyses, this observation was made
on embryos deficient for maternal and zygotic DGCR8, which means the embryos
will exhibit a complete miRNA deficiency (Suh et al., 2010). The Suh et al. study
shows that loss of the general miRNA population does not result in loss of the
trophectoderm lineage, which suggests that this transition is not dependent on
the presence of miRNAs.
miR-92a showed higher expression in undifferentiated cells relative to differen-
tiated cells, and was functionally associated with regulating the proliferation of
ES cells. Inhibition of miR-92a expression resulted in a reduction in ES cell
numbers and, along with data from other laboratories, suggested that miR-92a
is involved in cell cycle regulation in ES cells. In contrast, suppression of miR-
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92a expression had no effect on the expression of pluripotency marker genes or
genes associated with trophectoderm differentiation showing that this miRNA
is not critical for trophectoderm differentiation. It is believed that expression
of miR-92a may be downregulated during ES cell differentiation to facilitate the
transition between the different proliferation rates of ES cells and trophectoderm,
a conclusion consistent with miR-92a functioning to ensure canalisation during
this developmental transition. Suppression of miR-92a expression had no effect
on 3T3 cell numbers, suggesting that it regulates the cell cycle of ES cells, but not
all cell types. This may be explained by the fact that ES cells have an unusual
cell cycle, which lacks the G1 phase (Savatier et al., 1994), and illustrates that
some miRNA functions are cell-type specific.
6.4 Intronic miRNAs may show cooperative or
antagonistic functions to those of their host
gene
Several of the miRNAs that were expressed at higher levels in differentiated cells
were encoded in a miRNA cluster within intron 10 of the Sfmbt2 gene. Sfmbt2
is interesting in the context of early development because it shows continued ex-
pression in the extraembryonic ectoderm of E5.5-E8.0 mouse embryos, which is
derived from the trophectoderm and contains the trophoblast stem cell popula-
tion (Frankenberg et al., 2008). Furthermore, Sfmbt2 is expressed from only the
paternal allele in extraembryonic lineages, but expression is biallelic in embry-
onic lineages, which means that Sfmbt2 is an imprinted gene and increases the
likelihood of roles for Sfmbt2, and its encoded miRNA cluster, in placental de-
velopment (Kuzmin et al., 2007). Several other differentially expressed miRNAs
were also encoded within introns of protein-coding genes, and most were found
to share similar expression profiles, a finding that is supported by previous re-
ports (Baskerville and Bartel, 2005, Lutter et al., 2010, Najafi-Shoushtari et al.,
2010). It is interesting to consider the possibility that intronic miRNAs may show
some functional cooperativity with their host genes. Indeed, it has been reported
that host genes show correlated expression patterns with encoded miRNA target
genes, which have synergistic or antagonistic functions to that of the host gene
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(Lutter et al., 2010). For example, the sterol regulatory element–binding pro-
teins (SREBPs) are key transcription regulators of genes involved in cholesterol
biosynthesis and uptake, and the miRNA, miR-33, is encoded within an intron of
SREBP. Investigation of the function of miR-33 revealed that it directly targets
adenosine triphosphate – binding cassette A1 (ABCA1), which is a key choles-
terol transporter and controls intracellular cholesterol efflux. The authors propose
that through targeting ABCA1, miR-33 functionally cooperates with SREBP to
control intracellular cholesterol levels (Najafi-Shoushtari et al., 2010). In this
sense, intronic miRNAs may be functioning to ensure robustness of events as-
sociated with host gene function, although functional cooperativity of host gene
and encoded miRNA is not incompatible with the idea of miRNAs functioning
as master regulators. As well as functional cooperativity, there are also exam-
ples of miRNAs that appear to exert antagonistic functions to that of their host
gene. C-MYC is a transcription factor that regulates cell proliferation, growth
and apoptosis, and directly regulates expression of the transcription factor E2F1,
which promotes cell proliferation. It also directly regulates expression of the
miR-17-92 cluster of miRNAs, and it has been reported that two of the miRNA
encoded within this cluster, miR-17 and miR-20a, directly regulate expression
of E2F1 (O’Donnell et al., 2005). This reveals a mechanism whereby C-MYC
directly activates expression of E2F1, and indirectly limits its translation, which
is thought to allow tight control of this proliferative signal. This is an example
of miRNAs functioning to maintain expression of key factors within particular
limits, which supports a model of miRNAs functioning to ensure canalisation.
6.5 Related miRNAs may have different functions
Some miRNA belong to miRNA families that share the same seed sequence and,
because the seed sequence is thought to be the most important region for target
recognition, these miRNAs are often predicted to regulate the same targets (Lewis
et al., 2003). However, data presented here suggest that related miRNAs do not
always share the same function. Inhibition of miR-92a expression, but not the
expression of the related miRNAs, miR-25 and miR-363, resulted in a decrease
in ES cell numbers. These three miRNAs all have an identical seed sequence so
these data suggest that sequences outside of the seed region must be important
for miRNA function. Indeed, there is mounting evidence that ‘non-seed’ sites may
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mediate miRNA-directed regulation. Computer predictions that do not rely on
seed complementarity or 3’UTR bias have predicted functional binding sites for
miRNAs in the coding regions of the pluripotency factors Oct4, Sox2 and Nanog,
most of which do not show perfect seed region binding (Miranda et al., 2006, Tay
et al., 2008a). This illustrates that there is still much that we do not understand
about the criteria for a functional miRNA target site, and suggests the possibility
that miRNAs with identical seed regions may have different functions.
6.6 Do miRNAs function as master regulators during
the switch from self-renewal to differentiation?
The findings that the expression of key ES cell genes are similar in wt and
DGCR8-/- ES cells, but that ES cell marker genes are not downregulated during
EB differentiation, and expression of lineage markers is absent, reduced or de-
layed during differentiation, suggests that while miRNAs may not be required for
the maintenance of the ES cell state, they are required for both the efficient exit
of ES cells from self-renewal, and for proper ES cell differentiation.
Maintenance of the ES cell state, as assessed by expression of key ES cell genes and
activation of signalling pathways, appears to be largely independent of miRNA
regulation. In fact, expression of Nanog was elevated in miRNA-deficient ES
cells suggesting that these cells may be in a more naïve state that wt ES cells.
However, the observation that the proliferation rate of DGCR8-/- cells was slower
than that of wt ES cells may mean that, while the general miRNA population is
not required for maintenance of the ES cell state per se, miRNAs are involved in
fine-tuning of the ES cell state. Findings from other laboratories support these
conclusions (Murchison et al., 2005, Kanellopoulou et al., 2005, Wang et al., 2007,
Shekar et al., 2011).
The data presented here, together with reports from other laboratories, suggest
that miRNAs are required for exit of ES cells from self-renewal (Kanellopoulou
et al., 2005, Wang et al., 2007). This raises the possibility that miRNAs may
function as master regulators to control the switch between self-renewal and dif-
ferentiation of pluripotent cells in the early embryo. However, the gross pheno-
type of miRNA-deficient embryos does not support this. DGCR8-/- blastocysts
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are reported to show OCT4 expression in the ICM by IHC analysis, but not in
the trophectoderm, suggesting that pluripotency genes can be downregulated in
vivo (although given the limits of the sensitivity of the IHC method, it cannot
be concluded that OCT4 expression is completely absent in the trophectoderm
of DGCR8-/- embryos) (Suh et al., 2010). Similarly, at E6.5 Dicer-/- embryos do
not show aberrant expression of Oct4 compared to wt embryos, supporting the
conclusion that loss of miRNAs does not prevent silencing of self-renewal in vivo
(Spruce et al., 2010). A caveat with the data from Spruce et al. is that processed
miRNAs were found to be present in the Dicer-/- embryos, presumably due to the
presence of maternal Dicer. Nonetheless, in combination with the report from
Suh et al., these data suggest that self-renewal can be silenced in vivo in the
absence of miRNAs.
The discrepancy between in vitro and in vivo findings may arise from the strength
of the signal driving differentiation in these systems. It would be expected that
conditions for differentiation are optimal in vivo, and therefore miRNAs may func-
tion to fine-tune the switch between self-renewal and differentiation, rather than
directly control it. In vitro, however, the differentiation-inducing conditions may
not be strong enough to drive differentiation in the absence of additional ‘support’
from extra levels of genetic regulation such as miRNAs. Supporting this is the
observation that DGCR8-/- ES cells are capable of downregulating expression of
pluripotency marker genes when Oct4 expression was suppressed using siRNAs.
This shows that the DGCR8-/- ES cells are capable of silencing self-renewal, but
that it happens at a reduced frequency during non-stringent differentiation in the
absence of miRNAs. Rather than supporting the theory that miRNAs may func-
tion as master regulators during silencing of self-renewal, these findings suggest
that miRNAs act to ensure canalisation during the switch between self-renewal
and differentiation, and loss of this canalising activity is enough to disrupt the
silencing of self-renewal in non-directed differentiation protocols.
6.7 miRNAs are required for robust developmental
transitions
Interestingly, miRNA-deficient ES cells appeared to be able to initiate trophecto-
derm and neuroectoderm differentiation during stringent differentiation protocols,
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but showed impaired differentiation capacity during embryoid body differentia-
tion, with mesoderm and endoderm lineages appearing particularly compromised.
The observation that miRNA-deficient ES cells appear to initiate trophectoderm
and neuroectoderm differentiation may suggest that miRNAs are not required for
these developmental transitions. However, mice deficient for Ago2 have hyper-
trophic placentas with a marked reduction in the thickness of the labyrinthine
layer, and Dicer -/- embryos cannot maintain the TS cell compartment (Cheloufi
et al., 2010, Spruce et al., 2010). Additionally, Dicer ablation in the mouse neo-
cortex leads to defects in neural survival and differentiation (De Pietri Tonelli
et al., 2008). This suggests that although miRNA-deficient ES cells may be ca-
pable of initiating trophectoderm and neuroectoderm differentiation in stringent
differentiation conditions in vitro, it is doubtful that these cells are functionally
equivalent to cells generated from ES cells with miRNAs. Furthermore, it is un-
likely that miRNAs are functioning as master regulators during trophectoderm
or neuroectoderm specification. In this context, miRNAs may be functioning to
ensure canalisation during differentiation to ensure formation of fully functional
differentiated lineages.
miRNA-deficient ES cells showed particular defects in mesoderm and endoderm
formation during embryoid body differentiation, and never formed beating car-
diomyocytes or cystic structures. Perhaps then miRNAs directly control meso-
derm and endoderm formation? Indeed, in the absence of miRNAs, the key early
marker of mesoderm formation, brachyury, is undetectable in ES cells and shows
drastically impaired induction during embryoid body formation. Conflicting data
exist around the expression of brachyury in early Dicer-/- embryos: At E7.5 Bern-
stein et al. reported that, while wt embryos showed robust brachyury expression
denoting the primitive streak, Dicer-/- embryos did not express brachyury ; In con-
trast, Spruce et al. reported expression of brachyury in the primitive streak region
of Dicer-/- embryos as well as expression of Eomes and Nodal (Bernstein et al.,
2003, Spruce et al., 2010). As previously mentioned, a caveat of the Spruce et al.
data is the presence of mature miRNAs in early Dicer-/- embryos. Bernstein et al.
demonstrated that the mutant DICER protein produced in their Dicer-/- embryos
was incapable of processing siRNAs, but did not test expression of miRNAs in
the embryos themselves.
The data presented in this thesis are consistent with the findings of Bernstein
et al., and suggest that miRNAs are required for proper expression of brachyury.
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However, the conflicting report from Spruce et al. means that it cannot be con-
cluded that miRNAs are essential for initiation of the mesoderm lineage. miRNAs
are certainly required for aspects of proper mesoderm and endoderm formation
however. In human ES cells, loss of miR-302 function strongly inhibits mesoder-
mal and endodermal lineages, which may be mediated through miR-302 regula-
tion of the Nodal inhibitor Lefty, and in Xenopus embryos miR-427 is required
for proper mesoderm and endoderm specification (Rosa et al., 2009). While the
Rosa et al. study shows that miRNAs are important for mesoderm and endoderm
development, it does not show that miRNAs are required for mesoderm or endo-
derm specification per se. Taken together, it is still not clear whether the general
miRNA population is essential for mesoderm and endoderm lineage specification,
but it is thought that miRNAs are involved in proper mesoderm and endoderm
development in vivo and in vitro.
6.8 Concluding remarks
The discovery, a decade ago, that miRNAs functioned as post-transcriptional reg-
ulators of gene expression in numerous species, and were not an idiosyncrasy of
nematode development, led to their identification as critical regulators of proper
mammalian development. The data presented in this thesis furthers our under-
standing of the roles of specific miRNAs, as well as the general miRNA popula-
tion, in regulating developmental transitions. Rather than functioning as master
regulators, these data support a model in which miRNAs primarily act to ensure
canalisation during development.
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Oct4 Yes 10,000 fold (Ct 22-35.5) 0.994 99.9
Sox2 Yes 100,000 fold (Ct 16-32) 0.995 103.9
Nanog Yes 100, 000 fold (Ct 16-33) 0.995 96.5
Esrrß Yes 10,000 fold (Ct 22-36) 0.992 100.1
Cdx2 Yes 100,000 fold (Ct 22-38) 0.968 98.5
Eomes Yes 10,000 fold (Ct 23.5-36) 0.928 106.8
Hand1 Yes 10,000 fold (Ct 22-35.5) 0.988 103.2
Mash2 Yes 1000 fold (Ct 24-34.5) 0.996 98.8
Id2 Yes 1000 fold (Ct 23-33.5) 0.999 94.7
Sfmbt2 Yes 100,000 fold (Ct 20-36) 0.998 101.1
Gata4 Yes 1000 fold (Ct 26.5 - 36.5) 0.993 101.3
Gata6 Yes 1000 fold (Ct 26-35.5) 0.982 103.6
Fgf5 Yes 1000 fold (Ct 26-36) 0.985 98.4
Brachyury Yes 1000 fold (Ct 27.5-37) 0.970 101.6
Snail Yes 1000 fold (Ct 26-36) 0.992 97.8
Goosecoid Yes 100 fold (Ct 29-36) 0.971 95.4
Nestin Yes 1000 fold (Ct 25-34.5) 0.990 99.7
Odz4 Yes 1000 fold (Ct 27-37) 0.991 96.5
Nfyc Yes 100,000 (Ct 21-38) 0.997 96.8
C77370 Yes 1000 fold (Ct 27-37) 0.995 102.3
Trim33 Yes 10,000 fold (Ct 23.5-36.5) 0.990 103.1
Dnmt3a Yes 100 fold (Ct 23-30) 0.989 94.6
Mylip Yes 1,000 fold (Ct 26-35.5) 0.996 105.6
Actß Yes 100,000 fold (Ct 16-33) 0.999 101.1
Dgcr8 Yes 10,000 fold (Ct 25-38) 0.978 104.8
A2





































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Appendix C - Optimisation of MTT
and Cyquant assays
C1
Optimisation of cell proliferation assays The MTT and Cyquant assays were tested to confirm
that they gave a linear absorbance output from increasing numbers of ES cells and 3T3 cells in
the conditions used (Figure a, b, c & d). Between 0 and 32,000 ZHBTc4 ES cells or 3T3 cells
were plated per well of 96-well plates. Following ~24 hours of cell growth cultures were subjected
to a 1, 2 or 4 hour incubation with MTT reagent. Analysis of MTT assay results showed that a
1 hour MTT incubation gave a linear absorbance output for between 2000 and 32,000 ZHBTc4
ES cells and a 2 hour MTT incubation gave a linear absorbance output for between 2000 and
32,000 3T3 cells. Scatter plots of these data are shown in Figure a and b. Scatter plots of other
incubation times are not shown. In order to optimise the Cyquant assay between 0 and 32,000
ZHBTc4 ES cells or 3T3 cells were plated per well of 96-well plates. Following ~24 hours of
cell growth cultures were subjected to incubation with Cyquant reagent. Analysis of Cyquant
assay results showed that assays were linear between 1000 and 16,000 ZHBTc4 ES cells, and
1000 and 16,000 3T3 cells. In both cases the assay was not linear at 32,000 plated cells. The
32,000 plated cells point has not been included in the ZHBTc4 or the 3T3 optimisation graphs.
Scatter plots of these data are shown in Figure c and d.
The MTT assay was used to assess the effects of different transfection reagents on cell viability.
ES cells were plated and grown in the presence of different concentrations of Lipofectamine
2000, Lipofectamine LTX, Fugene HD or Interferin transfection reagents before being assayed
for cell proliferation by MTT assay (Figure e). As shown in Figure e, addition of Lipofectamine
LTX, Fugene HD and Interferin at the concentrations used had no effect on cell numbers. In
contrast, addition of all concentrations of Lipofectamine 2000 caused a reduction in MTT assay
absorbance. The reduction in absorbance was greater for higher concentrations of Lipofectamine
2000 suggesting the effect is concentration dependent. This result suggests that Lipofectamine
2000 is toxic to ES cells. In light of these results, Lipofectamine 2000 was replaced with
Lipofectamine LTX as the transfection reagent for future experiments.
LNAs complementary to a range of different miRNAs were transfected into ES cells in order
to select an appropriate LNA for use as a control for proliferation experiments (Figure f). The
LNAs were transfected at a concentration of 225nM, which was deliberately high in order to
correspond to the total concentration of LNA present if multiple LNAs were transfected into a
single culture. As expected, transfection of any LNA caused a slight decrease in cell numbers
relative to transfection reagent alone. Of the 9 LNAs tested, only 3 LNAs designed to target
chicken miRNAs had a significant effect on cell numbers. Of the remainder, an LNA designed
to inhibit expression of mmu-miR-155 was chosen for use as a control because in addition to
it having little effect on cell numbers, this miRNA was not sequenced in the miRNA profiling
experiment and was not detected in mouse ES cells by miRNA northern analysis (data not
shown).
C2
Optimisation of MTT and Cyquant Assays. The linear range of the MTT and Cyquant assays
was determined for ZHBTc4 ES cells (a & c) and 3T3 cells (b & d). Various numbers of cells
were plated/well of 96-well plates and grown for 24 hours then MTT (a & b) or CYQUANT
(c & d) analysis was carried out. Scatter charts show mean absorbance of 12 replicate wells of
cells plotted against number of cells/well. Error bars show SD. (e) 1500 ZHBTc4 ES cells were
plated/well of a 96-well plate. After 24 hours of growth cells were incubated O/N with various
volumes of different transfection reagents (0.1=0.1ml/well, 0.5=0.5ml/well, 1.0=1.0ml/well) be-
fore MTT analysis. Bar chart shows mean absorbance of 8 replicate wells of cells. Error bars
show SD. (f) 1000 ZHBTc4 ES cells were plated/well of a 96-well plate and grown for 24 hours.
Cells were transfected O/N with 225nM of different LNA oligonucleotides before MTT analysis.
Bar chart shows mean absorbance of 8 replicate wells. Error bars show SD.
C3
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